id,pmid,year,seq,MAP,name,cter,nter,lyn_cyc,ldmix,non_nat,len,nature,activity,source,origin,exp_str,non_hem,dssp,smiles
1724,17067722,2006,MKLGLLVVLAVAVLVPSLSEGQNVPSCQLKDPNQTPVEAGNMRNKREADDSSEESDLAEI,MKLGLLVVLAVAVLVPSLSEGQNVPSCQLKDPNQTPVEAGNMRNKREADDSSEESDLAEI,Pp B,Free,Free,Linear,L,None,60,Antibacterial,3.2 HU/mg,Horse,Grammistins (Pogonoperca punctata),NA,NA,CCSSCCBTHHHHTTSCCCCCCSSSSTTCCCSSCCCGGGTCCCCCCSSSCCCCCCCCCCBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
1725,17067722,2006,IGGIISFFKRLF,IGGIISFFKRLF,Gs B,Free,Free,Linear,L,None,12,Antibacterial,<10 HU/mg,Horse,Grammistins (Pogonoperca punctata),NA,NA,CCCSSSTTTTTC,CC[C@H](C)[C@H](N)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
1726,17067722,2006,MKLGLLVVLAVAVLVPSLSEQDFPSCQLKEPNQTPVEAGNMRNKREADESSEEFDLAEM,MKLGLLVVLAVAVLVPSLSEQDFPSCQLKEPNQTPVEAGNMRNKREADESSEEFDLAEM,Pp l,Free,Free,Linear,L,None,60,Antibacterial,79 HU/mg,Horse,Grammistins (Pogonoperca punctata),NA,NA,NA,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)O
1727,17067722,2006,VKRALSALKPKNKRFIGGIISFFKRLFG,VKRALSALKPKNKRFIGGIISFFKRLFG,Pp 2b,Free,Free,Linear,L,None,28,Antibacterial,63 HU/mg,Horse,Grammistins (Pogonoperca punctata),NA,NA,CTTTTSSCCCSSCCCCCTHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O)[C@@H](C)CC
2084,22484288,2012,FLFSLIPHAIGGLISAFK,FLFSLIPHAIGGLISAFK,AamAP1,Free,Free,Linear,L,None,18,Antimicrobial,0% Hemolysis at 10 µM,Horse,"AamAP1 from the venom of the North African scorpion, Androctonus amoreuxi",NA,NA,CCCSSSCSSCBTTBCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
2085,22484288,2012,FLFSLIPHAIGGLISAFK,FLFSLIPHAIGGLISAFK,AamAP1,Free,Free,Linear,L,None,18,Antimicrobial,100% Hemolysis at 100 µM,Horse,"AamAP1 from the venom of the North African scorpion, Androctonus amoreuxi",NA,NA,CCCSSSCSSCBTTBCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
2086,22484288,2012,FPFSLIPHAIGGLISAIK,FPFSLIPHAIGGLISAIK,AamAP2,Free,Free,Linear,L,None,18,Antimicrobial,19% Hemolysis at 10 µM,Horse,"AamAP2 from the venom of the North African scorpion, Androctonus amoreuxi",NA,NA,CCSSSCCSSCBTTBCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2087,22484288,2012,FPFSLIPHAIGGLISAIK,FPFSLIPHAIGGLISAIK,AamAP2,Free,Free,Linear,L,None,18,Antimicrobial,75% Hemolysis at 100 µM,Horse,"AamAP2 from the venom of the North African scorpion, Androctonus amoreuxi",NA,NA,CCSSSCCSSCBTTBCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
2088,22484288,2012,FLFSLIPKAIGGLISAFK,FLFSLIPKAIGGLISAFK,AamAP-S1,Free,Free,Linear,L,None,18,Antimicrobial,17.8% Hemolysis at 10 µM,Horse,AamAP1 analog (Androctonus amoreuxi),NA,NA,CCCCSSGGGGCSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
2089,22484288,2012,FLFSLIPKAIGGLISAFK,FLFSLIPKAIGGLISAFK,AamAP-S1,Free,Free,Linear,L,None,18,Antimicrobial,53% Hemolysis at 100 µM,Horse,AamAP1 analog (Androctonus amoreuxi),NA,NA,CCCCSSGGGGCSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
2111,11279030,2001,WLGSALKIGAKLLPSVVGLFKKKKQ,WLGSALKIGAKLLPSVVGLFKKKKQ,Ponericin-W1,Free,Free,Linear,L,None,25,Antimicrobial and Insecticidal,zone of inhibition (2 mm) at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CCCCTHHHHTTHHHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
2113,11279030,2001,GIWGTLAKIGIKAVPRVISMLKKKKQ,GIWGTLAKIGIKAVPRVISMLKKKKQ,Ponericin-W3,Free,Free,Linear,L,None,26,Antimicrobial and Insecticidal,zone of inhibition (1 mm) at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CCCGGGHHHHTSCCHHHHHHHTSCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
2115,11279030,2001,GIWGTALKWGVKLLPKLVGMAQTKKQ,GIWGTALKWGVKLLPKLVGMAQTKKQ,Ponericin-W4,Free,Free,Linear,L,None,26,Antimicrobial and Insecticidal,zone of inhibition (2 mm) at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CTTSCSSGGGGGTHIIIIISSCCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O
2117,11279030,2001,FWGALIKGAAKLIPSVVGLFKKKQ,FWGALIKGAAKLIPSVVGLFKKKQ,Ponericin-W5,Free,Free,Linear,L,None,24,Antimicrobial and Insecticidal,zone of inhibition (4 mm) at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CGGGTTTTTSTTCGGGTSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC
2119,11279030,2001,FIGTALGIASAIPAIVKLFK,FIGTALGIASAIPAIVKLFK{ct:Amid},Ponericin-W6,Amidation,Free,Linear,L,None,20,Antimicrobial and Insecticidal,zone of inhibition (3 mm) at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CCCCSEETTEEHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
2121,11279030,2001,GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ,GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ,Ponericin-G1,Free,Free,Linear,L,None,30,Antimicrobial and Insecticidal,zone of inhibition not detected at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CCTTHHHHSSSCCCSSCTTTTTTTGGGTCC,CSCC[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)O
2123,11279030,2001,GWKDWLNKGKEWLKKKGPGIMKAALKAATQ,GWKDWLNKGKEWLKKKGPGIMKAALKAATQ,Ponericin-G3,Free,Free,Linear,L,None,30,Antimicrobial and Insecticidal,zone of inhibition not detected at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CCTTIIIIIHHHHHTSSCCTHHHHTTSTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O
2125,11279030,2001,DFKDWMKTAGEWLKKKGPGILKAAMAAAT,DFKDWMKTAGEWLKKKGPGILKAAMAAAT,Ponericin-G4,Free,Free,Linear,L,None,29,Antimicrobial and Insecticidal,zone of inhibition not detected at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CTTTGGGTHHHHTTTTSSCSTHHHHTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O
2127,11279030,2001,GLVDVLGKVGGLIKKLLP,GLVDVLGKVGGLIKKLLP{ct:Amid},Ponericin-G6,Amidation,Free,Linear,L,None,18,Antimicrobial and Insecticidal,zone of inhibition not detected at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CCCCCCGGGSTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O
2129,11279030,2001,LLKELWTKIKGAGKAVLGKIKGLL,LLKELWTKIKGAGKAVLGKIKGLL{ct:Amid},Ponericin-L2,Amidation,Free,Linear,L,None,24,Antimicrobial and Insecticidal,zone of inhibition not detected at 0.4-0.5mM,Horse,Synthetic peptide (Pachycondyla goeldii venom),NA,NA,CHHHHHHHTTTTTSHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
2539,10669014,1999,LFGFLIKLIPSLFGALSNIGRNRNQ,LFGFLIKLIPSLFGALSNIGRNRNQ,Gs1,Free,Free,Linear,L,None,25,Hemolytic and Ichthyotoxic,LC50 = 1.9 µM,Horse,Grammistins peptide (Grammistes sexlineatus),NA,NA,CCCSCTTTHHHHHHHHHTTSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
2540,10669014,1999,LFGFLIPLLPHIIGAIPQVIGAIR,LFGFLIPLLPHIIGAIPQVIGAIR,Gs2,Free,Free,Linear,L,None,24,Hemolytic and Ichthyotoxic,LC50 = 0.19 µM,Horse,Grammistins peptide (Grammistes sexlineatus),NA,NA,CCSSSGGGCSSTTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3315,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,Formylation,26,Cytolytic,73% Hemolysis at 25μg,Horse,δ-toxin (Staphylococcus aurezis),NA,NA,CTTGGGTHHHHHHHTTTTTSCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3316,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,Formylation,26,Cytolytic,85% Hemolysis at 75μg,Horse,δ-toxin (Staphylococcus aurezis),NA,NA,CTTGGGTHHHHHHHTTTTTSCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3325,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,Formylation,26,Cytolytic,34% Hemolysis at 25μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CTTGGGTHHHHHHHTTTTTSCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3326,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,Formylation,26,Cytolytic,43% Hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CTTGGGTHHHHHHHTTTTTSCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3333,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK,Peptide-C,Free,Free,Linear,L,None,26,Cytolytic,50% Hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CTTGGGTHHHHHHHTTTTTSCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3340,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,0% Hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CCSSSIIIIIHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3341,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,20% Hemolysis at 250μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CCSSSIIIIIHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3342,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,19% Hemolysis at 500μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CCSSSIIIIIHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC
3351,2474443,1989,MAQDIISTIGD,MAQDIISTIGD{nt:Formylation},Peptide-E,Free,Formylation,Linear,L,Formylation,11,Cytolytic,0% Hemolysis at 1000μg (non hemolytic),Horse,δ-toxin derivative (Synthetic peptide),NA,Non-hemolytic,CCHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
3356,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation},Peptide-F,Free,Formylation,Linear,L,Formylation,26,Cytolytic,12% Hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CTTTHHHHTTTHHHHHHHTTGGGGTC,CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O
3361,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK,Peptide-G,Free,Free,Linear,L,None,26,Cytolytic,31% Hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CTTTHHHHTTTHHHHHHHTTGGGGTC,CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O
3366,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc},Peptide-H,Free,Fmoc,Linear,L,None,26,Cytolytic,25% Hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CTTTHHHHHHHHHHHHHHHHHHHTTC,CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
3370,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK,Peptide-I,Free,Free,Linear,L,None,26,Cytolytic,11% Hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA,CTTTHHHHHHHHHHHHHHHHHHHTTC,CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
3484,19427345,2009,FLGAIAAALPHVINAVTNAL,FLGAIAAALPHVINAVTNAL{ct:Amid},Kassinatuerin-2Ma,Amidation,Free,Linear,L,None,20,Antimicrobial,45-50% Hemolysis at 120 µM,Horse,Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata),NA,NA,CCTTHHHHSSSTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C
3485,19427345,2009,FFGAIAAALPHVISAIKNAL,FFGAIAAALPHVISAIKNAL{ct:Amid},Kassinatuerin-2Mb,Amidation,Free,Linear,L,None,20,Antimicrobial,45-50% Hemolysis at 120 µM,Horse,Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata),NA,NA,CCCTHHHHSSSTTHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
3486,19427345,2009,FVGAIAAALPHVISAIKNAL,FVGAIAAALPHVISAIKNAL{ct:Amid},Kassinatuerin-2Mc,Amidation,Free,Linear,L,None,20,Antimicrobial,45-50% Hemolysis at 120 µM,Horse,Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata),NA,NA,CCSTHHHHSSSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C
3487,19427345,2009,IIGAIAAALPHVINAIKNTF,IIGAIAAALPHVINAIKNTF{ct:Amid},Kassinatuerin-2Md,Amidation,Free,Linear,L,None,20,Antimicrobial,45-50% Hemolysis at 120 µM,Horse,Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata),NA,NA,CTTTHHHHSSSHHHHTTCC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC
3488,19427345,2009,FIQYLAPLIPHAVKAISDLI,FIQYLAPLIPHAVKAISDLI{ct:Amid},Kassinatuerin-2S,Amidation,Free,Linear,L,None,20,Antimicrobial,45-50% Hemolysis at 120 µM,Horse,Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata),NA,NA,CCTTCTTTSSCGGGGSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)O
3489,19427345,2009,GFMKYIGPLIPHAVKAISDLI,GFMKYIGPLIPHAVKAISDLI{ct:Amid},Kassinatuerin-1S,Amidation,Free,Linear,L,None,21,Antimicrobial,45-50% Hemolysis at 120 µM,Horse,Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata),NA,NA,CCCCCCSSSSSSGGGTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)O
3714,23415652,2013,LLGMIPLAISAISALSKL,LLGMIPLAISAISALSKL,Medusin-AC,Free,Free,Linear,L,None,18,Antimicrobial,8.7% Hemolysis at 32mg/ml,Horse,Medusin (Phyllomedusine frogs),NA,NA,CCSSCHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
3715,23415652,2013,LLGMIPVAISAISALSKL,LLGMIPVAISAISALSKL,Medusin-PH,Free,Free,Linear,L,None,18,Antimicrobial,1.9% Hemolysis at 128mg/ml,Horse,Medusin (Phyllomedusine frogs),NA,NA,CCTTSTTHHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
3716,23415652,2013,LLGMIPLAISAISSLSKL,LLGMIPLAISAISSLSKL,Medusin-PD,Free,Free,Linear,L,None,18,Antimicrobial,6.9% Hemolysis at 64mg/ml,Horse,Medusin (Phyllomedusine frogs),NA,NA,CCSSCGGGGHHHHSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
3780,21396976,2011,SFPFFPPGICKRLKRC,SFPFFPPGICKRLKRC,Limnonectin-1Fa,Free,Free,Linear,L,None,16,Antimicrobial,0% Hemolysis upto 160 µM (Non hemolytic),Horse,Limnonectin (Limnonectes fujianensis),NA,Non-hemolytic,CCCCCCHHHHTTCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O
3781,21396976,2011,SFHVFPPWMCKSLKKC,SFHVFPPWMCKSLKKC,Limnonectin-1Fb,Free,Free,Linear,L,None,16,Antimicrobial,0% Hemolysis upto 160 µM (Non hemolytic),Horse,Limnonectin (Limnonectes fujianensis),NA,Non-hemolytic,CCSCCSGGGGTCCCC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
4127,11279030,2001,WLGSALKIGAKLLPSVVGLFKKKKQ,WLGSALKIGAKLLPSVVGLFKKKKQ,W1,Free,Free,Linear,L,None,25,"Antimicrobial, Insecticidal",Zone of inhibition 2mm at 0.4-0.5mM,Horse,Ponericin,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
4129,11279030,2001,WLGSALKIGAKLLPSVVGLFQKKKK,WLGSALKIGAKLLPSVVGLFQKKKK,W2,Free,Free,Linear,L,None,25,"Antimicrobial, Insecticidal",Zone of inhibition 1mm at 0.4-0.5mM,Horse,Ponericin,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
4130,11279030,2001,GIWGTALKWGVKLLPKLVGMAQTKKQ,GIWGTALKWGVKLLPKLVGMAQTKKQ,W4,Free,Free,Linear,L,None,26,"Antimicrobial, Insecticidal",Zone of inhibition 2mm at 0.4-0.5mM,Horse,Ponericin,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O
4131,11279030,2001,FWGALIKGAAKLIPSVVGLFKKKQ,FWGALIKGAAKLIPSVVGLFKKKQ,W5,Free,Free,Linear,L,None,24,"Antimicrobial, Insecticidal",Zone of inhibition 4mm at 0.4-0.5mM,Horse,Ponericin,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC
4133,11279030,2001,FIGTALGIASAIPAIVKLFK,FIGTALGIASAIPAIVKLFK{ct:Amid},W6,Amidation,Free,Linear,L,None,20,"Antimicrobial, Insecticidal",Zone of inhibition 3mm at 0.4-0.5mM,Horse,Ponericin,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
4547,23770440,2013,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,Antimicrobial,0 % Hemolysis at 5 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,Non-hemolytic,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4548,23770440,2013,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,Antimicrobial,0 % Hemolysis at 10 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,Non-hemolytic,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4549,23770440,2013,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,Antimicrobial,0 % Hemolysis at 20 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,Non-hemolytic,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4550,23770440,2013,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,Antimicrobial,0 % Hemolysis at 40 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,Non-hemolytic,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4551,23770440,2013,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,Antimicrobial,<10 % Hemolysis at 80 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4552,23770440,2013,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,Antimicrobial,<10 % Hemolysis at 120 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4553,23770440,2013,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,Antimicrobial,4 % Hemolysis at 160 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4554,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,0 % Hemolysis at 2.5 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,Non-hemolytic,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4555,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,0 % Hemolysis at 5 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,Non-hemolytic,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4556,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,0 % Hemolysis at 10 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,Non-hemolytic,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4557,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,0 % Hemolysis at 15 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,Non-hemolytic,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4558,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,18 % Hemolysis at 20 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4559,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,~90 % Hemolysis at 40 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4560,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 80 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4561,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 120 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4562,23770440,2013,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 160 µM,Horse,"Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4563,23770440,2013,FLSLIPKLVKKIIKAFK,FLSLIPKLVKKIIKAFK{ct:Amid},TsAP-S1,Amidation,Free,Linear,L,None,17,Antimicrobial,30 % Hemolysis at 5 µM,Horse,"Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4564,23770440,2013,FLSLIPKLVKKIIKAFK,FLSLIPKLVKKIIKAFK{ct:Amid},TsAP-S1,Amidation,Free,Linear,L,None,17,Antimicrobial,<90 % Hemolysis at 10 µM,Horse,"Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4565,23770440,2013,FLSLIPKLVKKIIKAFK,FLSLIPKLVKKIIKAFK{ct:Amid},TsAP-S1,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 20 µM,Horse,"Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4566,23770440,2013,FLSLIPKLVKKIIKAFK,FLSLIPKLVKKIIKAFK{ct:Amid},TsAP-S1,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 40 µM,Horse,"Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4567,23770440,2013,FLSLIPKLVKKIIKAFK,FLSLIPKLVKKIIKAFK{ct:Amid},TsAP-S1,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 80 µM,Horse,"Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4568,23770440,2013,FLSLIPKLVKKIIKAFK,FLSLIPKLVKKIIKAFK{ct:Amid},TsAP-S1,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 120 µM,Horse,"Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4569,23770440,2013,FLSLIPKLVKKIIKAFK,FLSLIPKLVKKIIKAFK{ct:Amid},TsAP-S1,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 160 µM,Horse,"Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CTTTHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
4570,23770440,2013,FLGMIPKLIKKLIKAFK,FLGMIPKLIKKLIKAFK{ct:Amid},TsAP-S2,Amidation,Free,Linear,L,None,17,Antimicrobial,30 % Hemolysis at 5 µM,Horse,"Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCCCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4571,23770440,2013,FLGMIPKLIKKLIKAFK,FLGMIPKLIKKLIKAFK{ct:Amid},TsAP-S2,Amidation,Free,Linear,L,None,17,Antimicrobial,80 % Hemolysis at 10 µM,Horse,"Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCCCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4572,23770440,2013,FLGMIPKLIKKLIKAFK,FLGMIPKLIKKLIKAFK{ct:Amid},TsAP-S2,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 20 µM,Horse,"Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCCCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4573,23770440,2013,FLGMIPKLIKKLIKAFK,FLGMIPKLIKKLIKAFK{ct:Amid},TsAP-S2,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 40 µM,Horse,"Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCCCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4574,23770440,2013,FLGMIPKLIKKLIKAFK,FLGMIPKLIKKLIKAFK{ct:Amid},TsAP-S2,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 80 µM,Horse,"Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCCCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4575,23770440,2013,FLGMIPKLIKKLIKAFK,FLGMIPKLIKKLIKAFK{ct:Amid},TsAP-S2,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 120 µM,Horse,"Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCCCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4576,23770440,2013,FLGMIPKLIKKLIKAFK,FLGMIPKLIKKLIKAFK{ct:Amid},TsAP-S2,Amidation,Free,Linear,L,None,17,Antimicrobial,100 % Hemolysis at 160 µM,Horse,"Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus",α-Helix,NA,CCCCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
4802,25003126,2014,GIGGALLNVGKVALKGLAKGLAEHFAN,GIGGALLNVGKVALKGLAKGLAEHFAN{ct:Amid},Bombinin,Amidation,Free,Linear,L,None,24,Antimicrobial,100 % Hemolysis at 64 mg/L,Horse,European Yellow-Bellied Toad (Bombina Variegata),α-Helix,NA,CCCHHHHHHHTTHHHHHHHHHHCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C
4803,25003126,2014,FLGLLGGLL,FLGLLGGLL{ct:Amid},Feleucin-BV1,Amidation,Free,Linear,L,None,9,Antimicrobial,100 % Hemolysis at >512 mg/L,Horse,Skin Secretion-Derived (Bombina Variegata),α-Helix,NA,CGGGGGSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
4804,25003126,2014,FLGLIGSLL,FLGLIGSLL{ct:Amid},Feleucin-BV2,Amidation,Free,Linear,L,None,9,Antimicrobial,100 % Hemolysis at >512 mg/L,Horse,Skin Secretion-Derived(Bombina Variegata),α-Helix,NA,CCCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
4805,25054164,2014,LRPAILVRIK,LRPAILVRIK{ct:Amid},balteatide,Amidation,Free,Linear,L,None,10,Antimicrobial,<8 % Hemolysis at 512 mg/L,Horse,"Purple-Sided Leaf Frog, Phyllomedusa Baltea",NA,Low hemolytic,CCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
4806,25054164,2014,LRPAILVRTK,LRPAILVRTK{ct:Amid},sauvatide,Amidation,Free,Linear,L,None,10,myotropic agent on rat,<8 % Hemolysis at 512 mg/L,Horse,Phyllomedusa Sauvagei Skin Secretion,NA,Low hemolytic,CCCCCTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C
4879,24378871,2014,GVLSAFKNALPGIMKIIV,GVLSAFKNALPGIMKIIV{ct:Amid},hylaranin-L1,Amidation,Free,Linear,L,None,18,Antimicrobial,3 % Hemolysis at 8 mg/L,Horse,Hylarana Latouchii,α-Helix,NA,CCHHHHGGGSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
4880,24378871,2014,GVLSAFKNALPGIMKIIV,GVLSAFKNALPGIMKIIV{ct:Amid},hylaranin-L1,Amidation,Free,Linear,L,None,18,Antimicrobial,4.2 % Hemolysis at 16 mg/L,Horse,Hylarana Latouchii,α-Helix,NA,CCHHHHGGGSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
4881,24378871,2014,GVLSAFKNALPGIMKIIV,GVLSAFKNALPGIMKIIV{ct:Amid},hylaranin-L1,Amidation,Free,Linear,L,None,18,Antimicrobial,22.9 % Hemolysis at 64 mg/L,Horse,Hylarana Latouchii,α-Helix,NA,CCHHHHGGGSHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
4882,24378871,2014,GVLSVIKNALPGIMRFIA,GVLSVIKNALPGIMRFIA{ct:Amid},hylaranin-L2,Amidation,Free,Linear,L,None,18,Antimicrobial,5.8 % Hemolysis at 8 mg/L,Horse,Hylarana Latouchii,α-Helix,NA,CTHHHHTTTSHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC
4883,24378871,2014,GVLSVIKNALPGIMRFIA,GVLSVIKNALPGIMRFIA{ct:Amid},hylaranin-L2,Amidation,Free,Linear,L,None,18,Antimicrobial,58.6 % Hemolysis at 16 mg/L,Horse,Hylarana Latouchii,α-Helix,NA,CTHHHHTTTSHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC
5048,25332684,2014,FLFSLIPHAISGLISAFK,FLFSLIPHAISGLISAFK{ct:Amid},AcrAP1,Amidation,Free,Linear,L,None,18,Antimicrobial,100 % Hemolysis at 64 µM,Horse,"Venom Of The Arabian Scorpion, Androctonus Crassicauda",α-Helix/Random coil,NA,CCTTTSSCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
5049,25332684,2014,FLFSLIPNAISGLLSAFK,FLFSLIPNAISGLLSAFK{ct:Amid},AcrAP2,Amidation,Free,Linear,L,None,18,Antimicrobial,100 % Hemolysis at 64 µM,Horse,"Venom Of The Arabian Scorpion, Androctonus Crassicauda",α-Helix/Random coil,NA,CCSSCCHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
5050,25332684,2014,FLFKLIPKAIKGLIKAFK,FLFKLIPKAIKGLIKAFK{ct:Amid},AcrAP1a,Amidation,Free,Linear,L,None,18,Antimicrobial,100 % Hemolysis at 32 µM,Horse,"Analogue Of Acrap1, Venom Of The Arabian Scorpion, Androctonus Crassicauda",α-Helix/Random coil,NA,CCTTTCGGGHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
5051,25332684,2014,FLFKLIPKAIKGLLKAFK,FLFKLIPKAIKGLLKAFK{ct:Amid},AcrAP2a,Amidation,Free,Linear,L,None,18,Antimicrobial,100 % Hemolysis at 32 µM,Horse,"Analogue Of Acrap2, Venom Of The Arabian Scorpion, Androctonus Crassicauda",α-Helix/Random coil,NA,CCTTTCGGGHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
5305,25056849,2015,FLGLLGSLL,FLGLLGSLL{ct:Amid},Feleucin-BO1,Amidation,Free,Linear,L,None,9,Antibaterial,100 % Hemolysis at 80 µM,Horse,"Synthetic,Skin Secretion Of Bombina Orientalis",Random coil,NA,CCCTTTCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
5306,25056849,2015,FLKLLKKLL,FLKLLKKLL{ct:Amid},Feleucin-K3,Amidation,Free,Linear,L,None,9,"Antibaterial, Antifungal",100 % Hemolysis at >250 µM,Horse,"Analogue Of Fpa-Bombinin-Bo, Skin Secretion Of Bombina Orientalis",α-Helix,NA,CHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
5307,25056849,2015,GIGGALLSAKAALGLAKGLAEHFAN,GIGGALLSAKAALGLAKGLAEHFAN{ct:Amid},FPA-Bombinin-BO,Amidation,Free,Linear,L,None,25,"Antibaterial, Antifungal",100 % Hemolysis at 125 µM,Horse,"Synthetic, Skin Secretion Of Bombina Orientalis",α-Helix,NA,CCGGGTSSHHHHHHHHHHHHCCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O
5679,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,0 % Hemolysis at 0 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5680,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,0.2 % Hemolysis at 1 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5681,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,1.4 % Hemolysis at 2 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5682,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,1.3 % Hemolysis at 4 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5683,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,5 % Hemolysis at 8 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5684,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,9.5 % Hemolysis at 16 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5685,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,38.6 % Hemolysis at 32 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5686,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,79.6 % Hemolysis at 64 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5687,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,107.4 % Hemolysis at 128 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5688,26633506,2015,FFSMIPKIAGGIASLVKNLG,FFSMIPKIAGGIASLVKNLG{ct:Amid},Phylloseptin-PBa,Amidation,Free,Linear,L,None,22,Antimicrobial,104.1 % Hemolysis at 512 mg/L,Horse,Leaf Frog (Phyllomedusa Baltea),α-Helix,NA,CTTTCTTTSTTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C
5696,26656394,2015,GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI,GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI,Cap11,Free,Free,Linear,L,None,43,Antibacterial,4 ± 0 % Hemolysis at 64 μg/ml,Horse,"Mammalian, Guinea Pig, Neutrophils",α-Helical,NA,CBCSTTTTTGGGHHHHGGGSHHHHHHHHHHHHHCCCBCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(=O)O
5697,26656394,2015,KLRKLFRKLLKLIRKLLR,KLRKLFRKLLKLIRKLLR,Cap11-1-18m2,Free,Free,Linear,L,None,18,Antibacterial,52 ± 6 % Hemolysis at 64 μg/ml,Horse,Truncated Derivative Of Cap11,α-Helical,NA,CHHHHHHHHHHHGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5698,26656394,2015,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,Cap18,Free,Free,Linear,L,None,37,Antibacterial,1 ± 0 % Hemolysis at 64 μg/ml,Horse,"Mammalian, Rabbit, Neutrophils",α-Helical,NA,CHHHHHHHHTTHHHHHHHHHHHHHHHHSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
5699,26656394,2015,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,Antibacterial,110 ± 1 % Hemolysis at 128 μg/ml,Horse,"Insects, Honey Bee",α-Helical,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
5700,26656394,2015,ILPWKWPWWPWR,ILPWKWPWWPWR,Indolicidin,Free,Free,Linear,L,None,12,Antibacterial,12 ± 0 % Hemolysis at 128 μg/ml,Horse,"Mammalian, Bovine Neutrophils",Extended,NA,CCSCSSSSSTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
5701,26656394,2015,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,Cecropin P1,Free,Free,Linear,L,None,31,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Mammalian, Pig, Small Intestine",α-Helical,Non-hemolytic,CCTHHHHHHHHHHHHHHTTSSSCCCCCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
5702,26656394,2015,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG{ct:Amid},Cecropin B,Amidation,Free,Linear,L,None,36,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Insects, Giant Silk Moth, Pupae",α-Helical,Non-hemolytic,CHHHHHHHHHHHHHHTTCTTCCSSSSSSSSCHHHHC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5703,26656394,2015,RLARIVVIRVAR,RLARIVVIRVAR,Bac2A,Free,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,Non-Amidated Version Of Bac2A-Nh2,α-Helical/β-Sheet,Non-hemolytic,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5704,26656394,2015,RLARIVVIRVAR,RLARIVVIRVAR{ct:Amid},Bac2A-NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,Linear Variant Of Bactenecin From Bovine Neutrophils,NA,Non-hemolytic,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5705,26656394,2015,RRWKIVVIRWRR,RRWKIVVIRWRR{ct:Amid},Sub5-NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,Synthetic Variant Of Bac2A-Nh2,NA,Non-hemolytic,CCCCCCHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5706,26656394,2015,GIHDILKYGKPS,GIHDILKYGKPS,Myxinidin,Free,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Fish, Epidermal Mucus Of Hagfish",NA,Non-hemolytic,CCSGGGSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
5707,26656394,2015,GIHDILKYGKPS,GIHDILKYGKPS{ct:Amid},Myxinidin-NH2,Amidation,Free,Linear,L,None,12,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,Amidated Form Of Myxinidin,NA,Non-hemolytic,CCSGGGSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC
5708,26656394,2015,VDKGSYLPRPTPPRPIYNRN,VDKGSYLPRPTPPRPIYNRN,Pyrrhocoricin,Free,Free,Linear,L,None,20,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Insects, Pyrrhocoris Apterus",NA,Non-hemolytic,CCSSSCCSSCCCSCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
5709,26656394,2015,GNNRPVYIPQPRPPHPRI,GNNRPVYIPQPRPPHPRI,Apidaecin IA,Free,Free,Linear,L,None,18,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Insects, Honey Bee","Extended, proline rich",Non-hemolytic,CTTSSSCCSSSSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)O
5710,26656394,2015,VDKPDYRPRPRPPNM,VDKPDYRPRPRPPNM,Metalnikowin I,Free,Free,Linear,L,None,15,Antibacterial,0 ± 0 % Hemolysis at 256 μg/ml,Horse,"Insects, Palomena Prasina",NA,Non-hemolytic,CCCSSSCCCCCCSCC,CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)C(=O)O
6180,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 7 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6181,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 15 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6182,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 29 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6183,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 59 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6184,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 118 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6185,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 235 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6186,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<10 % Hemolysis at 470 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6187,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<30 % Hemolysis at 940 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6188,27038545,2016,GLPGPLGPAGPK,GLPGPLGPAGPK,Collagencin,Free,Free,Linear,L,None,12,Antibacterial,<50 % Hemolysis at 1880 µM,Horse,Fish Collagen,β-Sheet and β-Turn,NA,CCSTTSGGGSCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
6227,27187467,2016,GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ,GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ{ct:Amid},Dermaseptin-PD-1,Amidation,Free,Linear,L,None,30,"Antibacterial, Antifungal, Anticancer",100 % Hemolysis at >156.8 µM,Horse,Pachymedusa Dacnicolor,α-Helix,Low hemolytic,CHHHHHHHHTTTTCTHHHHTTCCGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6228,27187467,2016,GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI,GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI{ct:Amid},Dermaseptin-PD-2,Amidation,Free,Linear,L,None,32,"Antibacterial, Antifungal, Anticancer",100 % Hemolysis at >161.6 µM,Horse,Pachymedusa Dacnicolor,α-Helix,Low hemolytic,CCGGGTSCCCCBSSSSSCCCSSSTTTSSBSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)O
6421,27311856,2016,AAKIILNPKFRCKAAFC,#ERROR!,Kunitzin-RE,Free,Free,Linear,L,None,17,Antibacterial,little Hemolysis % at 120 µM,Horse,"European Frog, Rana Esculenta",Loop,Low hemolytic,CCSCCSCCCCSSCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
6422,27311856,2016,AVNIPFKVHLRCKAAFC,AVNIPFKVHLRCKAAFC,Kunitzin-OS,Free,Free,Linear,L,None,12,Antibacterial,little Hemolysis % at 120 µM,Horse,"Chinese Frog, Odorrana Schmackeri",Loop,Low hemolytic,CCCCSSCCCSSTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C
6434,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",0 % Hemolysis at 2 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6435,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",0 % Hemolysis at 4 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6436,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",1 % Hemolysis at 8 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6437,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",9 % Hemolysis at 16 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6438,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",20 % Hemolysis at 32 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6439,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",33 % Hemolysis at 64 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6440,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",62 % Hemolysis at 128 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6441,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",105 % Hemolysis at 256 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6442,27321580,2016,GFLDIVKGVGKVALGAVSKLF,GFLDIVKGVGKVALGAVSKLF{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",107 % Hemolysis at 512 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHHHHHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
6443,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-1,Amidation,Free,Linear,L,None,21,"Antibacterial, Antifungal",0 % Hemolysis at 2 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6444,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",1 % Hemolysis at 4 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6445,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",1 % Hemolysis at 8 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6446,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",6 % Hemolysis at 16 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6447,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",26 % Hemolysis at 32 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6448,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",54 % Hemolysis at 64 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6449,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",75 % Hemolysis at 128 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6450,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",93 % Hemolysis at 256 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6451,27321580,2016,GFLDVIKHVGKAALGVVTHLINQ,GFLDVIKHVGKAALGVVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",100 % Hemolysis at 512 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHTCCHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6452,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",0 % Hemolysis at 2 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6453,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",1 % Hemolysis at 4 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6454,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",1 % Hemolysis at 8 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6455,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",2 % Hemolysis at 16 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6456,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",6 % Hemolysis at 32 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6457,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",24 % Hemolysis at 64 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6458,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",59 % Hemolysis at 128 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6459,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",83 % Hemolysis at 256 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6460,27321580,2016,GFLDVVKHIGKAALGAVTHLINQ,GFLDVVKHIGKAALGAVTHLINQ{ct:Amid},CZS-3,Amidation,Free,Linear,L,None,23,"Antibacterial, Antifungal",96 % Hemolysis at 512 mg/L,Horse,Splendid Leaf Frog Cruziohyla Calcarife,α-Helix,NA,CHHHHHSSHHHHHHHHSCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C
6540,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 1 mg/L,Horse,Phyllomedusa Tarsius,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6541,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 128 mg/L,Horse,Phyllomedusa Tarsius,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6542,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 256 mg/L,Horse,Phyllomedusa Tarsius,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6543,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 512 mg/L,Horse,Phyllomedusa Tarsius,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6544,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 1 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6545,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 2 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6546,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 4 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6547,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 8 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6548,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,5 % Hemolysis at 16 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6549,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,5 % Hemolysis at 32 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6550,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 64 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6551,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 128 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6552,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 256 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6553,27918477,2016,FLSLIPHAIKAVGVHAKHF,FLSLIPHAIKAVGVHAKHF{ct:Amid},PS-PT1,Amidation,Free,Linear,L,None,19,Antimicrobial,<10 % Hemolysis at 512 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CBTTBSSCCTTSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6554,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,5 % Hemolysis at 1 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6555,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,5 % Hemolysis at 2 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6556,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,5 % Hemolysis at 4 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6557,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,<10 % Hemolysis at 8 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6558,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,<10 % Hemolysis at 16 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6559,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 32 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6560,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 64 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6561,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,<10 % Hemolysis at 128 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6562,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,<10 % Hemolysis at 256 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6563,27918477,2016,FLSLIPKAIKAVGVKAKKF,FLSLIPKAIKAVGVKAKKF{ct:Amid},PS-PT2,Amidation,Free,Linear,L,None,19,Antimicrobial,5 % Hemolysis at 512 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
6564,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 1 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6565,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 2 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6566,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 4 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6567,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 8 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6568,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 16 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6569,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 32 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6570,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 64 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6571,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 128 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6572,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 256 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6573,27918477,2016,FLSLIPkAIkAVGVkAkkF,FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid},PS-PT2a,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<10 % Hemolysis at 512 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6574,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 2 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6575,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 4 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6576,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 8 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6577,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 16 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6578,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 32 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6579,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 64 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6580,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 128 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6581,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 256 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6582,27918477,2016,FLSLIPkAIKAVGVKAKKF,FLSLIPK{d}AIKAVGVKAKKF{ct:Amid},PS-PT2b,Amidation,Free,Linear,Mix,k = D-lysine,19,Antimicrobial,<5 % Hemolysis at 512 mg/L,Horse,Ps-Pt Analog,α-Helix,NA,CCCSCTTTGGGTCCSCCCC,NA
6666,27008420,2016,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6667,27008420,2016,KKLKK(CO-C7H15)FKKLQ,KKLKK{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC498,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,NA
6668,27008420,2016,KKLKK(CO-C3H7)FKKLQ,KKLKK{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC500,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,28 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6669,27008420,2016,KKLKK(CO-C4H9)FKKLQ,KKLKK{conj:CO-C4H9}FKKLQ{cyc:N-C},BPC526,Free,Free,Cyclic,L,CO-C4H9 = pentanoyl,10,Anti-plant-pathogenic bacteria and fungi,62 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6670,27008420,2016,KKLKK(CO-isoC5H11)FKKLQ,KKLKK{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC504,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,89 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6671,27008420,2016,KKLKK(CO-nC5H11)FKKLQ,KKLKK{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC528,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,98 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6672,27008420,2016,KKLKK(LK-CO-nC5H11)FKKLQ,KKLKKLK-{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC596,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,93 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6673,27008420,2016,KKLKK(CO-C6H13)FKKLQ,KKLKK{conj:CO-C6H13}FKKLQ{cyc:N-C},BPC592,Free,Free,Cyclic,L,CO-C6H13 = 2-methylhexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6674,27008420,2016,KKLKK(CO-C8H17)FKKLQ,KKLKK{conj:CO-C8H17}FKKLQ{cyc:N-C},BPC594,Free,Free,Cyclic,L,CO-C8H17 = 4-methyloctanoyl,10,Anti-plant-pathogenic bacteria and fungi,93 ± 11 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6675,27008420,2016,KKLKK(CO-C11H23)FKKLQ,KKLKK{conj:CO-C11H23}FKKLQ{cyc:N-C},BPC530,Free,Free,Cyclic,L,CO-C11H23 = lauroyl,10,Anti-plant-pathogenic bacteria and fungi,89 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6676,27008420,2016,KKLKK(CO-C11H22OH)FKKLQ,KKLKK{conj:CO-C11H22OH}FKKLQ{cyc:N-C},BPC524,Free,Free,Cyclic,L,CO-C11H22OH = 12-hydroxylauroyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 8 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6677,27008420,2016,KKLKK(CO-C15H31)FKKLQ,KKLKK{conj:CO-C15H31}FKKLQ{cyc:N-C},BPC502,Free,Free,Cyclic,L,CO-C15H31 = palmitoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6678,27008420,2016,KKLKK(CO-C17H33)FKKLQ,KKLKK{conj:CO-C17H33}FKKLQ{cyc:N-C},BPC622,Free,Free,Cyclic,L,CO-C17H33 = oleoyl,10,Anti-plant-pathogenic bacteria and fungi,91 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6679,27008420,2016,KKLKKFKK(CO-nC5H11)LQ,KKLKKFKK{conj:CO-nC5H11}LQ{cyc:N-C},BPC582,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6680,27008420,2016,KKLKKFK(CO-nC5H11)KLQ,KKLKKFK{conj:CO-nC5H11}KLQ{cyc:N-C},BPC584,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,72 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6681,27008420,2016,KKLK(CO-nC5H11)KFKKLQ,KKLK{conj:CO-nC5H11}KFKKLQ{cyc:N-C},BPC586,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 9 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6682,27008420,2016,KK(CO-nC5H11)LKKFKKLQ,KK{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC588,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,95 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6683,27008420,2016,KK(CO-C3H7)LKKFKKLQ,KK{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC708,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,2 ± 0.5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6684,27008420,2016,K(CO-nC5H11)KLKKFKKLQ,K{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC590,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 9 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6685,27008420,2016,K(CO-C3H7)KLKKFKKLQ,K{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC710,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6686,27008420,2016,KKLKK(CO-C3H7)fKKLQ,KKLKK{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC712,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,30 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6687,27008420,2016,KKLKK(LK-CO-C3H7)fKKLQ,KKLKKLK-{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC726,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,0 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6688,27008420,2016,KKLKK(CO-nC5H11)fKKLQ,KKLKK{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC624,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,53 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6689,27008420,2016,KKLKK(CO-isoC5H11)fKKLQ,KKLKK{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC626,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,51 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6690,27008420,2016,KKLKK(LK-CO-nC5H11)fKKLQ,KKLKKLK-{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC674,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,51 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6691,27008420,2016,KKLKK(CO-C7H15)fKKLQ,KKLKK{conj:CO-C7H15}F{d}KKLQ{cyc:N-C},BPC668,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,79 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6692,27008420,2016,KK(CO-C3H7)LKKfKKLQ,KK{conj:CO-C3H7}LKKF{d}KKLQ{cyc:N-C},BPC714,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6693,27008420,2016,KK(CO-nC5H11)LKKfKKLQ,KK{conj:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C},BPC680,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,77 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6694,27008420,2016,K(CO-C3H7)KLKKfKKLQ,K{conj:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C},BPC716,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,2 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6695,27008420,2016,K(CO-nC5H11)KLKKfKKLQ,K{conj:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C},BPC686,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,10 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6696,27008420,2016,KKLKk(CO-C3H7)FKKLQ,KKLKK{d}{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC702,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,1 ± 0.1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6697,27008420,2016,KKLKk(LK-CO-C3H7)FKKLQ,KKLKK{d}LK-{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC724,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,3 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6698,27008420,2016,KKLKk(CO-nC5H11)FKKLQ,KKLKK{d}{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC628,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,19 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6699,27008420,2016,KKLKk(CO-isoC5H11)FKKLQ,KKLKK{d}{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC630,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,22 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6700,27008420,2016,KKLKk(LK-CO-nC5H11)FKKLQ,KKLKK{d}LK-{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC672,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,33 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6701,27008420,2016,KKLKk(CO-C7H15)FKKLQ,KKLKK{d}{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC666,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,61 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6702,27008420,2016,Kk(CO-nC5H11)LKKFKKLQ,KK{d}{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC678,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,68 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6703,27008420,2016,Kk(CO-C3H7)LKKFKKLQ,KK{d}{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC704,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,9 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6704,27008420,2016,k(CO-nC5H11)KLKKFKKLQ,K{d}{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC684,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,8 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6705,27008420,2016,k(CO-C3H7)KLKKFKKLQ,K{d}{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC706,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,35 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6706,27008420,2016,KKLKk(CO-nC5H11)fKKLQ,KKLKK{d}{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC632,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,21 ± 13 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6707,27008420,2016,KKLKk(CO-isoC5H11)fKKLQ,KKLKK{d}{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC634,Free,Free,Cyclic,Mix,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6708,27008420,2016,KKLKK(CO-C3H7)HKKLQ,KKLKK{conj:CO-C3H7}HKKLQ{cyc:N-C},BPC718,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6709,27008420,2016,KKLKK(LK-CO-C3H7)HKKLQ,KKLKKLK{conj:CO-C3H7}HKKLQ{cyc:N-C},BPC728,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,12,Anti-plant-pathogenic bacteria and fungi,0 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Non-hemolytic,NA,NA
6710,27008420,2016,KKLKK(CO-nC5H11)HKKLQ,KKLKK{conj:CO-nC5H11}HKKLQ{cyc:N-C},BPC636,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,5 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6711,27008420,2016,KKLKK(CO-isoC5H11)HKKLQ,KKLKK{conj:CO-isoC5H11}HKKLQ{cyc:N-C},BPC638,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,6 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6712,27008420,2016,KKLKK(LK-CO-nC5H11)HKKLQ,KKLKKLK{conj:CO-nC5H11}HKKLQ{cyc:N-C},BPC676,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6713,27008420,2016,KKLKK(CO-C7H15)HKKLQ,KKLKK{conj:CO-C7H15}HKKLQ{cyc:N-C},BPC670,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,34 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6714,27008420,2016,KK(CO-nC5H11)LKKHKKLQ,KK{conj:CO-nC5H11}LKKHKKLQ{cyc:N-C},BPC682,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,20 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6715,27008420,2016,KK(CO-C3H7)LKKHKKLQ,KK{conj:CO-C3H7}LKKHKKLQ{cyc:N-C},BPC720,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6716,27008420,2016,K(CO-nC5H11)KLKKHKKLQ,K{conj:CO-nC5H11}KLKKHKKLQ{cyc:N-C},BPC688,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,1 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6717,27008420,2016,K(CO-C3H7)KLKKHKKLQ,K{conj:CO-C3H7}KLKKHKKLQ{cyc:N-C},BPC722,Free,Free,Cyclic,L,CO-C3H7= butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6718,27008420,2016,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Anti-plant-pathogenic bacteria and fungi,6 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6719,27008420,2016,KKLKK(CO-C7H15)FKKLQ,KKLKK{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC498,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6720,27008420,2016,KKLKK(CO-C3H7)FKKLQ,KKLKK{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC500,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,38 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6721,27008420,2016,KKLKK(CO-C4H9)FKKLQ,KKLKK{conj:CO-C4H9}FKKLQ{cyc:N-C},BPC526,Free,Free,Cyclic,L,CO-C4H9 = pentanoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6722,27008420,2016,KKLKK(CO-isoC5H11)FKKLQ,KKLKK{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC504,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,93 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6723,27008420,2016,KKLKK(CO-nC5H11)FKKLQ,KKLKK{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC528,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6724,27008420,2016,KKLKK(LK-CO-nC5H11)FKKLQ,KKLKKLK{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC596,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,100 ± 11 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6725,27008420,2016,KKLKK(CO-C6H13)FKKLQ,KKLKK{conj:CO-C6H13}FKKLQ{cyc:N-C},BPC592,Free,Free,Cyclic,L,CO-C6H13 = 2-methylhexanoyl,10,Anti-plant-pathogenic bacteria and fungi,98 ± 6 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6726,27008420,2016,KKLKK(CO-C8H17)FKKLQ,KKLKK{conj:CO-C8H17}FKKLQ{cyc:N-C},BPC594,Free,Free,Cyclic,L,CO-C8H17 = 4-methyloctanoyl,10,Anti-plant-pathogenic bacteria and fungi,96 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6727,27008420,2016,KKLKK(CO-C11H23)FKKLQ,KKLKK{conj:CO-C11H23}FKKLQ{cyc:N-C},BPC530,Free,Free,Cyclic,L,CO-C11H23 = lauroyl,10,Anti-plant-pathogenic bacteria and fungi,91 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6728,27008420,2016,KKLKK(CO-C11H22OH)FKKLQ,KKLKK{conj:CO-C11H22OH}FKKLQ{cyc:N-C},BPC524,Free,Free,Cyclic,L,CO-C11H22OH = 12-hydroxylauroyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 6 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6729,27008420,2016,KKLKK(CO-C15H31)FKKLQ,KKLKK{conj:CO-C15H31}FKKLQ{cyc:N-C},BPC502,Free,Free,Cyclic,L,CO-C15H31 = palmitoyl,10,Anti-plant-pathogenic bacteria and fungi,99 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6730,27008420,2016,KKLKK(CO-C17H33)FKKLQ,KKLKK{conj:CO-C17H33}FKKLQ{cyc:N-C},BPC622,Free,Free,Cyclic,L,CO-C17H33 = oleoyl,10,Anti-plant-pathogenic bacteria and fungi,97 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6731,27008420,2016,KKLKKFKK(CO-nC5H11)LQ,KKLKKFKK{conj:CO-nC5H11}LQ{cyc:N-C},BPC582,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,96 ± 10 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6732,27008420,2016,KKLKKFK(CO-nC5H11)KLQ,KKLKKFK{conj:CO-nC5H11}KLQ{cyc:N-C},BPC584,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,97 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6733,27008420,2016,KKLK(CO-nC5H11)KFKKLQ,KKLK{conj:CO-nC5H11}KFKKLQ{cyc:N-C},BPC586,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,95 ± 20 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6734,27008420,2016,KK(CO-nC5H11)LKKFKKLQ,KK{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC588,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6735,27008420,2016,KK(CO-C3H7)LKKFKKLQ,KK{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC708,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6736,27008420,2016,K(CO-nC5H11)KLKKFKKLQ,K{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC590,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6737,27008420,2016,K(CO-C3H7)KLKKFKKLQ,K{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC710,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,13 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6738,27008420,2016,KKLKK(CO-C3H7)fKKLQ,KKLKK{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC712,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,38 ± 7 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6739,27008420,2016,KKLKK(LK-CO-C3H7)fKKLQ,KKLKKLK-{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC726,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,4 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6740,27008420,2016,KKLKK(CO-nC5H11)fKKLQ,KKLKK{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC624,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,64 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6741,27008420,2016,KKLKK(CO-isoC5H11)fKKLQ,KKLKK{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC626,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,54 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6742,27008420,2016,KKLKK(LK-CO-nC5H11)fKKLQ,KKLKKLK-{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC674,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,56 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6743,27008420,2016,KKLKK(CO-C7H15)fKKLQ,KKLKK{conj:CO-C7H15}F{d}KKLQ{cyc:N-C},BPC668,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,79 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6744,27008420,2016,KK(CO-C3H7)LKKfKKLQ,KK{conj:CO-C3H7}LKKF{d}KKLQ{cyc:N-C},BPC714,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6745,27008420,2016,KK(CO-nC5H11)LKKfKKLQ,KK{conj:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C},BPC680,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,81 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6746,27008420,2016,K(CO-C3H7)KLKKfKKLQ,K{conj:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C},BPC716,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,4 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6747,27008420,2016,K(CO-nC5H11)KLKKfKKLQ,K{conj:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C},BPC686,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,14 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6748,27008420,2016,KKLKk(CO-C3H7)FKKLQ,KKLKK{d}{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC702,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,2 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6749,27008420,2016,KKLKk(LK-CO-C3H7)FKKLQ,KKLKK{d}LK-{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC724,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,3 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6750,27008420,2016,KKLKk(CO-nC5H11)FKKLQ,KKLKK{d}{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC628,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,34 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6751,27008420,2016,KKLKk(CO-isoC5H11)FKKLQ,KKLKK{d}{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC630,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,28 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6752,27008420,2016,KKLKk(LK-CO-nC5H11)FKKLQ,KKLKK{d}LK-{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC672,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,33 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6753,27008420,2016,KKLKk(CO-C7H15)FKKLQ,KKLKK{d}{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC666,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,73 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6754,27008420,2016,Kk(CO-nC5H11)LKKFKKLQ,KK{d}{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC678,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,73 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6755,27008420,2016,Kk(CO-C3H7)LKKFKKLQ,KK{d}{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC704,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,16 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6756,27008420,2016,k(CO-nC5H11)KLKKFKKLQ,K{d}{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC684,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,13 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6757,27008420,2016,k(CO-C3H7)KLKKFKKLQ,K{d}{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC706,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,46 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6758,27008420,2016,KKLKk(CO-nC5H11)fKKLQ,KKLKK{d}{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC632,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,22 ± 10 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6759,27008420,2016,KKLKk(CO-isoC5H11)fKKLQ,KKLKK{d}{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC634,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,17 ± 8 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6760,27008420,2016,KKLKK(CO-C3H7)HKKLQ,KKLKK{conj:CO-C3H7}HKKLQ{cyc:N-C},BPC718,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6761,27008420,2016,KKLKK(LK-CO-C3H7)HKKLQ,KKLKKLK{conj:CO-C3H7}HKKLQ{cyc:N-C},BPC728,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,12,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6762,27008420,2016,KKLKK(CO-nC5H11)HKKLQ,KKLKK{conj:CO-nC5H11}HKKLQ{cyc:N-C},BPC636,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,16 ± 5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6763,27008420,2016,KKLKK(CO-isoC5H11)HKKLQ,KKLKK{conj:CO-isoC5H11}HKKLQ{cyc:N-C},BPC638,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,8 ± 5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6764,27008420,2016,KKLKK(LK-CO-nC5H11)HKKLQ,KKLKKLK{conj:CO-nC5H11}HKKLQ{cyc:N-C},BPC676,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6765,27008420,2016,KKLKK(CO-C7H15)HKKLQ,KKLKK{conj:CO-C7H15}HKKLQ{cyc:N-C},BPC670,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,40 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6766,27008420,2016,KK(CO-nC5H11)LKKHKKLQ,KK{conj:CO-nC5H11}LKKHKKLQ{cyc:N-C},BPC682,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,27 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6767,27008420,2016,KK(CO-C3H7)LKKHKKLQ,KK{conj:CO-C3H7}LKKHKKLQ{cyc:N-C},BPC720,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6768,27008420,2016,K(CO-nC5H11)KLKKHKKLQ,K{conj:CO-nC5H11}KLKKHKKLQ{cyc:N-C},BPC688,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,1 ± 0.2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Non-hemolytic,NA,NA
6769,27008420,2016,K(CO-C3H7)KLKKHKKLQ,K{conj:CO-C3H7}KLKKHKKLQ{cyc:N-C},BPC722,Free,Free,Cyclic,L,CO-C3H7= butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6972,28122029,2017,FFHHIFRGIVHVGKTIHKLVTG,FFHHIFRGIVHVGKTIHKLVTG{ct:Amid},moro-NH2,Amidation,Free,Linear,L,None,22,Antimicrobial,60 % Hemolysis at 25 µM,Horse,Hybrid Striped Bass,α-Helix,NA,CCSHHHHSSTTTCSCTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
6973,28122029,2017,FFHHIFRGIVHVGKTIHKLVTG,FFHHIFRGIVHVGKTIHKLVTG{ct:Amid},moro-NH2,Amidation,Free,Linear,L,None,22,Antimicrobial,70 % Hemolysis at 50 µM,Horse,Hybrid Striped Bass,α-Helix,NA,CCSHHHHSSTTTCSCTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
6974,28122029,2017,FFHHIFRGIVHVGKTIHKLVTG,FFHHIFRGIVHVGKTIHKLVTG{ct:Amid},moro-NH2,Amidation,Free,Linear,L,None,22,Antimicrobial,40 % Hemolysis at 6.25 µM,Horse,Hybrid Striped Bass,α-Helix,NA,CCSHHHHSSTTTCSCTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
6975,28122029,2017,FFHHIFRGIVHVGKTIHKLVTG,FFHHIFRGIVHVGKTIHKLVTG{ct:Amid},moro-NH2,Amidation,Free,Linear,L,None,22,Antimicrobial,20 % Hemolysis at 5 µM,Horse,Hybrid Striped Bass,α-Helix,NA,CCSHHHHSSTTTCSCTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
6976,28122029,2017,FFWHHIGHALDAAKRVHGMLSG,FFWHHIGHALDAAKRVHGMLSG{ct:Amid},moroNC-NH2,Amidation,Free,Linear,L,None,24,Antimicrobial,~10 % Hemolysis at 50 µM,Horse,Notothenia Coriiceps,α-Helix,NA,CCSCSSHHHHHHCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(C)C
6978,28122029,2017,FFWHHIGHALDAAKRVHGMLSG,FFWHHIGHALDAAKRVHGMLSG{ct:Amid},moroNC-NH2,Amidation,Free,Linear,L,None,24,Antimicrobial,<1 % Hemolysis at 25 µM,Horse,Notothenia Coriiceps,α-Helix,NA,CCSCSSHHHHHHCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)C(C)C
6981,28122029,2017,FFGHLFRGIINVGKHIHGLLSG,FFGHLFRGIINVGKHIHGLLSG{ct:Amid},moroPC-NH2,Amidation,Free,Linear,L,None,22,Antimicrobial,50 % Hemolysis at 50 µM,Horse,Parachaenichthys Charcoti,α-Helix,NA,CCSCHHHHHHHHCCCCTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
6982,28122029,2017,FFGHLFRGIINVGKHIHGLLSG,FFGHLFRGIINVGKHIHGLLSG{ct:Amid},moroPC-NH2,Amidation,Free,Linear,L,None,22,Antimicrobial,<10 % Hemolysis at 25 µM,Horse,Parachaenichthys Charcoti,α-Helix,NA,CCSCHHHHHHHHCCCCTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
6991,28012857,2017,FALALKALKKALKKLKKALKKAL,FALALKALKKALKKLKKALKKAL,Hecate,Free,Free,Linear,L,None,23,Antimicrobial,0 % Hemolysis at 0-25 µM,Horse,"Synthetic, Derivate Of Melittin",α-Helix,NA,CCTHHHHHHHHHHHHHHHGGGCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)O
6994,28012857,2017,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antimicrobial,50 % Hemolysis at 5 µM,Horse,Apis Mellifera,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
6995,28012857,2017,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antimicrobial,75 % Hemolysis at 10 µM,Horse,Apis Mellifera,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
6996,28012857,2017,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antimicrobial,100 % Hemolysis at 15-25 µM,Horse,Apis Mellifera,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
7000,28012857,2017,ILGPVLGLVSDTLDDVLGIL,ILGPVLGLVSDTLDDVLGIL,Maximin H5,Free,Free,Linear,L,None,20,Antimicrobial,0 % Hemolysis at 0-25 µM,Horse,Bombina Maxima Smap2 9 Rglrrlgrkiahgvkkygptvlriiri Ag 29 3256.0 0 12.3 1 +9 Derivative Of Ovispi,α-Helix,Non-hemolytic,CTTGGGGGGGTSCCIIIIIC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C
7001,28012857,2017,RGLRRLGRKIAHGVKKYGPTVLRIIRIAG,RGLRRLGRKIAHGVKKYGPTVLRIIRIAG,SMAP29,Free,Free,Linear,L,None,29,Antimicrobial,0 % Hemolysis at 0-25 µM,Horse,"Derivative Of Ovispirin, Ovis Aries",α-Helix,Non-hemolytic,CCHHHHGGGCSCTTSSCSSSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C
7007,28012857,2017,KWKLWKKIEKWGQGIGAVLKWLTTWL,KWKLWKKIEKWGQGIGAVLKWLTTWL,CAM-W,Free,Free,Linear,L,None,26,Antimicrobial,80 % Hemolysis at 5 µM,Horse,"Synthetic, Cecropin A / Melittin Hybrid",α-Helix,NA,CHHHHHHHHHHIIIIIHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
7008,28012857,2017,KWKLWKKIEKWGQGIGAVLKWLTTWL,KWKLWKKIEKWGQGIGAVLKWLTTWL,CAM-W,Free,Free,Linear,L,None,26,Antimicrobial,100 % Hemolysis at 10 µM,Horse,"Synthetic, Cecropin A / Melittin Hybrid",α-Helix,NA,CHHHHHHHHHHIIIIIHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
7009,28012857,2017,WEAALAEALAEALAEHLAEALAEALEALAA,WEAALAEALAEALAEHLAEALAEALEALAA,GALA,Free,Free,Linear,L,None,30,Antimicrobial,10 % Hemolysis at 25 µM,Horse,"Synthetic, Cecropin A / Melittin Hybrid",α-Helix,NA,CCHHHHHHHHHHTTSCTTTHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
7012,28012857,2017,WEAKLAKALAKALAKHLAKALAKALKACEA,WEAKLAKALAKALAKHLAKALAKALKACEA,KALA,Free,Free,Linear,L,None,30,Antimicrobial,<60 % Hemolysis at 25 µM,Horse,Synthetic,α-Helix,NA,CCSTHHHHHHHHHTCCHHHHHHHHTSSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
7013,28012857,2017,WEAKLAKALAKALAKHLAKALAKALKACEA,WEAKLAKALAKALAKHLAKALAKALKACEA,KALA,Free,Free,Linear,L,None,30,Antimicrobial,50 % Hemolysis at 15 µM,Horse,Synthetic,α-Helix,NA,CCSTHHHHHHHHHTCCHHHHHHHHTSSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
7014,28012857,2017,WEAKLAKALAKALAKHLAKALAKALKACEA,WEAKLAKALAKALAKHLAKALAKALKACEA,KALA,Free,Free,Linear,L,None,30,Antimicrobial,40 % Hemolysis at 10 µM,Horse,Synthetic,α-Helix,NA,CCSTHHHHHHHHHTCCHHHHHHHHTSSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O
7343,28850103,2017,FLSLIPKIAGGIAALAKHL,FLSLIPKIAGGIAALAKHL{ct:Amid},Phylloseptin-PTa,Amidation,Free,Linear,L,None,22,Antimicrobial,10 % Hemolysis at 7.79 µM,Horse,Phyllomedusa Tarsius,α-Helix,NA,CCCCCCSSCCTHHHHTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7344,28850103,2017,FLSLIPKIAGGIAALAKHL,FLSLIPKIAGGIAALAKHL{ct:Amid},Phylloseptin-PTa,Amidation,Free,Linear,L,None,22,Antimicrobial,50 % Hemolysis at 22.8 µM,Horse,Phyllomedusa Tarsius,α-Helix,NA,CCCCCCSSCCTHHHHTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7345,28850103,2017,FLSLIPAAISAVSALANHF,FLSLIPAAISAVSALANHF{ct:Amid},phylloseptin-PHa,Amidation,Free,Linear,L,None,22,Antimicrobial,10 % Hemolysis at 76.5 µM,Horse,Phyllomedusa Hypochondrialis,α-Helix,NA,CCCSCCGGGHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
7346,28850103,2017,FLSLIPAAISAVSALANHF,FLSLIPAAISAVSALANHF{ct:Amid},phylloseptin-PHa,Amidation,Free,Linear,L,None,22,Antimicrobial,50 % Hemolysis at 109.5 µM,Horse,Phyllomedusa Hypochondrialis,α-Helix,NA,CCCSCCGGGHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
7451,28894024,2017,GIGGALLSFGKSALKGLAKGLAEHF,GIGGALLSFGKSALKGLAKGLAEHF{ct:Amid},BHL-bombinin,Amidation,Free,Linear,L,None,25,Antimicrobial,50 % Hemolysis at 64 mg/l,Horse,Bombina Orientalis,α-Helix,NA,CCHHHHHHHHHHHHHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
7452,28894024,2017,LLGPVLGLVSNVLGGLL,LLGPVLGLVSNVLGGLL{ct:Amid},Bombinin HL,Amidation,Free,Linear,L,None,17,Antimicrobial,50 % Hemolysis at >512 mg/l,Horse,Bombina Orientalis,α-Helix,NA,CTTHHHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(C)C)C(=O)O
7453,28894024,2017,LLGPVLGLVSNVLGGLL,LLGPVLGLVSNVLGGLL{ct:Amid},Bombinin HD,Amidation,Free,Linear,L,None,17,Antimicrobial,50 % Hemolysis at >512 mg/l,Horse,Bombina Orientalis,α-Helix,NA,CTTHHHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(C)C)C(=O)O
7454,28894024,2017,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antimicrobial,50 % Hemolysis at 1 mg/l,Horse,Bee Venom,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
7476,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",50 % Hemolysis at 23 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7477,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",~100 % Hemolysis at 64 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7478,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",~100 % Hemolysis at 128 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7479,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",~100 % Hemolysis at 256 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7480,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",~100 % Hemolysis at 512 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7857,28026016,2017,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Antimicrobial,3 ± 0.6 % Hemolysis at 150 µM,Horse,Synthetic Peptidotriazoles,NA,NA,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
7858,28026016,2017,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Antimicrobial,3 ± 0.6 % Hemolysis at 250 µM,Horse,Synthetic Peptidotriazoles,NA,NA,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
7859,28026016,2017,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Antimicrobial,4 ± 0.7 % Hemolysis at 375 µM,Horse,Synthetic Peptidotriazoles,NA,NA,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
7860,28026016,2017,AAA(TrBn),AAA{nnr:Tr-Bn}{cyc:N-C},BPC458,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,3,Antimicrobial,2 ± 0.3 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7861,28026016,2017,AAA(TrBn),AAA{nnr:Tr-Bn}{cyc:N-C},BPC458,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,3,Antimicrobial,3 ± 0.5 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7862,28026016,2017,AAA(TrBn),AAA{nnr:Tr-Bn}{cyc:N-C},BPC458,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,3,Antimicrobial,5 ± 0.2 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7863,28026016,2017,AAA(TrNle),AAA{nnr:Tr-Nle}{cyc:N-C},BPC460,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.3 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7864,28026016,2017,AAA(TrNle),AAA{nnr:Tr-Nle}{cyc:N-C},BPC460,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.3 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7865,28026016,2017,AAA(TrNle),AAA{nnr:Tr-Nle}{cyc:N-C},BPC460,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7866,28026016,2017,AAA(TrPhNH2),AAA{nnr:TrPhNH2}{cyc:N-C},BPC518,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.1 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7867,28026016,2017,AAA(TrPhNH2),AAA{nnr:TrPhNH2}{cyc:N-C},BPC518,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.1 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7868,28026016,2017,AAA(TrPhNH2),AAA{nnr:TrPhNH2}{cyc:N-C},BPC518,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7869,28026016,2017,AAA(TrPhMe),AAA{nnr:TrPhMe}{cyc:N-C},BPC540,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,2 ± 0.5 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7870,28026016,2017,AAA(TrPhMe),AAA{nnr:TrPhMe}{cyc:N-C},BPC540,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,4 ± 0.4 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7871,28026016,2017,AAA(TrPhMe),AAA{nnr:TrPhMe}{cyc:N-C},BPC540,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,6 ± 1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7872,28026016,2017,AAA(TrPhOMe),AAA{nnr:TrPhOMe}{cyc:N-C},BPC542,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,1 ± 0.6 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7873,28026016,2017,AAA(TrPhOMe),AAA{nnr:TrPhOMe}{cyc:N-C},BPC542,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,2 ± 0.2 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7874,28026016,2017,AAA(TrPhOMe),AAA{nnr:TrPhOMe}{cyc:N-C},BPC542,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,4 ± 0.4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7875,28026016,2017,AAA(TrPh),AAA{nnr:TrPh}{cyc:N-C},BPC544,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,1 ± 0.4 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7876,28026016,2017,AAA(TrPh),AAA{nnr:TrPh}{cyc:N-C},BPC544,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,1 ± 0.3 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7877,28026016,2017,AAA(TrPh),AAA{nnr:TrPh}{cyc:N-C},BPC544,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,2 ± 0.4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7878,28026016,2017,NleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC516,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,5 ± 0.2 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7879,28026016,2017,NleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC516,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,6 ± 0.4 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7880,28026016,2017,NleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC516,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,8 ± 0.1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7881,28026016,2017,NleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC538,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.8 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7882,28026016,2017,NleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC538,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.4 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7883,28026016,2017,NleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC538,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,2 ± 0.4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7884,28026016,2017,NleNleNle(TrPhMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C},BPC548,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,12 ± 0.3 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7885,28026016,2017,NleNleNle(TrPhMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C},BPC548,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,24 ± 1 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7886,28026016,2017,NleNleNle(TrPhMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C},BPC548,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,26 ± 4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7887,28026016,2017,NleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC550,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,7 ± 0.8 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7888,28026016,2017,NleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC550,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,10 ± 0.8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7889,28026016,2017,NleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC550,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,19 ± 5 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7890,28026016,2017,KKK(COTr),KKK{nnr:COTr}{cyc:N-C},BPC692,Free,Free,Cyclic,L,Tr = unsubsituted triazole,3,Antimicrobial,5 ± 0.7 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7891,28026016,2017,KKK(COTr),KKK{nnr:COTr}{cyc:N-C},BPC692,Free,Free,Cyclic,L,Tr = unsubsituted triazole,3,Antimicrobial,5 ± 0.8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7892,28026016,2017,KKK(COTr),KKK{nnr:COTr}{cyc:N-C},BPC692,Free,Free,Cyclic,L,Tr = unsubsituted triazole,3,Antimicrobial,7 ± 0.2 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7893,28026016,2017,KKK(COTrBn),KKK{nnr:COTrBn}{cyc:N-C},BPC696,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",3,Antimicrobial,19 ± 4 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7894,28026016,2017,KKK(COTrBn),KKK{nnr:COTrBn}{cyc:N-C},BPC696,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",3,Antimicrobial,20 ± 5 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7895,28026016,2017,KKK(COTrBn),KKK{nnr:COTrBn}{cyc:N-C},BPC696,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",3,Antimicrobial,30 ± 4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7896,28026016,2017,KKK(COTrNle),KKK{nnr:COTrNle}{cyc:N-C},BPC700,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 2 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7897,28026016,2017,KKK(COTrNle),KKK{nnr:COTrNle}{cyc:N-C},BPC700,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.4 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7898,28026016,2017,KKK(COTrNle),KKK{nnr:COTrNle}{cyc:N-C},BPC700,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7899,28026016,2017,AAAAA(TrBn),AAAAA{nnr:TrBn}{cyc:N-C},BPC510,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",5,Antimicrobial,32 ± 2 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7900,28026016,2017,AAAAA(TrBn),AAAAA{nnr:TrBn}{cyc:N-C},BPC510,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",5,Antimicrobial,35 ± 3 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7901,28026016,2017,AAAAA(TrBn),AAAAA{nnr:TrBn}{cyc:N-C},BPC510,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",5,Antimicrobial,40 ± 4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7902,28026016,2017,AAAAA(TrNle),AAAAA{nnr:Tr-Nle}{cyc:N-C},BPC512,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",5,Antimicrobial,2 ± 0.1 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7903,28026016,2017,AAAAA(TrNle),AAAAA{nnr:Tr-Nle}{cyc:N-C},BPC512,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",5,Antimicrobial,2 ± 0.2 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7904,28026016,2017,AAAAA(TrNle),AAAAA{nnr:Tr-Nle}{cyc:N-C},BPC512,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",5,Antimicrobial,3 ± 0.4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7905,28026016,2017,AAAAA(TrPhNH2),AAAAA{nnr:TrPhNH2}{cyc:N-C},BPC514,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",5,Antimicrobial,16 ± 0.9 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7906,28026016,2017,AAAAA(TrPhNH2),AAAAA{nnr:TrPhNH2}{cyc:N-C},BPC514,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",5,Antimicrobial,19 ± 0.8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7907,28026016,2017,AAAAA(TrPhNH2),AAAAA{nnr:TrPhNH2}{cyc:N-C},BPC514,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",5,Antimicrobial,23 ± 2 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7908,28026016,2017,NleNleNleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC562,Free,Free,Cyclic,L,Tr-Ph = triazole bearing a phenyl group,5,Antimicrobial,42 ± 5 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7909,28026016,2017,NleNleNleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC562,Free,Free,Cyclic,L,Tr-Ph = triazole bearing a phenyl group,5,Antimicrobial,51 ± 3 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7910,28026016,2017,NleNleNleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC562,Free,Free,Cyclic,L,Tr-Ph = triazole bearing a phenyl group,5,Antimicrobial,58 ± 1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7911,28026016,2017,NleNleNleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC572,Free,Free,Cyclic,L,Tr-Ph-NH2 = triazole bearing an aniline moiety,5,Antimicrobial,8 ± 0.2 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7912,28026016,2017,NleNleNleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC572,Free,Free,Cyclic,L,Tr-Ph-NH2 = triazole bearing an aniline moiety,5,Antimicrobial,13 ± 0.2 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7913,28026016,2017,NleNleNleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC572,Free,Free,Cyclic,L,Tr-Ph-NH2 = triazole bearing an aniline moiety,5,Antimicrobial,25 ± 5 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7914,28026016,2017,NleNleNleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC558,Free,Free,Cyclic,L,Tr-PhOMe = triazole bearing an anisole moiety,5,Antimicrobial,54 ± 4 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7915,28026016,2017,NleNleNleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC558,Free,Free,Cyclic,L,Tr-PhOMe = triazole bearing an anisole moiety,5,Antimicrobial,76 ± 8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7916,28026016,2017,NleNleNleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC558,Free,Free,Cyclic,L,Tr-PhOMe = triazole bearing an anisole moiety,5,Antimicrobial,90 ± 8 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7917,28026016,2017,KKKKK(COTr),KKKKK{nnr:COTr}{cyc:N-C},BPC690,Free,Free,Cyclic,L,Tr = unsubsituted triazole,5,Antimicrobial,47 ± 7 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7918,28026016,2017,KKKKK(COTr),KKKKK{nnr:COTr}{cyc:N-C},BPC690,Free,Free,Cyclic,L,Tr = unsubsituted triazole,5,Antimicrobial,67 ± 8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7919,28026016,2017,KKKKK(COTr),KKKKK{nnr:COTr}{cyc:N-C},BPC690,Free,Free,Cyclic,L,Tr = unsubsituted triazole,5,Antimicrobial,75 ± 7 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7920,28026016,2017,KKKKK(COTrBn),KKKKK{nnr:COTrBn}{cyc:N-C},BPC694,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,57 ± 5 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7921,28026016,2017,KKKKK(COTrBn),KKKKK{nnr:COTrBn}{cyc:N-C},BPC694,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,74 ± 15 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7922,28026016,2017,KKKKK(COTrBn),KKKKK{nnr:COTrBn}{cyc:N-C},BPC694,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,93 ± 15 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7923,28026016,2017,KKKKK(COTrNle),KKKKK{nnr:COTrNle}{cyc:N-C},BPC698,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,3 ± 0.5 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7924,28026016,2017,KKKKK(COTrNle),KKKKK{nnr:COTrNle}{cyc:N-C},BPC698,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,4 ± 1 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7925,28026016,2017,KKKKK(COTrNle),KKKKK{nnr:COTrNle}{cyc:N-C},BPC698,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,5 ± 0.7 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
8455,38794259,2024,AVNIPFKVHFRCKAAFC,AVNIPFKVHFRCKAAFC,OSTI−1949,Free,Free,Linear,L,None,17,Antimicrobial,20 % Hemolysis at 287.8 µM,Horse,Kunitz-Type Inhibitor From Odorrana Schmackeri,α-Helical,NA,CCCSSCCCSCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C
8456,38794259,2024,VIFKVFWRCKAAFC,VIFKVFWRCKAAFC,OSTI−1716,Free,Free,Linear,L,None,14,Antimicrobial,20 % Hemolysis at 270.4 µM,Horse,Osti−1949 Analogues,α-Helical,NA,CCCSSCCCSCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C
8457,38794259,2024,IKFKVHFRCKAAFC,IKFKVHFRCKAAFC,OSTI−1696,Free,Free,Linear,L,None,14,Antimicrobial,20 % Hemolysis at 297.7 µM,Horse,Osti−1949 Analogues,β-Strand,NA,CCCSSCCCSCCCTTSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C
8458,38794259,2024,AVKRAVKRFKVHFRCKAAFC,AVKRAVKRFKVHFRCKAAFC,OSTI−2363,Free,Free,Linear,L,None,20,Antimicrobial,20 % Hemolysis at 555.4 µM,Horse,Osti−1949 Analogues,β-Strand,NA,CCCSCCC,CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
8459,38794259,2024,AVNIPFKVHFKVHFRCKAAFC,AVNIPFKVHFKVHFRCKAAFC,OSTI−2461,Free,Free,Linear,L,None,20,Antimicrobial,20 % Hemolysis at 304.2 µM,Horse,Osti−1949 Analogues,α-Helical,NA,CTTHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
8533,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 2 µM,Horse,Synthetic,α-Helical,NA,CCCCCSSSSCSCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8534,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<10 % Hemolysis at 4 µM,Horse,Synthetic,α-Helical,NA,CCCCCSSSSCSCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8535,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 8 µM,Horse,Synthetic,α-Helical,NA,CCCCCSSSSCSCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8536,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 16 µM,Horse,Synthetic,α-Helical,NA,CCCCCSSSSCSCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8537,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 32 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8538,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 64 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8539,38673786,2024,KKPKPKPKPWWWW,KKPKPKPKPWWWW{ct:Amid},K9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 128 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8540,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8541,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 4 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8542,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 8 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8543,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 16 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8544,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 32 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8545,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 64 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8546,38673786,2024,KKPRPRPRPWWWW,KKPRPRPRPWWWW{ct:Amid},KR9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<40 % Hemolysis at 128 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8547,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8548,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 4 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8549,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 8 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8550,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<20 % Hemolysis at 16 µM,Horse,Synthetic,α-Helical,NA,CCCCCTTSSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8551,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<30 % Hemolysis at 32 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8552,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<50 % Hemolysis at 64 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8553,38673786,2024,RRPRPRPRPWWWW,RRPRPRPRPWWWW{ct:Amid},R9W4,Amidation,Free,Linear,L,None,13,Antibacterial,<80 % Hemolysis at 128 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8554,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8555,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<20 % Hemolysis at 4 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8556,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<40 % Hemolysis at 8 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8557,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<70 % Hemolysis at 16 µM,Horse,Synthetic,α-Helical,NA,CCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8558,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<120 % Hemolysis at 32 µM,Horse,Synthetic,α-Helical,NA,CCCHHHHSSTTTCCSCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8559,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<120 % Hemolysis at 64 µM,Horse,Synthetic,α-Helical,NA,CCCHHHHSSTTTCCSCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8560,38673786,2024,RRPRPRPRPWWWWW,RRPRPRPRPWWWWW{ct:Amid},R9W5,Amidation,Free,Linear,L,None,14,Antibacterial,<120 % Hemolysis at 128 µM,Horse,Synthetic,α-Helical,NA,CCCHHHHSSTTTCCSCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
8561,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8562,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 4 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8563,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 8 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8564,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<20 % Hemolysis at 16 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8565,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<40 % Hemolysis at 32 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CBCCTTCCSSCCCSSSSSTTBSCSGGGSSSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8566,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<40 % Hemolysis at 64 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CCSSCCSCSSSSSCCCCCCSCIIIIISSSSBSSSSBCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8567,38673786,2024,ILRWPWWPWRRK,ILRWPWWPWRRK{ct:Amid},Omiganan,Amidation,Free,Linear,L,None,12,Antibacterial,<40 % Hemolysis at 128 µM,Horse,Synthetic Analog To Indolicidin,α-Helical,NA,CHHHHHGGGTTCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
8568,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<20 % Hemolysis at 2 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8569,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<40 % Hemolysis at 4 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CTHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8570,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<70 % Hemolysis at 8 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHGGGTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8571,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<120 % Hemolysis at 16 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8572,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<120 % Hemolysis at 32 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CTHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8573,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<120 % Hemolysis at 64 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHGGGTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8574,38673786,2024,FFHHIFRGIVHVGKTIHRLVTG,FFHHIFRGIVHVGKTIHRLVTG{ct:Amid},Piscidin 1,Amidation,Free,Linear,L,None,22,Antibacterial,<120 % Hemolysis at 128 µM,Horse,Mast Cells Of Fish,α-Helical,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C
8622,37760707,2024,VKVGINGFGRIGRLVTRAAFHGKKVAIVAINA,VKVGINGFGRIGRLVTRAAFHGKKVAIVAINA{ct:Amid},Analog 5,Amidation,Free,Linear,L,None,33,Antimicrobial,14.1 % Hemolysis at 1024 μg/ml,Horse,Analog Of Sjgap,α-Helical,NA,CCSSSCCHHHHHHHHHHHHHHHSSSCCSTTGGGTHHHHHHHHHHHGGGSHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8623,37760707,2024,VKVGINGFGRIGRLVTRAAFHGKKVAIVAINA,VKVGINGFGRIGRLVTRAAFHGKKVAIVAINA{ct:Amid},Analog 5,Amidation,Free,Linear,L,None,33,Antimicrobial,11.8 % Hemolysis at 512 μg/ml,Horse,Analog Of Sjgap,α-Helical,NA,CCSSSCCHHHHHHHHHHHHHHHSSSCCSTTGGGTHHHHHHHHHHHGGGSHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8624,37760707,2024,VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND,VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid},Analog 1(SJGAP),Amidation,Free,Linear,L,None,33,Antimicrobial,<4 % Hemolysis at 1024 μg/ml,Horse,Skipjack Tuna Glyceraldehyde-3-Phosphate Dehydrogenase (Gapdh)-Related Peptide (Sjgap),α-Helical,NA,CCSSSCCHHHHHHHHHHHHHHHSSSCCSTTGGGTHHHHHHHHHHHGGGSHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8625,37760707,2024,VKVGINGFGRIGRLVTRAAFHGKKVKIVAINK,VKVGINGFGRIGRLVTRAAFHGKKVKIVAINK{ct:Amid},Analog 6,Amidation,Free,Linear,L,None,33,Antimicrobial,10 % Hemolysis at 1024 μg/ml,Horse,Analog Of Sjgap,α-Helical,NA,CCCTTCSTHHHHHHHHHHCCSTTTSGGGHHHHHHHHHHHHHHHTTCGGGHHHHHCGGGSSSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8626,37760707,2024,VKVGINGFGRIGRLVTRAAFHGKKVKIVAINK,VKVGINGFGRIGRLVTRAAFHGKKVKIVAINK{ct:Amid},Analog 6,Amidation,Free,Linear,L,None,33,Antimicrobial,<10 % Hemolysis at 512 μg/ml,Horse,Analog Of Sjgap,α-Helical,NA,CCCTTCSTHHHHHHHHHHCCSTTTSGGGHHHHHHHHHHHHHHHTTCGGGHHHHHCGGGSSSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8627,37760707,2024,VKVGINGFGRIGRLVTRLLFHGKKVEIVLIND,VKVGINGFGRIGRLVTRLLFHGKKVEIVLIND{ct:Amid},Analog 7,Amidation,Free,Linear,L,None,33,Antimicrobial,<10 % Hemolysis at 1024 μg/ml,Horse,Analog Of Sjgap,α-Helical,NA,CCCTTCSTHHHHHHHHHHCCSTTTSGGGHHHHHHHHHHHHHHHTTCGGGHHHHHCGGGSSSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8628,37760707,2024,VKVGINGFGRIGRLVTRLLFHGKKVEIVLIND,VKVGINGFGRIGRLVTRLLFHGKKVEIVLIND{ct:Amid},Analog 7,Amidation,Free,Linear,L,None,33,Antimicrobial,<6 % Hemolysis at 512 μg/ml,Horse,Analog Of Sjgap,α-Helical,NA,CCCTTCSTHHHHHHHHHHCCSTTTSGGGHHHHHHHHHHHHHHHTTCGGGHHHHHCGGGSSSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8629,37760707,2024,VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND,VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid},Analog 8,Amidation,Free,Linear,L,None,33,Antimicrobial,<6 % Hemolysis at 1024 μg/ml,Horse,Analog Of Sjgap,α-Helical,NA,CHHHHHHHHHHHHHHHHHCCSHHHHHHTHHHHHHHHHHHTTTTTSSTTHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8630,37760707,2024,VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND,VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid},Analog 8,Amidation,Free,Linear,L,None,33,Antimicrobial,4 % Hemolysis at 512 μg/ml,Horse,Analog Of Sjgap,α-Helical,NA,CHHHHHHHHHHHHHHHHHCCSHHHHHHTHHHHHHHHHHHTTTTTSSTTHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)CC
8706,29219046,2017,FFGSTIGALANFLPSLISKIRN,FFGSTIGALANFLPSLISKIRN{ct:Amid},brevinin-1ULf,Amidation,Free,Linear,L,None,22,Antimicrobial Peptides,13.1 % Hemolysis at 32 μg/ml,Horse,Brown Frog Rana Ulma,NA,NA,CTHHHHHTCCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
8707,29219046,2017,FFGSTIGALANFLPSLISKIRN,FFGSTIGALANFLPSLISKIRN{ct:Amid},brevinin-1ULf,Amidation,Free,Linear,L,None,22,Antimicrobial Peptides,54.7 % Hemolysis at 64 μg/ml,Horse,Brown Frog Rana Ulma,NA,NA,CTHHHHHTCCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
8708,29219046,2017,FFGSTIGALANFLPSLISKIRN,FFGSTIGALANFLPSLISKIRN{ct:Amid},brevinin-1ULf,Amidation,Free,Linear,L,None,22,Antimicrobial Peptides,90.1 % Hemolysis at 128 μg/ml,Horse,Brown Frog Rana Ulma,NA,NA,CCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
8709,29219046,2017,LALRTAGWLRLLGFRDKKKN,LALRTAGWLRLLGFRDKKKN,Ulmin-1ULa,Free,Free,Linear,L,None,20,Antimicrobial Peptides,4 % Hemolysis at 32 μg/ml,Horse,Brown Frog Rana Ulma,NA,NA,CTTSCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
8710,29219046,2017,LALRTAGWLRLLGFRDKKKN,LALRTAGWLRLLGFRDKKKN,Ulmin-1ULa,Free,Free,Linear,L,None,20,Antimicrobial Peptides,5 % Hemolysis at 64 μg/ml,Horse,Brown Frog Rana Ulma,NA,NA,CCCHHHHTTCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
8711,29219046,2017,LALRTAGWLRLLGFRDKKKN,LALRTAGWLRLLGFRDKKKN,Ulmin-1ULa,Free,Free,Linear,L,None,20,Antimicrobial Peptides,8 % Hemolysis at 128 μg/ml,Horse,Brown Frog Rana Ulma,NA,NA,CCCHHHHTTCCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O
8971,29191658,2018,FLPIVAKLLSGLL,FLPIVAKLLSGLL{ct:Amid},Temporin-PE,Amidation,Free,Linear,L,None,13,Antimicrobial,50 % Hemolysis at 39.64 µM,Horse,Frog(Pelophylax Kl. Esculentus),α-Helical,NA,CCCCSSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
8972,29191658,2018,FLYIVAKLLSGLL,FLYIVAKLLSGLL{ct:Amid},Temporin-PEa,Amidation,Free,Linear,L,None,13,Antimicrobial,50 % Hemolysis at 531.7 µM,Horse,Frog(Pelophylax Kl. Esculentus),α-Helical,NA,CCCSSSCSSSSCTTSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
8973,29191658,2018,FLPIVAKLLSGLLGRKKRRQRRR,FLPIVAKLLSGLLGRKKRRQRRR{ct:Amid},Temporin-PEb,Amidation,Free,Linear,L,None,23,Antimicrobial,50 % Hemolysis at 44.64 µM,Horse,Frog(Pelophylax Kl. Esculentus),α-Helical,NA,CCCCCSCCSSBCSSSBCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
9128,29643444,2018,TVLRGCWTFSFPPKPCI,TVLRGCWTFSFPPKPCI{ct:Amid},HECI,Amidation,Free,Linear,L,None,17,Anticancer,<15 % Hemolysis at 128 µM,Horse,Frogs (Hylarana Erythraea Chymotrypsin Inhibitor),NA,NA,CCSSSSSSSSSSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)O
9129,29643444,2018,TVLRGCWTKSFPPKPCI,TVLRGCWTKSFPPKPCI{ct:Amid},K9-HECI,Amidation,Free,Linear,L,None,17,Anti-proliferation of cancer cells,~5 % Hemolysis at 128 µM,Horse,Analogue Of Heci,NA,Low hemolytic,NA,NA
9149,29904274,2018,LNLKALLAVAKKIL,LNLKALLAVAKKIL{ct:Amid},MP-C,Amidation,Free,Linear,L,None,14,Antimicrobial,50 % Hemolysis at 40.11 µM,Horse,European Hornet (Vespa Crabro),"Random-coil at aq, α-Helical at membrane mimic solution",NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
9150,29904274,2018,CLNLKALLAVAKKILC,CLNLKALLAVAKKILC{cyc:N-C}{ct:Amid},cMP-C,Amidation,Free,Cyclic,L,None,16,Antimicrobial,50 % Hemolysis at 9.19 µM,Horse,Modifcation In Mp-C A Skeleton-Based Cyclization By Two Cysteine Residues,"α-Helical at aq, α-Helical at membrane mimic solution",NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
9151,29904274,2018,RKKRRQRRRLNLKALLAVAKKIL,RKKRRQRRRLNLKALLAVAKKIL{ct:Amid},tMP-C,Amidation,Free,Linear,L,None,23,Anticancer,50 % Hemolysis at 77.94 µM,Horse,Modifcation In Mp-N-Terminal Extension Via Tat-Linked,"Random-coil at aq, α-Helical at membrane mimic solution",NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
9203,30674824,2018,NapFFKK-OH,{nnr:Nap}FFKK-{nnr:OH}{nt:(Naphthalene-2-ly)-Acetylation}{ct:OH},(naphthalene-2-ly)-acetyl-diphenylalanine-dilysine-OH,OH,(Naphthalene-2-ly)-Acetylation,Linear,L,"OH = Hydroxy, Nap = (Naphthalene-2-ly)-acetyl",4,Antifungal and hydrogel forming properties,<2 % Hemolysis at 500 µM,Horse,Synthetic Ultrashort Peptide,β-Sheet,Non-hemolytic,NA,NA
9208,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,Cap18 - pure,Free,Free,Linear,L,None,37,Antimicrobial,1 ± 1 % Hemolysis at 64 μg/ml,Horse,Rabbit Neutrophils,α-Helical,Non-hemolytic,CHHHHHHHHTTHHHHHHHHHHHHHHHHSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9209,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,Cap18 - library,Free,Free,Linear,L,None,37,Antimicrobial,2 ± 1 % Hemolysis at 32 μg/ml,Horse,Rabbit Neutrophils,α-Helical,Non-hemolytic,CTHHHHHHHGGGHHHHHHHHHHHHHTTSSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9210,29852015,2018,GLRKRPRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRPRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,Peptide 1,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHTTHHHHHHHHHHHHHHHHSTTCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9211,29852015,2018,GLRKRLRKFLNKIKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFLNKIKEKLKKIGQKIQGLLPKLAPRTDY,Peptide 2,Free,Free,Linear,L,None,37,Antimicrobial,6 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,NA,CHHHHHHHHGGGHHHHHHHHHHHHHTTSSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9212,29852015,2018,GLRKRLRKFRNKDKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKDKEKLKKIGQKIQGLLPKLAPRTDY,Peptide 3,Free,Free,Linear,L,None,37,NA,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHGGGHHHHHHHHHHHHHTSTTSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9213,29852015,2018,GLRKRLRKFRNKFKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKFKEKLKKIGQKIQGLLPKLAPRTDY,Peptide 4,Free,Free,Linear,L,None,37,Antimicrobial,2 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHGGGHHHHHHHHHHHTTTTSCCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9214,29852015,2018,GLRKRLRKFRNKHKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKHKEKLKKIGQKIQGLLPKLAPRTDY,Peptide 5,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHTTHHHHHHHHHHHHHHTTSSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9215,29852015,2018,GLRKRLRKFRNKMKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKMKEKLKKIGQKIQGLLPKLAPRTDY,Peptide 6,Free,Free,Linear,L,None,37,Antimicrobial,2 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CTHHHHHHHHTTHHHHHHHHHHHHHHHSCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9216,29852015,2018,GLRKRLRKFRNKQKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKQKEKLKKIGQKIQGLLPKLAPRTDY,Peptide 7,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHGGGHHHHHHHHHHHHHTTSCCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9217,29852015,2018,GLRKRLRKFRNKSKEKLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKSKEKLKKIGQKIQGLLPKLAPRTDY,Peptide 8,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CGGGTHHHHHTTGGGTTHHHHHHHHTTSCCCCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9218,29852015,2018,GLRKRLRKFRNKIKECLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKECLKKIGQKIQGLLPKLAPRTDY,Peptide 9,Free,Free,Linear,L,None,37,Antimicrobial,4 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Low hemolytic,CHHHHHHHHGGGGGGGTTHHHHHHHHSTTSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9219,29852015,2018,GLRKRLRKFRNKIKEDLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEDLKKIGQKIQGLLPKLAPRTDY,Peptide 10,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHHHHHHHHHHHHTTTHHHHSSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9220,29852015,2018,GLRKRLRKFRNKIKEFLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEFLKKIGQKIQGLLPKLAPRTDY,Peptide 11,Free,Free,Linear,L,None,37,Antimicrobial,9 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,NA,CHHHHHHHHGGGGGHHHHCCHHHHTTTTSCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9221,29852015,2018,GLRKRLRKFRNKIKEILKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEILKKIGQKIQGLLPKLAPRTDY,Peptide 12,Free,Free,Linear,L,None,37,Antimicrobial,10 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,NA,CHHHHHHHHGGGTTHHHHHHHHHHHTTSSCCSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9222,29852015,2018,GLRKRLRKFRNKIKELLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKELLKKIGQKIQGLLPKLAPRTDY,Peptide 13,Free,Free,Linear,L,None,37,Antimicrobial,14 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,NA,CHHHHHHHHTTHHHHHHHHHHHHHHTSSSSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9223,29852015,2018,GLRKRLRKFRNKIKEMLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEMLKKIGQKIQGLLPKLAPRTDY,Peptide 14,Free,Free,Linear,L,None,37,Antimicrobial,8 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,NA,CHHHHHHHHGGGHHHHHHHHHHHHHHHSSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9224,29852015,2018,GLRKRLRKFRNKIKEYLKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEYLKKIGQKIQGLLPKLAPRTDY,Peptide 15,Free,Free,Linear,L,None,37,Antimicrobial,9 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,NA,CHHHHHHHHTTHHHHHHHHHTHHHHTTSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9225,29852015,2018,GLRKRLRKFRNKIKEKDKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKDKKIGQKIQGLLPKLAPRTDY,Peptide 16,Free,Free,Linear,L,None,37,NA,0 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHTTHIIIIIIIIITTTSCSSCCSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9226,29852015,2018,GLRKRLRKFRNKIKEKKKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKKKKIGQKIQGLLPKLAPRTDY,Peptide 17,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHTTHHHHHHHHHHGGGGTTTTCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9227,29852015,2018,GLRKRLRKFRNKIKEKPKKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKPKKIGQKIQGLLPKLAPRTDY,Peptide 18,Free,Free,Linear,L,None,37,NA,0 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHGGGGGHHHHHHHHTTSCSSSCSCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9228,29852015,2018,GLRKRLRKFRNKIKEKLPKIGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLPKIGQKIQGLLPKLAPRTDY,Peptide 19,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHTTHHHHHHHHHHHHHHHHSCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9229,29852015,2018,GLRKRLRKFRNKIKEKLKKEGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKEGQKIQGLLPKLAPRTDY,Peptide 20,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHGGGHHHHHHHHHHHHHHHSTTCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9230,29852015,2018,GLRKRLRKFRNKIKEKLKKHGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKHGQKIQGLLPKLAPRTDY,Peptide 21,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHGGGHHHHHHHHHTTSSSSCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9231,29852015,2018,GLRKRLRKFRNKIKEKLKKNGQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKNGQKIQGLLPKLAPRTDY,Peptide 22,Free,Free,Linear,L,None,37,Antimicrobial,0 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHTTHHHHHHHHHHGGGGGTTTTTSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9232,29852015,2018,GLRKRLRKFRNKIKEKLKKICQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKICQKIQGLLPKLAPRTDY,Peptide 23,Free,Free,Linear,L,None,37,Antimicrobial,4 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Low hemolytic,CHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9233,29852015,2018,GLRKRLRKFRNKIKEKLKKILQKIQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKILQKIQGLLPKLAPRTDY,Peptide 24,Free,Free,Linear,L,None,37,Antimicrobial,7 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,NA,CHHHHHHHHTTHHHHHHHHHTHHHHHHHCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9234,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKCQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKCQGLLPKLAPRTDY,Peptide 25,Free,Free,Linear,L,None,37,Antimicrobial,2 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHTTHHHHHHHHHTHHHHHTSSSCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9235,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKDQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKDQGLLPKLAPRTDY,Peptide 26,Free,Free,Linear,L,None,37,NA,0 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHTTHHHHHHHHHTHHHHTTTTTCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9236,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKGQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKGQGLLPKLAPRTDY,Peptide 27,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CCCCCHHHHHHHHSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9237,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKNQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKNQGLLPKLAPRTDY,Peptide 28,Free,Free,Linear,L,None,37,NA,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CHHHHHHHHHHHHTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9238,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKSQGLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKSQGLLPKLAPRTDY,Peptide 29,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CTHHHHTHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O
9239,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQTLLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQTLLPKLAPRTDY,Peptide 30,Free,Free,Linear,L,None,37,Antimicrobial,2 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC
9240,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQGPLPKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGPLPKLAPRTDY,Peptide 31,Free,Free,Linear,L,None,37,Antimicrobial,1 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Non-hemolytic,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9241,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQGLLAKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLAKLAPRTDY,Peptide 32,Free,Free,Linear,L,None,37,Antimicrobial,4 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Low hemolytic,CCBTTBTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9242,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQGLLDKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLDKLAPRTDY,Peptide 33,Free,Free,Linear,L,None,37,Antimicrobial,3 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Low hemolytic,CCGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9243,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQGLLFKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLFKLAPRTDY,Peptide 34,Free,Free,Linear,L,None,37,Antimicrobial,7 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,NA,CCGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9244,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQGLLHKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLHKLAPRTDY,Peptide 35,Free,Free,Linear,L,None,37,Antimicrobial,3 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Low hemolytic,CTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9245,29852015,2018,GLRKRLRKFRNKIKEKLKKIGQKIQGLLSKLAPRTDY,GLRKRLRKFRNKIKEKLKKIGQKIQGLLSKLAPRTDY,Peptide 36,Free,Free,Linear,L,None,37,Antimicrobial,4 % Hemolysis at 64 μg/ml,Horse,Cap18 Derivatives,NA,Low hemolytic,CCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC
9280,30108987,2018,KP FFKP FFKP FFK,{nnr:KP}FF{nnr:KP}FF{nnr:KP}FFK{nt:H}{ct:Amid},CAP11,Amidation,H,Linear,L,KP = phosphonium isostere of (trimethyl)lysine,10,Antimicrobial,1.5 ± 0.1 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,Non-hemolytic,NA,NA
9281,30108987,2018,RP FFRP FFRP FFRP,{nnr:RP}FF{nnr:RP}FF{nnr:RP}FF{nnr:RP}{nt:H}{ct:Amid},CAP12,Amidation,H,Linear,L,RP = phosphonium side chain length comparable o that of arginine,10,Antimicrobial,3.1 ± 0.1 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,Low hemolytic,NA,NA
9282,30108987,2018,KP WWKP WWKP WWKP,{nnr:KP}WW{nnr:KP}WW{nnr:KP}WW{nnr:KP}{nt:H}{ct:Amid},CAP13,Amidation,H,Linear,L,KP = phosphonium isostere of (trimethyl)lysine,10,NA,11.0 ± 1.6 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,NA,NA,NA
9283,30108987,2018,RP WWRP WWRP WWRP,{nnr:RP}WW{nnr:RP}WW{nnr:RP}WW{nnr:RP}{nt:H}{ct:Amid},CAP14,Amidation,H,Linear,L,RP = phosphonium side chain length comparable o that of arginine,10,NA,5.8 ± 1.0 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,NA,NA,NA
9284,30108987,2018,KP LLKP LLKP LLKP,{nnr:KP}LL{nnr:KP}LL{nnr:KP}LL{nnr:KP}{nt:H}{ct:Amid},CAP15,Amidation,H,Linear,L,KP = phosphonium isostere of (trimethyl)lysine,10,NA,2.1 ± 0.5 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,Low hemolytic,CCTTHHHHHHHHHHHHHHHHHC,NA
9285,30108987,2018,RP LLRP LLRP LLRP,{nnr:RP}LL{nnr:RP}LL{nnr:RP}LL{nnr:RP}{nt:H}{ct:Amid},CAP16,Amidation,H,Linear,L,RP = phosphonium side chain length comparable o that of arginine,10,NA,0.6 ± 0.2 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,Non-hemolytic,CCCCCCCCCCCCSCCCTTC,NA
9286,30108987,2018,KP IIKP IIKP IIKP,{nnr:KP}II{nnr:KP}II{nnr:KP}II{nnr:KP}{nt:H}{ct:Amid},CAP17,Amidation,H,Linear,L,KP = phosphonium isostere of (trimethyl)lysine,10,NA,2.3 ± 1.5 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,Low hemolytic,CHHHHHHHHHHHHTTC,NA
9287,30108987,2018,RP IIRP IIRP IIRP,{nnr:RP}II{nnr:RP}II{nnr:RP}II{nnr:RP}{nt:H}{ct:Amid},CAP18,Amidation,H,Linear,L,RP = phosphonium side chain length comparable o that of arginine,10,NA,3.9 ± 0.7 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,Low hemolytic,CHHHHHHHHHHHHTTC,NA
9288,30108987,2018,KRWWKWIRW,KRWWKWIRW{nt:H}{ct:Amid},HHC10,Amidation,H,Linear,L,None,9,Antimicrobial,14.3 ± 3.6 % Hemolysis at 512 µM,Horse,Phosphonium Based Cationic Amphiphilic Peptides,NA,NA,CCSCCCCCSSSCCSSCCSSCCCCCCCTTTSTTSSSCSSSCCCSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
9315,30052685,2018,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antibacterial,43 ± 1.4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
9316,30052685,2018,C5H11CO-KKLFKKILKYL,KKLFKKILKYL{nt:hexanoyl}{ct:Amid},BP367,Amidation,hexanoyl,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,83 ± 6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9317,30052685,2018,K(COC5H11)KLFKKILKYL,K{conj:COC5H11}KLFKKILKYL{nt:Acet}{ct:Amid},BP368,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,96 ± 0.9 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9318,30052685,2018,KK(COC5H11)LFKKILKYL,KK{conj:COC5H11}LFKKILKYL{nt:Acet}{ct:Amid},BP369,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,84 ± 8 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9319,30052685,2018,KKK(COC5H11)FKKILKYL,KKK{conj:COC5H11}FKKILKYL{nt:Acet}{ct:Amid},BP370,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antimicrobial,11 ± 2 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9320,30052685,2018,KKLK(COC5H11)KKILKYL,KKLK{conj:COC5H11}KKILKYL{nt:Acet}{ct:Amid},BP371,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,75 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9321,30052685,2018,KKLFK(COC5H11)KILKYL,KKLFK{conj:COC5H11}KILKYL{nt:Acet}{ct:Amid},BP372,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,97 ± 2 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9322,30052685,2018,KKLFKK(COC5H11)ILKYL,KKLFKK{conj:COC5H11}ILKYL{nt:Acet}{ct:Amid},BP373,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,92 ± 1 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9323,30052685,2018,KKLFKKK(COC5H11)LKYL,KKLFKKK{conj:COC5H11}LKYL{nt:Acet}{ct:Amid},BP374,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,19 ± 3 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9324,30052685,2018,KKLFKKIK(COC5H11)KYL,KKLFKKIK{conj:COC5H11}KYL{nt:Acet}{ct:Amid},BP375,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,70 ± 6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9325,30052685,2018,KKLFKKILK(COC5H11)YL,KKLFKKILK{conj:COC5H11}YL{nt:Acet}{ct:Amid},BP376,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,90 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9326,30052685,2018,KKLFKKILKK(COC5H11)L,KKLFKKILKK{conj:COC5H11}L{nt:Acet}{ct:Amid},BP377,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,92 ± 5 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9327,30052685,2018,KKLFKKILKYK(COC5H11),KKLFKKILKYK{conj:COC5H11}{nt:Acet}{ct:Amid},BP378,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antimicrobial,26 ± 0.4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9328,30052685,2018,C3H7CO-KKLFKKILKYL,KKLFKKILKYL{nt:butanoyl}{ct:Amid},BP379,Amidation,butanoyl,Linear,L,COC3H7 = butanoyl,11,Antibacterial,93 ± 0.8 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9329,30052685,2018,K(COC3H7)KLFKKILKYL,K{conj:COC3H7}KLFKKILKYL{nt:Acet}{ct:Amid},BP380,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,93 ± 6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9330,30052685,2018,KK(COC3H7)LFKKILKYL,KK{conj:COC3H7}LFKKILKYL{nt:Acet}{ct:Amid},BP381,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antimicrobial,54 ± 6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9331,30052685,2018,KKK(COC3H7)FKKILKYL,KKK{conj:COC3H7}FKKILKYL{nt:Acet}{ct:Amid},BP382,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 0.9 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9332,30052685,2018,KKLK(COC3H7)KKILKYL,KKLK{conj:COC3H7}KKILKYL{nt:Acet}{ct:Amid},BP383,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,22 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9333,30052685,2018,KKLFK(COC3H7)KILKYL,KKLFK{conj:COC3H7}KILKYL{nt:Acet}{ct:Amid},BP384,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9334,30052685,2018,KKLFKK(COC3H7)ILKYL,KKLFKK{conj:COC3H7}ILKYL{nt:Acet}{ct:Amid},BP385,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 3 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9335,30052685,2018,KKLFKKK(COC3H7)LKYL,KKLFKKK{conj:COC3H7}LKYL{nt:Acet}{ct:Amid},BP386,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,NA,1 ± 0.1 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,Non-hemolytic,NA,NA
9336,30052685,2018,KKLFKKIK(COC3H7)KYL,KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid},BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antimicrobial,14 ± 0.5 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9337,30052685,2018,KKLFKKILK(COC3H7)YL,KKLFKKILK{conj:COC3H7}YL{nt:Acet}{ct:Amid},BP388,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,38 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9338,30052685,2018,KKLFKKILKK(COC3H7)L,KKLFKKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},BP389,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antimicrobial,22 ± 2 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9339,30052685,2018,KKLFKKILKYK(COC3H7),KKLFKKILKYK{conj:COC3H7}{nt:Acet}{ct:Amid},BP390,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,5 ± 0.3 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,Low hemolytic,NA,NA
9340,30052685,2018,C11H23CO-KKLFKKILKYL,KKLFKKILKYL{nt:lauroyl}{ct:Amid},BP391,Amidation,lauroyl,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 0.9 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9341,30052685,2018,K(COC11H23)KLFKKILKYL,K{conj:COC11H23}KLFKKILKYL{nt:Acet}{ct:Amid},BP392,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 0.9 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9342,30052685,2018,KK(COC11H23)LFKKILKYL,KK{conj:COC11H23}LFKKILKYL{nt:Acet}{ct:Amid},BP393,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,97 ± 0.6 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9343,30052685,2018,KKK(COC11H23)FKKILKYL,KKK{conj:COC11H23}FKKILKYL{nt:Acet}{ct:Amid},BP394,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 1 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9344,30052685,2018,KKLK(COC11H23)KKILKYL,KKLK{conj:COC11H23}KKILKYL{nt:Acet}{ct:Amid},BP395,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 2 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9345,30052685,2018,KKLFK(COC11H23)KILKYL,KKLFK{conj:COC11H23}KILKYL{nt:Acet}{ct:Amid},BP396,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9346,30052685,2018,KKLFKK(COC11H23)ILKYL,KKLFKK{conj:COC11H23}ILKYL{nt:Acet}{ct:Amid},BP397,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9347,30052685,2018,KKLFKKK(COC11H23)LKYL,KKLFKKK{conj:COC11H23}LKYL{nt:Acet}{ct:Amid},BP398,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 3 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9348,30052685,2018,KKLFKKIK(COC11H23)KYL,KKLFKKIK{conj:COC11H23}KYL{nt:Acet}{ct:Amid},BP399,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 5 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9349,30052685,2018,KKLFKKILK(COC11H23)YL,KKLFKKILK{conj:COC11H23}YL{nt:Acet}{ct:Amid},BP400,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,99 ± 0.4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9350,30052685,2018,KKLFKKILKK(COC11H23)L,KKLFKKILKK{conj:COC11H23}L{nt:Acet}{ct:Amid},BP401,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 1 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9351,30052685,2018,KKLFKKILKYK(COC11H23),KKLFKKILKYK{conj:COC11H23}{nt:Acet}{ct:Amid},BP402,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 4 % Hemolysis at 250 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9352,30052685,2018,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antibacterial,57 ± 4.6 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
9353,30052685,2018,C5H11CO-KKLFKKILKYL,KKLFKKILKYL{nt:hexanoyl}{ct:Amid},BP367,Amidation,hexanoyl,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,95 ± 13 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9354,30052685,2018,K(COC5H11)KLFKKILKYL,K{conj:COC5H11}KLFKKILKYL{nt:Acet}{ct:Amid},BP368,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,97 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9355,30052685,2018,KK(COC5H11)LFKKILKYL,KK{conj:COC5H11}LFKKILKYL{nt:Acet}{ct:Amid},BP369,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,86 ± 8 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9356,30052685,2018,KKK(COC5H11)FKKILKYL,KKK{conj:COC5H11}FKKILKYL{nt:Acet}{ct:Amid},BP370,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antimicrobial,14 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9357,30052685,2018,KKLK(COC5H11)KKILKYL,KKLK{conj:COC5H11}KKILKYL{nt:Acet}{ct:Amid},BP371,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,95 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9358,30052685,2018,KKLFK(COC5H11)KILKYL,KKLFK{conj:COC5H11}KILKYL{nt:Acet}{ct:Amid},BP372,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,100 ± 0.9 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9359,30052685,2018,KKLFKK(COC5H11)ILKYL,KKLFKK{conj:COC5H11}ILKYL{nt:Acet}{ct:Amid},BP373,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,95 ± 6 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9360,30052685,2018,KKLFKKK(COC5H11)LKYL,KKLFKKK{conj:COC5H11}LKYL{nt:Acet}{ct:Amid},BP374,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,28 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9361,30052685,2018,KKLFKKIK(COC5H11)KYL,KKLFKKIK{conj:COC5H11}KYL{nt:Acet}{ct:Amid},BP375,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,86 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9362,30052685,2018,KKLFKKILK(COC5H11)YL,KKLFKKILK{conj:COC5H11}YL{nt:Acet}{ct:Amid},BP376,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,89 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9363,30052685,2018,KKLFKKILKK(COC5H11)L,KKLFKKILKK{conj:COC5H11}L{nt:Acet}{ct:Amid},BP377,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antibacterial,89 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9364,30052685,2018,KKLFKKILKYK(COC5H11),KKLFKKILKYK{conj:COC5H11}{nt:Acet}{ct:Amid},BP378,Amidation,Acetylation,Linear,L,COC5H11 = hexanoyl,11,Antimicrobial,52 ± 6 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9365,30052685,2018,C3H7CO-KKLFKKILKYL,KKLFKKILKYL{nt:butanoyl}{ct:Amid},BP379,Amidation,butanoyl,Linear,L,COC3H7 = butanoyl,11,Antibacterial,96 ± 1 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9366,30052685,2018,K(COC3H7)KLFKKILKYL,K{conj:COC3H7}KLFKKILKYL{nt:Acet}{ct:Amid},BP380,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,97 ± 5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9367,30052685,2018,KK(COC3H7)LFKKILKYL,KK{conj:COC3H7}LFKKILKYL{nt:Acet}{ct:Amid},BP381,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antimicrobial,76 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9368,30052685,2018,KKK(COC3H7)FKKILKYL,KKK{conj:COC3H7}FKKILKYL{nt:Acet}{ct:Amid},BP382,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9369,30052685,2018,KKLK(COC3H7)KKILKYL,KKLK{conj:COC3H7}KKILKYL{nt:Acet}{ct:Amid},BP383,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,40 ± 4 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9370,30052685,2018,KKLFK(COC3H7)KILKYL,KKLFK{conj:COC3H7}KILKYL{nt:Acet}{ct:Amid},BP384,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9371,30052685,2018,KKLFKK(COC3H7)ILKYL,KKLFKK{conj:COC3H7}ILKYL{nt:Acet}{ct:Amid},BP385,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,100 ± 4 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9372,30052685,2018,KKLFKKK(COC3H7)LKYL,KKLFKKK{conj:COC3H7}LKYL{nt:Acet}{ct:Amid},BP386,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,NA,3 ± 0 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,Non-hemolytic,NA,NA
9373,30052685,2018,KKLFKKIK(COC3H7)KYL,KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid},BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antimicrobial,18 ± 1 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9374,30052685,2018,KKLFKKILK(COC3H7)YL,KKLFKKILK{conj:COC3H7}YL{nt:Acet}{ct:Amid},BP388,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,89 ± 10 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9375,30052685,2018,KKLFKKILKK(COC3H7)L,KKLFKKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},BP389,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antimicrobial,39 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9376,30052685,2018,KKLFKKILKYK(COC3H7),KKLFKKILKYK{conj:COC3H7}{nt:Acet}{ct:Amid},BP390,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,11,Antibacterial,7 ± 0.9 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,Low hemolytic,NA,NA
9377,30052685,2018,C11H23CO-KKLFKKILKYL,KKLFKKILKYL{nt:lauroyl}{ct:Amid},BP391,Amidation,lauroyl,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 0.5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9378,30052685,2018,K(COC11H23)KLFKKILKYL,K{conj:COC11H23}KLFKKILKYL{nt:Acet}{ct:Amid},BP392,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9379,30052685,2018,KK(COC11H23)LFKKILKYL,KK{conj:COC11H23}LFKKILKYL{nt:Acet}{ct:Amid},BP393,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,99 ± 0.5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9380,30052685,2018,KKK(COC11H23)FKKILKYL,KKK{conj:COC11H23}FKKILKYL{nt:Acet}{ct:Amid},BP394,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9381,30052685,2018,KKLK(COC11H23)KKILKYL,KKLK{conj:COC11H23}KKILKYL{nt:Acet}{ct:Amid},BP395,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 2 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9382,30052685,2018,KKLFK(COC11H23)KILKYL,KKLFK{conj:COC11H23}KILKYL{nt:Acet}{ct:Amid},BP396,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 7 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9383,30052685,2018,KKLFKK(COC11H23)ILKYL,KKLFKK{conj:COC11H23}ILKYL{nt:Acet}{ct:Amid},BP397,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9384,30052685,2018,KKLFKKK(COC11H23)LKYL,KKLFKKK{conj:COC11H23}LKYL{nt:Acet}{ct:Amid},BP398,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9385,30052685,2018,KKLFKKIK(COC11H23)KYL,KKLFKKIK{conj:COC11H23}KYL{nt:Acet}{ct:Amid},BP399,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 6 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9386,30052685,2018,KKLFKKILK(COC11H23)YL,KKLFKKILK{conj:COC11H23}YL{nt:Acet}{ct:Amid},BP400,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 14 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9387,30052685,2018,KKLFKKILKK(COC11H23)L,KKLFKKILKK{conj:COC11H23}L{nt:Acet}{ct:Amid},BP401,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 3 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9388,30052685,2018,KKLFKKILKYK(COC11H23),KKLFKKILKYK{conj:COC11H23}{nt:Acet}{ct:Amid},BP402,Amidation,Acetylation,Linear,L,COC11H23 = lauroyl,11,Antibacterial,100 ± 0.5 % Hemolysis at 375 µM,Horse,Cecropin A-Melittin Hybrid Peptide,NA,NA,NA,NA
9411,30087268,2018,ALWKDILKNAGKAALNEINQIVQ,ALWKDILKNAGKAALNEINQIVQ{ct:Amid},DPS3,Amidation,Free,Linear,L,None,23,Antimicrobial,50 % Hemolysis at 138.1 µM,Horse,Frog Phyllomedusa Sauvagii​,"aqueous = Random coils, membrane-mimicking solution = α-Helical",NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
9412,30087268,2018,ALWKKILKNAGKAALNKINQIVQ,ALWKKILKNAGKAALNKINQIVQ{ct:Amid},"K5, 17-DPS3",Amidation,Free,Linear,L,None,23,Antimicrobial,50 % Hemolysis at 14.98 µM,Horse,Analogs Of Dermaseptin-Ps3,"aqueous = Random coils, membrane-mimicking solution = α-Helical",NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
9413,30087268,2018,ALWKDILKNLLKAALNEINQIVQ,ALWKDILKNLLKAALNEINQIVQ{ct:Amid},"L10, 11-DPS3",Amidation,Free,Linear,L,None,23,"Antimicrobial, Anticancer",50 % Hemolysis at 3.44 µM,Horse,Analogs Of Dermaseptin-Ps3,"aqueous = Random coils, membrane-mimicking solution = α-Helical",NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
9479,30258724,2018,ALWKDLLKNVGKAAGKAVLNKVTDMVNQ,ALWKDLLKNVGKAAGKAVLNKVTDMVNQ{ct:Amid},DRS-CA-1,Amidation,Free,Linear,L,None,28,Antimicrobial,50 % Hemolysis at 114.7 µM,Horse,Callimedusa Camba(Phyllomedusa),α-Helical,NA,CCCCCCCTTCC,CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
9480,30258724,2018,ALWKSLLKNVGKAAGKAALNAVTDMVNQ,ALWKSLLKNVGKAAGKAALNAVTDMVNQ{ct:Amid},DRS-DU-1,Amidation,Free,Linear,L,None,28,Antimicrobial,50 % Hemolysis at 216.6 µM,Horse,Phyllomedusa Duellmani,α-Helical,NA,CCCCCCCTTCC,CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
9481,30258724,2018,ALWKSLLKNVGKA,ALWKSLLKNVGKA{ct:Amid},DP-1,Amidation,Free,Linear,L,None,13,Antimicrobial,50 % Hemolysis at >512 µM,Horse,Truncated Analogue,α-Helical,NA,CTTHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
9482,30258724,2018,GRKKRRQRRRGALWKSLLKNVGKA,GRKKRRQRRRGALWKSLLKNVGKA{ct:Amid},DP-2,Amidation,Free,Linear,L,None,24,Antimicrobial,50 % Hemolysis at >512 µM,Horse,Tat-Fused Dp-1,α-Helical,NA,CCSGGGHHHHGGGCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
9523,30322120,2018,FLGAVLKVAGKLVPAAICKISKKC,FLGAVLKVAGKLVPAAICKISKKC,Brevinin-1GHa,Free,Free,Linear,L,None,24,"Antibiofilm, Antibacterial, Antifungal",20 % Hemolysis at 16 µM,Horse,Frog Hylarana Guentheri,α-Helix,NA,CCBTTTBCSSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
9524,30322120,2018,FLGAVLKVAGKLVPAAI,FLGAVLKVAGKLVPAAI,Brevinin-1GHb,Free,Free,Linear,L,None,17,Antibacterial,20 % Hemolysis at 512 µM,Horse,Analogue Of Brevinin-1Gha,α-Helix,Low hemolytic,CCCSSCCCCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)O
9525,30322120,2018,FLGAVLKVCKISKKCAGKLVPAAI,FLGAVLKVCKISKKCAGKLVPAAI,Brevinin-1GHc,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal",20 % Hemolysis at 128 µM,Horse,Analogue Of Brevinin-1Gha,α-Helix,NA,CCCSTHHHHGGGHHHHSSSCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
9644,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,0 % Hemolysis at 2 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9645,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,1 % Hemolysis at 4 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9646,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,18.72 % Hemolysis at 16 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9647,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,32 % Hemolysis at 32 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9648,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,43 % Hemolysis at 64 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9649,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,67 % Hemolysis at 128 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CHHHHIIIIITTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9650,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,76 % Hemolysis at 256 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CCCSSSCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9651,30555431,2018,GLLSGILGAGKKIVCGLSGLC,GLLSGILGAGKKIVCGLSGLC,Nigrocin-HL,Free,Free,Linear,L,None,21,Antibacterial,85 % Hemolysis at 512 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CCCCCCCSCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
9652,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 2 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCCCCCCCSCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9653,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 4 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCCSSCCCCCCSSSCSSSCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9654,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 16 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCCCCCHHHHHHHHSCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9655,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,0 % Hemolysis at 32 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCTTTCCCCGGGGTSCSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9656,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,1 % Hemolysis at 64 µM,Horse,Frog Hylarana Latouchii,α-Helix,Non-hemolytic,CCCHHHHSSTTTCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9657,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,4 % Hemolysis at 128 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CGGGTHHHHTHHHHTTTSCCCCCCCCCCBTTTTBCHHHHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9658,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,11 % Hemolysis at 256 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CGGGGGCSHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9659,30555431,2018,GLLSGILGAGKKIVF,GLLSGILGAGKKIVF{ct:Amid},Nigrocin-HLM,Amidation,Free,Linear,L,None,15,Antibacterial,35 % Hemolysis at 512 µM,Horse,Frog Hylarana Latouchii,α-Helix,NA,CGGGGGCSHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
9769,30612735,2019,FLSLIPHIASGIASLVKNF,FLSLIPHIASGIASLVKNF{ct:Amid},Phylloseptin-PBa1,Amidation,Free,Linear,L,None,19,"Antimicrobial, Anticancer",50 % Hemolysis at 18.6 µM,Horse,Leaf Forg (Phyllomedusa Burmeisteri),α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
9770,30612735,2019,FLSLLPHIASGIASLVSKF,FLSLLPHIASGIASLVSKF{ct:Amid},Phylloseptin-PBa2,Amidation,Free,Linear,L,None,19,"Antimicrobial, Anticancer",50 % Hemolysis at 15.82 µM,Horse,Leaf Forg (Phyllomedusa Burmeisteri),α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
9771,30612735,2019,FLSLIPHIVSGVAALANHL,FLSLIPHIVSGVAALANHL{ct:Amid},Phylloseptin-PBa3,Amidation,Free,Linear,L,None,19,"Antimicrobial, Anticancer",50 % Hemolysis at 52.98 µM,Horse,Leaf Forg (Phyllomedusa Burmeisteri),α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
9936,30802593,2019,MFTLKKPLLLLFFLGTINLSLCEEERNADEEERRDDPEERDVEVEKRFIVPSIFLLKKAFCIALKKC,MFTLKKPLLLLFFLGTINLSLCEEERNADEEERRDDPEERDVEVEKRFIVPSIFLLKKAFCIALKKC,Japonicin-2LF,Free,Free,Linear,L,None,67,"Antibiofilm, Antimicrobial",> 80 % Hemolysis at 64 µM,Horse,Limnonectes Fujianensis (Fujian Large-Headed Frog),"aqueous = Random coil, membrane-mimic solutions = α-Helix",NA,CCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
10382,31242693,2019,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH},Ranatuerin-2Pb,OH,Free,Linear,L,None,34,"Antimicrobial, Antibiofilm",50 % Hemolysis at 16.11 µM,Horse,Frog Rana Pipiens,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix",NA,CCCCCCSTTCSSCSCCCSCSCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
10383,31242693,2019,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH},RPa,OH,Free,Linear,L,None,32,"Antimicrobial, Antibiofilm",50 % Hemolysis at 63.9 µM,Horse,Truncated Analogues Of Ranatuerin-2Pb,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix",NA,CEESSSEECCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
10384,31242693,2019,SFLTTVKKLVTNLAAL,SFLTTVKKLVTNLAAL{ct:Amid},RPb,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",50 % Hemolysis at 178 µM,Horse,Truncated Analogues Of Ranatuerin-2Pb,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix",NA,CCBCCSSSSSBSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
10385,31242693,2019,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH},Ranatuerin-2Pb,OH,Free,Linear,L,None,34,"Antimicrobial, Antibiofilm",20 % Hemolysis at 8 µM,Horse,Frog Rana Pipiens,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix",NA,CCCCCCSTTCSSCSCCCSCSCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
10386,31242693,2019,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH},RPa,OH,Free,Linear,L,None,32,"Antimicrobial, Antibiofilm",20 % Hemolysis at 32 µM,Horse,Truncated Analogues Of Ranatuerin-2Pb,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix",NA,CEESSSEECCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
10387,31242693,2019,SFLTTVKKLVTNLAAL,SFLTTVKKLVTNLAAL{ct:Amid},RPb,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",20 % Hemolysis at 64 µM,Horse,Truncated Analogues Of Ranatuerin-2Pb,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix",NA,CCBCCSSSSSBSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
10388,31261655,2019,MFTLKKSLLLLFFLGMVSLSLCEQERDADEDDNACEAKVENVKRVARPPGFTPFRVAPEIV,MFTLKKSLLLLFFLGMVSLSLCEQERDADEDDNACEAKVENVKRVARPPGFTPFRVAPEIV,RVA-Thr6-BK,Free,Free,Linear,L,None,61,NA,0 % Hemolysis at 256 µM,Horse,Frog Odorrana Hejiangensis,NA,Non-hemolytic,CCCCCCSTTCSSCSCCCSCSCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
10389,31261655,2019,MFTSKKSILLLFFLGAISLSLCEEERDADEDDTEGEAKVENVKRVALPPGFTPFRVAPEIV,MFTSKKSILLLFFLGAISLSLCEEERDADEDDTEGEAKVENVKRVALPPGFTPFRVAPEIV,"RVA-Leu1, Thr6-BK",Free,Free,Linear,L,None,61,NA,0 % Hemolysis at 256 µM,Horse,Frog Amolops Wuyiensis,NA,Non-hemolytic,CEESSSEECCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
10467,31426323,2019,ALWKTLLKHVGKAAGKAALNAVTDMVNQ,ALWKTLLKHVGKAAGKAALNAVTDMVNQ{ct:Amid},Der-PS4,Amidation,Free,Linear,L,None,28,"Antimicrobial, Antibiofilm, Antiproliferative, Anticancer",50 % Hemolysis at 128 µM,Horse,"Waxy Monkey Tree Frog, Phyllomedusa Sauvagii","mimetic environment(DOPE, DOPC and DOPG, TFE) = α-Helix",NA,CHHHHGGGGGTTC,CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
10641,31635388,2019,GLWSKIKDAAKTAGKAALGFVNEMV,GLWSKIKDAAKTAGKAALGFVNEMV,DPT9,Free,Free,Linear,L,None,25,"Antimicrobial, Antibiofilm, Anticancer",50 % Hemolysis at 210 µM,Horse,Derived From Frog Phyllomedusa Tarsius Dpt9,NA,NA,CGGGHHHHTTSCSTTTTTGGGGSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
10642,31635388,2019,GLWSKIKKAAKTAGKAALGFVNKMV,GLWSKIKKAAKTAGKAALGFVNKMV,"K8, 23-DPT9",Free,Free,Linear,L,None,25,"Antimicrobial, Antibiofilm, Anticancer",50 % Hemolysis at 107 µM,Horse,Analogue And Modified Dtp9,NA,Low hemolytic,CCCSSSSTTTCSCCTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
10643,31653005,2019,ALWKSILKNVGKAAGKAVLNAVTDMVNQ,ALWKSILKNVGKAAGKAVLNAVTDMVNQ{ct:Amid},DM-PC,Amidation,Free,Linear,L,None,28,Antimicrobial,>80 % Hemolysis at 256 µM,Horse,Frog Phyllomedusa Coelestis,"aqueous = Random coil, 50% TFE buffer = Helical",NA,CCTTHHHHHHHTTSGGGTHHHHGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C
10644,31653005,2019,ALWKSILKNVGKAAGKAVL,ALWKSILKNVGKAAGKAVL{ct:Amid},DMPC-19,Amidation,Free,Linear,L,None,19,Antimicrobial,<5 % Hemolysis at 256 µM,Horse,Dm-Pc Designed Truncated Derivatives,"aqueous = Random coil, 50% TFE buffer = Helical",Low hemolytic,CCSHHHHHHHTTCCSCTTTTTSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
10645,31653005,2019,ALWKKLLKKA,ALWKKLLKKA{ct:Amid},DMPC-10,Amidation,Free,Linear,L,None,10,Antimicrobial,<5 % Hemolysis at 256 µM,Horse,Dm-Pc Designed Truncated Derivatives,"aqueous = Random coil, 50% TFE buffer = Helical",Low hemolytic,CHHHHTTTTTSCCCCGGGGGTSSCCCC,CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10646,31653005,2019,ALWKKLLKK-Cha,ALWKKLLKK-{nnr:Cha}{ct:Amid},DMPC-10A,Amidation,Free,Linear,L,Cha = cyclohexylalanine,10,Antimicrobial,>35 % Hemolysis at 256 µM,Horse,Dm-Pc Designed Truncated Derivatives,"aqueous = Random coil, 50% TFE buffer = Helical",NA,NA,NA
11032,32397600,2020,SLWGKLKEMAAAAGKAALNAVNGLVNQ,SLWGKLKEMAAAAGKAALNAVNGLVNQ{ct:Amid},DRP-AC4,Amidation,Free,Linear,L,None,27,"Antimicrobial, Anti-biofilm",10 % Hemolysis at 26.25 µM,Horse,Frog Skin Agalychnis Callidryas(Dermaseptin),"aqueous = Random coil,50%(TFE) = α-Helix",NA,CCHHHHTTCSCGGGTGGGTSSSSCCCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
11033,32397600,2020,SLWGKLKEMLAKAGKAVANAVNGLANQ,SLWGKLKEMLAKAGKAVANAVNGLANQ{ct:Amid},DRP-AC4a,Amidation,Free,Linear,L,None,27,"Antimicrobial, Anti-biofilm",10 % Hemolysis at 14.49 µM,Horse,Analogue Of Drp-Ac4,"aqueous = Random coil,50%(TFE) = α-Helix",NA,CCGGGGCCTTSCGGGTSCCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
11034,32397600,2020,SLWGKLKEMLAAAGKAVANAVNGLANQ,SLWGKLKEMLAAAGKAVANAVNGLANQ{ct:Amid},DRP-AC4b,Amidation,Free,Linear,L,None,27,"Antimicrobial, Anti-biofilm",10 % Hemolysis at 21.53 µM,Horse,Analogue Of Drp-Ac4,"aqueous = Random coil,50%(TFE) = α-Helix",NA,CCGGGTSEEECSSCEEESCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
11049,32347293,2020,FLGALFKVASKLVPAAICSISKKC,FLGALFKVASKLVPAAICSISKKC,Brevinin-1GHd,Free,Free,Linear,L,None,24,"Antimicrobial, Anticancer, Antibiotic, Anti-biofilm",13 % Hemolysis at 32 µM,Horse,"Frog Skin, Hylarana Guenther","aqueous(10 mM NH4AC buffer) = Random coil, membrane-mimetic environment (50% TFE in 10 mM NH4AC)membrane-mimetic environment (50% TFE in 10 mM NH4AC) = α-Helix",NA,CTHHHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
11061,32582642,2020,ALWKDMLKGIGKLAGKAALGAVKTLV,ALWKDMLKGIGKLAGKAALGAVKTLV{ct:Amid},Dermaseptin-PP,Amidation,Free,Linear,L,None,26,"Antimicrobial, Anti-tumor",<20 % Hemolysis at 16 µM,Horse,Frog Phyllomedusa Palliata,50% TFE-10 mmol/L NH4Ac solution (MME) = α-Helical,NA,CTTHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C
11062,32582642,2020,ALWKDMLKGIGKLAGKAALGAVKTLV,ALWKDMLKGIGKLAGKAALGAVKTLV{ct:Amid},Dermaseptin-PP,Amidation,Free,Linear,L,None,26,"Antimicrobial, Anti-tumor",50 % Hemolysis at 38.77 µM,Horse,Frog Phyllomedusa Palliata,50% TFE-10 mmol/L NH4Ac solution (MME) = α-Helical,NA,CCHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C
11180,32630734,2020,FIQHLIPLIPHAIQGIKDIF,FIQHLIPLIPHAIQGIKDIF{ct:Amid},Kassiniatuerin-3,Amidation,Free,Linear,L,None,20,"Antimicrobial, Anti-biofilm, Antiproliferation",~2 % Hemolysis at 160 µM,Horse,Frog Kassina Senegalensis,"aqueous = Random coil, 50% TFE = Helical",Low hemolytic,CCTTTTTHHHHSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11451,32781587,2020,FLPLIAGLAAKFLPKIFCAITKKC,FLPLIAGLAAKFLPKIFCAITKKC,B1A,Free,Free,Linear,L,None,24,"Antibacterial, Antifungal",10 % Hemolysis at 1.576 µM,Horse,Modified From Brevinin-1 (Lithobates Palustris (Rana Palustris)) Frog,"aqueous, 1% SDS micelle solution = α-Helix",NA,CCCCCSCCTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11452,32781587,2020,FLPLIAGLAAKCAITKKC,FLPLIAGLAAKCAITKKC,B1A1,Free,Free,Linear,L,None,18,"Antibacterial, Antifungal",10 % Hemolysis at >512 µM,Horse,Truncated Analogue Of B1A,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",Low hemolytic,CCSCCCSCGGGTCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11453,32781587,2020,FLPKIFCAITKKC,FLPKIFCAITKKC,B1A2,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal",10 % Hemolysis at >512 µM,Horse,Truncated Analogue Of B1A,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",Low hemolytic,CCCSSSCCGGGSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11454,32781587,2020,KFLPKIFCAITKKC,KFLPKIFCAITKKC,KB2,Free,Free,Linear,L,None,14,"Antibacterial, Antifungal",10 % Hemolysis at 154 µM,Horse,Derived From B1A2,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCSSHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11455,32781587,2020,KKFLPKIFCAITKKC,KKFLPKIFCAITKKC,KKB2,Free,Free,Linear,L,None,15,"Antibacterial, Antifungal",10 % Hemolysis at 207 µM,Horse,Modification Of Kb2,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCSCCSSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11456,32781587,2020,KFLPWKIFCAITKKC,KFLPWKIFCAITKKC,KWB2,Free,Free,Linear,L,None,15,"Antibacterial, Antifungal",10 % Hemolysis at 99.81 µM,Horse,Modified From Kb2,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCSCCSSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11457,32781587,2020,KKFLPWKIFCAITKKC,KKFLPWKIFCAITKKC,KKWB2,Free,Free,Linear,L,None,16,"Antibacterial, Antifungal",10 % Hemolysis at 140.04 µM,Horse,Modification Of Kwb,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCSCCSSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11458,32781587,2020,KFWPWKIFCAITKKC,KFWPWKIFCAITKKC,"KW3,5B2",Free,Free,Linear,L,None,15,"Antibacterial, Antifungal",10 % Hemolysis at 32.07 µM,Horse,B1A Analogues,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCSCCSSSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11459,32781587,2020,KFLPWKWFCAITKKC,KFLPWKWFCAITKKC,"KW5,7B2",Free,Free,Linear,L,None,15,"Antibacterial, Antifungal",10 % Hemolysis at 58.42 µM,Horse,B1A Analogues,"aqueous = Random coil, 1% SDS micelle solution = α-Helix",NA,CCCCCCCCCCCCBTTTBCCSSCSTTHHHHTTTGGGTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11504,32872343,2020,SALRGCWTKSYPPKPCL,SALRGCWTKSYPPKPCL{ct:Amid},SL-BBI,Amidation,Free,Linear,L,None,17,Antimicrobial,≥5 % Hemolysis at 512 µM,Horse,Broad-Folded Frog (Sylvirana Latouchii),"NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet and Random coil",Non-hemolytic,CCCCSSHHHHHTCSSCCSSCCSGGGGTCCCCCCSSCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)O
11505,32872343,2020,AALRGCWTKSIPPKPCK,AALRGCWTKSIPPKPCK{ct:Amid},K-SL,Amidation,Free,Linear,L,None,17,Antimicrobial,≥5 % Hemolysis at 512 µM,Horse,Sl-Bbi Analogues,"NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet, Random coil and Helix",Non-hemolytic,CHHHHHHHHHTTSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O
11506,32872343,2020,SALRGCWTFSIPPKPCL,SALRGCWTFSIPPKPCL{ct:Amid},F-SL,Amidation,Free,Linear,L,None,17,"Antimicrobial, Anti-Cancer",≥10 % Hemolysis at 512 µM,Horse,Sl-Bbi Analogues,"NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet and Random coil",Low hemolytic,CTHHHHHHHHHHTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O
11550,32967333,2020,ALWKKLLKK-Cha,ALWKKLLKK-{nnr:Cha}{ct:Amid},DMPC-10A,Amidation,Free,Linear,L,Cha = Cyclohexanylalanine,10,"Antibacterial, Antibiofilm",≥20 % Hemolysis at 128 µM,Horse,Derived From A Dermaseptin (Phyllomedusa Frogs),amphipathic environment = α-Helix,NA,NA,NA
11551,32967333,2020,AlWkkllkk-Cha,AL{d}WK{d}K{d}L{d}L{d}K{d}K{d}-{nnr:Cha}{ct:Amid},DMPC-10B,Amidation,Free,Linear,Mix,Cha = Cyclohexanylalanine,10,"Antibacterial, Antibiofilm",0 % Hemolysis at 128 µM,Horse,Modificaiton Of Dmpc-10A,TFE = α-Helix,Non-hemolytic,NA,NA
11624,33193152,2020,FLSLIPKIAGGIAALVKNL,FLSLIPKIAGGIAALVKNL{ct:Amid},Phylloseptin-PV1 (PPV1),Amidation,Free,Linear,L,None,19,"Antimicrobial, Antiproliferative, Antibiofilm",≥50 % Hemolysis at 32 µM,Horse,White-Lined Leaf Frog Phyllomedusa Vaillantii,"aqueous = Random coil, 50% TFE = α-Helix",NA,CHHHHGGGGGGCSHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
11625,33193152,2020,FLSLIPKIAGGIAALVKNL,FLSLIPKIAGGIAALVKNL{ct:Amid},Phylloseptin-PV1 (PPV1),Amidation,Free,Linear,L,None,19,"Antimicrobial, Antiproliferative, Antibiofilm",≥95 % Hemolysis at 64 µM,Horse,White-Lined Leaf Frog Phyllomedusa Vaillantii,"aqueous = Random coil, 50% TFE = α-Helix",NA,CHHHHGGGGGGCSHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
11644,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C16},C16-fXXL,Free,C16,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,~10 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11645,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}L{nt:C14},C14-fXXL,Free,C14,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine",4,Antibacterial,~10 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11646,33085895,2020,fXXL,F{d}{nnr:X}{nnr:X}{nnr:L}{nt:C12},C12-fXXL,Free,C12,Linear,Mix,"X = L-2,4-diaminobutyric acid, f = D-phenylalanine, L = L-leucine",4,Antibacterial,<5 % Hemolysis at 5 μg/ml,Horse,Synthetic Lipopeptide,NA,NA,NA,NA
11773,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",>20 % Hemolysis at 32 µM,Horse,Frog Amolops Hainanensis,Helix,NA,CCSTTTSCSSCCCCCCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11774,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",50 % Hemolysis at 53.12 µM,Horse,Frog Amolops Hainanensis,Helix,NA,CTTHHHHTTSCCCSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11775,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",9.49 % Hemolysis at 4 µM,Horse,Frog Amolops Hainanensis,Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11776,32812694,2021,FALGAVTCLIRTKCKVLPKLF,FALGAVTCLIRTKCKVLPKLF,Brevinin-1Ha,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",22.1 % Hemolysis at 128 µM,Horse,Brevinin-1H Analogues,NA,NA,CTTHHHHHHHHHHHSSHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
11777,32812694,2021,FALGAVTKVLYKLFCLITRKC,FALGAVTKVLYKLFCLITRKC,Brevinin-1HY,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",28.48 % Hemolysis at 4 µM,Horse,Brevinin-1H Analogues,Helix,NA,CCSHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11830,33582221,2021,ALWKDLLKNVGIAAGKAALNKVTDMVNQ,ALWKDLLKNVGIAAGKAALNKVTDMVNQ{ct:Amid},DRS-TO,Amidation,Free,Linear,L,None,28,"Anticancer, Antimicrobial",50 % Hemolysis at 436.7 µM,Horse,Leaf Frog Phyllomedusa Tomopterna,Helical,Low hemolytic,CCCHHHHHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
11831,33582221,2021,ALWKTLLKNVGKAAGKAVLNAVTDMVNQ,ALWKTLLKNVGKAAGKAVLNAVTDMVNQ{ct:Amid},DRS-PS2,Amidation,Free,Linear,L,None,28,Antimicrobial,50 % Hemolysis at 210.7 µM,Horse,Waxy Monkey Tree Frog Phyllomedusa Sauvagii,Helical,Low hemolytic,CCTHHHHHHHTTTCC,CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
11910,34198776,2021,KKLFKKILKKL,KKLFKKILKKL{ct:Amid},BP16,Amidation,Free,Linear,L,None,11,Antibacterial,3 ± 3.5 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CGGGGTGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
11911,34198776,2021,RINSAKDDAAGLQIA,RINSAKDDAAGLQIA{ct:OH},flg15,OH,Free,Linear,L,None,15,Antibacterial,0 ± 0 % Hemolysis at 375 µM,Horse,Bacterial Flagellin,NA,Non-hemolytic,CGGGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
11912,34198776,2021,RINSAKDDAAGLQIA-KKLFKKILKKL,RINSAKDDAAGLQIA-KKLFKKILKKL{ct:Amid},BP358 (flg15-BP16),Amidation,Free,Linear,L,None,26,Antibacterial,5 ± 0.2 % Hemolysis at 375 µM,Horse,Combination Of Flg15 And Bp16,NA,Low hemolytic,CTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
11913,34198776,2021,KKLFKKILKKL-RINSAKDDAAGLQIA,KKLFKKILKKL-RINSAKDDAAGLQIA{ct:OH},BP359 (BP16-flg15),OH,Free,Linear,L,None,26,Antibacterial,0.8 ± 0.5 % Hemolysis at 375 µM,Horse,Combination Of Bp16 And Flg15,NA,Non-hemolytic,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
11955,34205705,2021,KKLfKKILKYL,KKLF{d}KKILKYL{nt:C5H11CO}{ct:Amid},BP472,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,11,"Antifungal, Antibacterial",78 ± 5 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11956,34205705,2021,KKLfKK(COC3H7)ILKYL,KKL{d}F{d}KK{conj:COC3H7}IL{d}KYL{d}{nt:Acet}{ct:Amid},BP473,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",84 ± 11 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11957,34205705,2021,KKLfKKIK(COC3H7)KYL,KKL{d}F{d}KKIK{conj:COC3H7}KYL{d}{nt:Acet}{ct:Amid},BP474,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",0 ± 0 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11958,34205705,2021,KKLfKKILKK(COC3H7)L,KKL{d}F{d}KKIL{d}KK{conj:COC3H7}L{d}{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",0 ± 0 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,α-Helical,Non-hemolytic,NA,NA
11959,34205705,2021,KKLfKKILKYK(COC11H23),KKL{d}F{d}KKIL{d}KYK{conj:COC11H23}{nt:Acet}{ct:Amid},BP476,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",94 ± 10 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11960,34205705,2021,KKLk(COC5H11)KKILKYL,KKL{d}k{conj:COC5H11}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP484,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",10 ± 2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11961,34205705,2021,KKLfKKILKYL,KKL{d}F{d}{d}KKIL{d}KYL{d}{nt:C3H7CO}{ct:Amid},BP485,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,11,"Antifungal, Antibacterial",24 ± 9 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11962,34205705,2021,KK(COC3H7)LfKKILKYL,KK{conj:COC3H7}L{d}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP486,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",14 ± 5 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11963,34205705,2021,KKLk(COC11H23)KKILKYL,KKL{d}k{conj:COC11H23}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP488,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",86 ± 14 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11964,34205705,2021,KKLfKKK(COC11H23)LKYL,KKL{d}F{d}KKK{conj:COC11H23}L{d}KYL{d}{nt:Acet}{ct:Amid},BP489,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 6 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11965,34205705,2021,KKLfKKIK(COC11H23)KYL,KKL{d}F{d}KKIK{conj:COC11H23}KYL{d}{nt:Acet}{ct:Amid},BP490,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 6 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11966,34205705,2021,KKLfKKK(COC5H11)LKYL,KKL{d}F{d}KKK{conj:COC5H11}L{d}KYL{d}{nt:Acet}{ct:Amid},BP494,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",0.2 ± 0.2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11967,34205705,2021,KKLfKKILKYK(COC5H11),KKL{d}F{d}KKIL{d}KYK{conj:COC5H11}{nt:Acet}{ct:Amid},BP495,Amidation,Acetylation,Linear,Mix,COC5H11 = hexanoyl,11,"Antifungal, Antibacterial",0.6 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11968,34205705,2021,KKLfKKILKYK(COC3H7),KKL{d}F{d}KKIL{d}KYK{conj:COC3H7}{nt:Acet}{ct:Amid},BP496,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",1 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,Non-hemolytic,NA,NA
11969,34205705,2021,KKLfKKILK(COC11H23)YL,KKL{d}F{d}KKIL{d}K{conj:COC11H23}YL{d}{nt:Acet}{ct:Amid},BP497,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",100 ± 2 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11970,34205705,2021,KKLfK(COC3H7)KILKYL,KKL{d}F{d}K{conj:COC3H7}KIL{d}KYL{d}{nt:Acet}{ct:Amid},BP498,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",21 ± 3 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11971,34205705,2021,KKLfKKILK(COC3H7)YL,KKL{d}F{d}KKIL{d}K{conj:COC3H7}YL{d}{nt:Acet}{ct:Amid},BP499,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,"Antifungal, Antibacterial",11 ± 1 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
11972,34205705,2021,KKK(COC11H23)fKKILKYL,KKK{conj:COC11H23}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid},BP500,Amidation,Acetylation,Linear,Mix,COC11H23 = lauroyl,11,"Antifungal, Antibacterial",71 ± 8 % Hemolysis at 256 µM,Horse,Synthetic Lipopeptides,NA,NA,NA,NA
12130,34342438,2021,RPFTRAQWFAIQHISPRTIAMRAINNYRWR,RPFTRAQWFAIQHISPRTIAMRAINNYRWR,hECP30,Free,Free,Linear,L,None,30,"Antimicrobial, Anti-biofilm",44 ± 4 % Hemolysis at 250 µM,Horse,Human Rnase 3 Eosinophil Cationic Protein (Ecp) Fragment,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",NA,CCCSSSSCCCCCSSCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12131,34342438,2021,OPFTOAQWFAIQHISPOTIAMOAINNYOWO,{nnr:O}PFT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},Orn analog,Free,Free,Linear,L,O = L-Ornithine,30,Antibacterial,10 ± 2 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",NA,NA,NA
12132,34342438,2021,XPFTXAQWFAIQHISPXTIAMXAINNYXWX,{nnr:X}PFT{nnr:X}AQWFAIQHISP{nnr:X}TIAM{nnr:X}AINNY{nnr:X}W{nnr:X},Dab analog,Free,Free,Linear,L,"X = L-2,4-diaminobutyric acid",30,Antibacterial,14 ± 6 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,NA,NA,NA,NA
12133,34342438,2021,ZPFTZAQWFAIQHISPZTIAMZAINNYZWZ,{nnr:Z}PFT{nnr:Z}AQWFAIQHISP{nnr:Z}TIAM{nnr:Z}AINNY{nnr:Z}W{nnr:Z},Har analog,Free,Free,Linear,L,Z = L-homoarginine,30,Antibacterial,43 ± 1 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,NA,NA,NA,NA
12134,34342438,2021,FTOAQWFAIQHISPOTIAMOAINNYOWO,FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},Des[Orn1-Pro2] analog,Free,Free,Linear,L,O = L-Ornithine,28,Antibacterial,11 ± 4 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,NA,NA,NA,NA
12135,34342438,2021,OpFTOAQWFAIQHISPOTIAMOAINNYOWO,{nnr:O}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},"[Orn,1D-Pro2] analog",Free,Free,Linear,Mix,"O = L-Ornithine, p = D-Proline",30,Antibacterial,1.1 ± 0.9 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",Low hemolytic,NA,NA
12136,34342438,2021,opFTOAQWFAIQHISPOTIAMOAINNYOWO,{nnr:o}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O},"[D-Orn,1D-Pro2] analog",Free,Free,Linear,Mix,"o = D-Ornithine, p = D-Proline",30,Antibacterial,3.6 ± 0.7 % Hemolysis at 250 µM,Horse,Hecp30 Analogs,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",Low hemolytic,NA,NA
12223,34738013,2021,FIPLVSGLFSKLL,FIPLVSGLFSKLL{ct:Amid},Temporin-FL,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",50 % Hemolysis at 157.4 µM,Horse,Frog Pelophylax Nigromaculatus,50%TFE/NH4Ac = Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12224,34738013,2021,FIPLVSGLFKLL,FIPLVSGLFKLL{ct:Amid},Temporin-FLa,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",50 % Hemolysis at 74.02 µM,Horse,Temporin-Fl Truncated Analogues,50%TFE/NH4Ac = Helix,NA,CCCTHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12225,34738013,2021,FIPVSGLFKLL,FIPVSGLFKLL{ct:Amid},Temporin-FLb,Amidation,Free,Linear,L,None,11,"Antimicrobial, Antibiofilm",50 % Hemolysis at 356 µM,Horse,Temporin-Fl Truncated Analogues,50%TFE/NH4Ac = Helix,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12226,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:OH},RR4-OH,OH,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",3.2 ± 1.0 % Hemolysis at 150 µM,Horse,Short Synthetic Peptide,NA,Low hemolytic,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12227,34819923,2021,WIRRIKKWIRRVHK,WIRRIKKWIRRVHK{ct:Amid},RR2-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",13.0 ± 1.7 % Hemolysis at 150 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
12228,34819923,2021,WLRRIKAWLRRKRK,WLRRIKAWLRRKRK{ct:Amid},RR3-NH2,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",19.0 ± 3.3 % Hemolysis at 150 µM,Horse,Short Synthetic Peptide,NA,NA,CTTHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
12229,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:Amid},RR4-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",64.3 ± 5.4 % Hemolysis at 150 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12230,34819923,2021,VFWRRIRVWVIR,VFWRRIRVWVIR{ct:Amid},LJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",28.4 ± 1.9 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12231,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",35.1 ± 8.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12232,34819923,2021,RIVWVRIRRWFV,RIVWVRIRRWFV{ct:Amid},RJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",19.2 ± 3.1 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12233,34819923,2021,KRIVKLILKWLR,KRIVKLILKWLR{ct:Amid},KR-12-a5,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm, Anti-inflammatory",79.0 ± 0.6 % Hemolysis at 150 µM,Horse,Ll-37 Derivatives Synthetic Peptide,α-Helical,NA,CCTTTSSCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12234,34819923,2021,WKKIRVRLSA,WKKIRVRLSA{ct:Amid},SB056,Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",1.7 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCTTTCGGGHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
12235,34819923,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},HP1404,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",100.0 ± 0.5 % Hemolysis at 150 µM,Horse,Scorpion Heterometrus Petersii,NA,NA,CCTTTCGGGHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
12236,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",0.3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12237,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",0.8 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12238,34819923,2021,FLFSLIPHAIGGLISAFK,FLFSLIPHAIGGLISAFK{ct:Amid},AamAP1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.00 ± 1.3 % Hemolysis at 150 µM,Horse,Scorpion Venom Antimicrobial Peptide,NA,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12239,34819923,2021,FLFSLIPKAIGGLISAFK,FLFSLIPKAIGGLISAFK{ct:Amid},AamAP-S1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.00 ± 4.9 % Hemolysis at 150 µM,Horse,Aamap1 Analog,NA,NA,CCCCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12240,34819923,2021,FLFSLIPRAIGGLISAFK,FLFSLIPRAIGGLISAFK{ct:Amid},AamAP-R,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.00 ± 4.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12241,34819923,2021,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},Magainin 2,Amidation,Free,Linear,L,None,26,"Antimicrobial, Antibiofilm",35.2 ± 1.1 % Hemolysis at 150 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
12242,34819923,2021,GIGKFLHSAK,GIGKFLHSAK{ct:Amid},Magainin 2(1-10),Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0.0 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
12243,34819923,2021,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",95.1 ± 5.0 % Hemolysis at 150 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12244,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",3.1 ± 1.0 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12245,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",8.3 ± 0.7 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12246,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",62.2 ± 4.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12247,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",92.1 ± 5.7 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12248,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",7.2 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12249,34819923,2021,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR-1018,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",35.6 ± 4.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12250,34819923,2021,KRFRIRVRVIRK,KRFRIRVRVIRK{ct:Amid},HH15,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",2.3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12251,34819923,2021,VQWRIRVRVIKK,VQWRIRVRVIKK{ct:Amid},1026,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",7.6 ± 0.8 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCGGGGGGTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12252,34819923,2021,KQFRIRVRV,KQFRIRVRV{ct:Amid},1029,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",2.3 ± 0.7 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12253,34819923,2021,VQFRIRVRIVIRK,VQFRIRVRIVIRK{ct:Amid},1036,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",6.5 ± 0.6 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CTTSGGGSGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C
12254,34819923,2021,KRFRIRVRV,KRFRIRVRV{ct:Amid},1037,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",2.4 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12255,34819923,2021,FRIRVRV,FRIRVRV{ct:Amid},FV7,Amidation,Free,Linear,L,None,7,"Antimicrobial, Antibiofilm",3.7 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CCCTHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12256,34819923,2021,RFRRLFRIRVRVLKKI,RFRRLFRIRVRVLKKI{ct:Amid},R-FV7-I16,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",6.3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)O
12257,34819923,2021,WLRRIKAWLRRIKA-OH,WLRRIKAWLRRIKA-OH{ct:OH},RR4-OH,OH,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",9.8 ± 3.7 % Hemolysis at 250 µM,Horse,Short Synthetic Peptide,NA,Low hemolytic,NA,NA
12258,34819923,2021,WIRRIKKWIRRVHK,WIRRIKKWIRRVHK{ct:Amid},RR2-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",14.0 ± 1.8 % Hemolysis at 250 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
12259,34819923,2021,WLRRIKAWLRRKRK,WLRRIKAWLRRKRK{ct:Amid},RR3-NH2,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",30.8 ± 4.2 % Hemolysis at 250 µM,Horse,Short Synthetic Peptide,NA,NA,CTTHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
12260,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:Amid},RR4-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",85.0 ± 5.7 % Hemolysis at 250 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12261,34819923,2021,VFWRRIRVWVIR,VFWRRIRVWVIR{ct:Amid},LJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",43.9 ± 3.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12262,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",64.4 ± 9.4 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12263,34819923,2021,RIVWVRIRRWFV,RIVWVRIRRWFV{ct:Amid},RJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",29.6 ± 2.2 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12264,34819923,2021,KRIVKLILKWLR,KRIVKLILKWLR{ct:Amid},KR-12-a5,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm, Anti-inflammatory",96.1 ± 1.8 % Hemolysis at 250 µM,Horse,Ll-37 Derivatives Synthetic Peptide,α-Helical,NA,CCTTTSSCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12265,34819923,2021,WKKIRVRLSA,WKKIRVRLSA{ct:Amid},SB056,Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",1.8 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Non-hemolytic,CCTTTCGGGHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
12266,34819923,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},HP1404,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",100.0 ± 3.9 % Hemolysis at 250 µM,Horse,Scorpion Heterometrus Petersii,NA,NA,CCTTTCGGGHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
12267,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",0.8 ± 1.1 % Hemolysis at 250 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12268,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",0.7 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12269,34819923,2021,FLFSLIPHAIGGLISAFK,FLFSLIPHAIGGLISAFK{ct:Amid},AamAP1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 4.1 % Hemolysis at 250 µM,Horse,Scorpion Venom Antimicrobial Peptide,NA,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12270,34819923,2021,FLFSLIPKAIGGLISAFK,FLFSLIPKAIGGLISAFK{ct:Amid},AamAP-S1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 2.1 % Hemolysis at 250 µM,Horse,Aamap1 Analog,NA,NA,CCCCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12271,34819923,2021,FLFSLIPRAIGGLISAFK,FLFSLIPRAIGGLISAFK{ct:Amid},AamAP-R,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 10.5 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12272,34819923,2021,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},Magainin 2,Amidation,Free,Linear,L,None,26,"Antimicrobial, Antibiofilm",54.5 ± 3.7 % Hemolysis at 250 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
12273,34819923,2021,GIGKFLHSAK,GIGKFLHSAK{ct:Amid},Magainin 2(1-10),Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0.0 ± 0.2 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
12274,34819923,2021,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",100.0 ± 4.4 % Hemolysis at 250 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12275,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",3.8 ± 0.8 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12276,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",20.4 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12277,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",73.6 ± 1.1 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12278,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",96.6 ± 3.1 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12279,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",12.5 ± 0.6 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12280,34819923,2021,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR-1018,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",43.0 ± 0.2 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12281,34819923,2021,KRFRIRVRVIRK,KRFRIRVRVIRK{ct:Amid},HH15,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",4.5 ± 1.9 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12282,34819923,2021,VQWRIRVRVIKK,VQWRIRVRVIKK{ct:Amid},1026,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",10.8 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCGGGGGGTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12283,34819923,2021,KQFRIRVRV,KQFRIRVRV{ct:Amid},1029,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",3.5 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12284,34819923,2021,VQFRIRVRIVIRK,VQFRIRVRIVIRK{ct:Amid},1036,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",11.0 ± 1.6 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CTTSGGGSGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C
12285,34819923,2021,KRFRIRVRV,KRFRIRVRV{ct:Amid},1037,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",3.3 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12286,34819923,2021,FRIRVRV,FRIRVRV{ct:Amid},FV7,Amidation,Free,Linear,L,None,7,"Antimicrobial, Antibiofilm",4.4 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CCCTHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12287,34819923,2021,RFRRLFRIRVRVLKKI,RFRRLFRIRVRVLKKI{ct:Amid},R-FV7-I16,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",8.0 ± 1.3 % Hemolysis at 250 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)O
12288,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:OH},RR4-OH,OH,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",17.8 ± 0.3 % Hemolysis at 375 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12289,34819923,2021,WIRRIKKWIRRVHK,WIRRIKKWIRRVHK{ct:Amid},RR2-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",17.9 ± 0.4 % Hemolysis at 375 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
12290,34819923,2021,WLRRIKAWLRRKRK,WLRRIKAWLRRKRK{ct:Amid},RR3-NH2,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",37.3 ± 4.4 % Hemolysis at 375 µM,Horse,Short Synthetic Peptide,NA,NA,CTTHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
12291,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:Amid},RR4-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",100.0 ± 5.4 % Hemolysis at 375 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12292,34819923,2021,VFWRRIRVWVIR,VFWRRIRVWVIR{ct:Amid},LJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",72.4 ± 8.9 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12293,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",71.0 ± 7.1 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12294,34819923,2021,RIVWVRIRRWFV,RIVWVRIRRWFV{ct:Amid},RJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",50.2 ± 5.4 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12295,34819923,2021,KRIVKLILKWLR,KRIVKLILKWLR{ct:Amid},KR-12-a5,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm, Anti-inflammatory",100.0 ± 1.7 % Hemolysis at 375 µM,Horse,Ll-37 Derivatives Synthetic Peptide,α-Helical,NA,CCTTTSSCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12296,34819923,2021,WKKIRVRLSA,WKKIRVRLSA{ct:Amid},SB056,Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",2.3 ± 0.7 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCTTTCGGGHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
12297,34819923,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},HP1404,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",100.0 ± 0.7 % Hemolysis at 375 µM,Horse,Scorpion Heterometrus Petersii,NA,NA,CCTTTCGGGHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
12298,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",1.3 ± 0.2 % Hemolysis at 375 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12299,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",1.5 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12300,34819923,2021,FLFSLIPHAIGGLISAFK,FLFSLIPHAIGGLISAFK{ct:Amid},AamAP1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 4.4 % Hemolysis at 375 µM,Horse,Scorpion Venom Antimicrobial Peptide,NA,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12301,34819923,2021,FLFSLIPKAIGGLISAFK,FLFSLIPKAIGGLISAFK{ct:Amid},AamAP-S1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 2.9 % Hemolysis at 375 µM,Horse,Aamap1 Analog,NA,NA,CCCCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12302,34819923,2021,FLFSLIPRAIGGLISAFK,FLFSLIPRAIGGLISAFK{ct:Amid},AamAP-R,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 3.1 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12303,34819923,2021,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},Magainin 2,Amidation,Free,Linear,L,None,26,"Antimicrobial, Antibiofilm",71.1 ± 6.0 % Hemolysis at 375 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
12304,34819923,2021,GIGKFLHSAK,GIGKFLHSAK{ct:Amid},Magainin 2(1-10),Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0.0 ± 0.7 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
12305,34819923,2021,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",100.0 ± 2.5 % Hemolysis at 375 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12306,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",10.0 ± 5.9 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12307,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",46.8 ± 3.3 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12308,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",100.0 ± 2.6 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12309,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",99.1 ± 8.0 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12310,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",39.0 ± 1.1 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12311,34819923,2021,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR-1018,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",45.9 ± 4.9 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12312,34819923,2021,KRFRIRVRVIRK,KRFRIRVRVIRK{ct:Amid},HH15,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",4.0 ± 0.4 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12313,34819923,2021,VQWRIRVRVIKK,VQWRIRVRVIKK{ct:Amid},1026,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",14.5 ± 5.5 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCGGGGGGTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12314,34819923,2021,KQFRIRVRV,KQFRIRVRV{ct:Amid},1029,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",3.4 ± 0.6 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCTTHHHHHTTTCHHHHHHSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12315,34819923,2021,VQFRIRVRIVIRK,VQFRIRVRIVIRK{ct:Amid},1036,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",17.3 ± 1.3 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCHHHHHHHTTSSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C
12316,34819923,2021,KRFRIRVRV,KRFRIRVRV{ct:Amid},1037,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",4.9 ± 0.2 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCSSHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12317,34819923,2021,FRIRVRV,FRIRVRV{ct:Amid},FV7,Amidation,Free,Linear,L,None,7,"Antimicrobial, Antibiofilm",9.5 ± 1.4 % Hemolysis at 375 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12318,34819923,2021,RFRRLFRIRVRVLKKI,RFRRLFRIRVRVLKKI{ct:Amid},R-FV7-I16,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",9.7 ± 0.6 % Hemolysis at 375 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)O
12319,34508563,2021,FLGALFKVASKLVPAAICSISKKC,FLGALFKVASKLVPAAICSISKKC,Brevinin-1HL,Free,Free,Linear,L,None,24,"Antimicrobial, Anticancer, Antibiofilm",50 % Hemolysis at 11.5 ± 0.2 µM,Horse,"Broad-Folded Frog, Hylarana Latouchii","aqueous = Random coil, 50% TFE = α-Helical",NA,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
12320,34508563,2021,FFPLIFGALSSILPKIL,FFPLIFGALSSILPKIL,Temporin-HLa,Free,Free,Linear,L,None,17,"Antimicrobial, Anticancer, Antibiofilm",50 % Hemolysis at 31.4 ± 0.7 µM,Horse,"Broad-Folded Frog, Hylarana Latouchii","aqueous = Random coil, 50% TFE = α-Helical",NA,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
12321,34508563,2021,FLQHIIGALSHIF,FLQHIIGALSHIF,Temporin-HLb,Free,Free,Linear,L,None,13,"Antimicrobial, Anticancer, Antibiofilm",50 % Hemolysis at 18.6 ± 10.0 mM,Horse,"Broad-Folded Frog, Hylarana Latouchii","aqueous = Random coil, 50% TFE = α-Helical",Low hemolytic,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12418,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",50 % Hemolysis at 76.55 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,CCSSCSCTTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12419,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",2.73 % Hemolysis at 2 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,CCGGGCTTCSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12420,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",4.31 % Hemolysis at 4 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12421,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",7.47 % Hemolysis at 8 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12665,36547631,2022,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,defensin-like protein 1 (D-lp1),Free,Free,Linear,L,None,47,"Antifungal, Antibiofilm, Anti-virulence, Anti-Candida",0.48 % Hemolysis at 0.19 mg/mL,Horse,Sulphur-Rich Defensin Present In Barley Endosperm,NA,Low hemolytic,CCCGGGTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
12666,36547631,2022,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,defensin-like protein 1 (D-lp1),Free,Free,Linear,L,None,47,"Antifungal, Antibiofilm, Anti-virulence, Anti-Candida",1.74 % Hemolysis at 0.39 mg/mL,Horse,Sulphur-Rich Defensin Present In Barley Endosperm,NA,Low hemolytic,CCCGGGTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
12667,36547631,2022,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,defensin-like protein 1 (D-lp1),Free,Free,Linear,L,None,47,"Antifungal, Antibiofilm, Anti-virulence, Anti-Candida",9.55 % Hemolysis at 0.78 mg/mL,Horse,Sulphur-Rich Defensin Present In Barley Endosperm,NA,Low hemolytic,CCCGGGTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
12668,36547631,2022,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,defensin-like protein 1 (D-lp1),Free,Free,Linear,L,None,47,"Antifungal, Antibiofilm, Anti-virulence, Anti-Candida",14.72 % Hemolysis at 1.56 mg/mL,Horse,Sulphur-Rich Defensin Present In Barley Endosperm,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
12692,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 5 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCTTTTTTTHHHHGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12693,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 10 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCTTTTTTTHHHHGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12694,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 20 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12695,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 40 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12696,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 60 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12697,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 80 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCGGGCSSHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12698,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 100 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCGGGCSSHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12895,25626077,2015,FLFSLIPSVIAGLVSAIRN,FLFSLIPSVIAGLVSAIRN{ct:Amid},AaeAP1,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",100 % Hemolysis at 16 μg/ml,Horse,Scorpion Androctonus Aeneas,21.05 % α-Helix,NA,CCCTTGGGTTGGGCCCTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
12896,25626077,2015,FLFSLIPSAIAGLVSAIRN,FLFSLIPSAIAGLVSAIRN{ct:Amid},AaeAP2,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal",100 % Hemolysis at 64 μg/ml,Horse,Scorpion Androctonus Aeneas,21.05 % α-Helix,NA,CCCTTGGGTTGGGCCCTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)CC)C(C)C
12897,25626077,2015,FLFKLIPKVIKGLVKAIRK,FLFKLIPKVIKGLVKAIRK{ct:Amid},AaeAP1a,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal. Anticancer, Antiproliferative",100 % Hemolysis at 32 μg/ml,Horse,Aaeap1 Analogues,31.58% α-Helix,NA,CTTTTTCTTGGGCCCHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
12898,25626077,2015,FLFKLIPKAIKGLVKAIRK,FLFKLIPKAIKGLVKAIRK{ct:Amid},AaeAP2a,Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal. Anticancer, Antiproliferative",100 % Hemolysis at 64 μg/ml,Horse,Aaeap2 Analogues,31.58% α-Helix,NA,CCCCCCSSCSSTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C
12951,35335979,2022,FVDLKKIANILNSIF,FVDLKKIANILNSIF{ct:Amid},Temporin-1CEh,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",50 % Hemolysis at 152.6 µM,Horse,Rana Chensinensis,α-Helix,NA,CTTCCHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12952,35335979,2022,FVDLKKIANILNSIF,FVDLKKIANILNSIF{ct:Amid},Temporin-1CEh,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",92.3 % Hemolysis at 256 µM,Horse,Rana Chensinensis,α-Helix,NA,CCCCTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12953,35335979,2022,FVDLKKIANIINSIF,FVDLKKIANIINSIF{ct:Amid},Temporin-1CEa,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",50 % Hemolysis at 160 µM,Horse,Synthetic,α-Helix,NA,CCSCTTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
12954,35335979,2022,FVDLKKIANIL,FVDLKKIANIL{ct:Amid},T1CEh-t,Amidation,Free,Linear,L,None,11,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCSCCGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12955,35335979,2022,FVDLKKIANII,FVDLKKIANII{ct:Amid},T1CEa-t,Amidation,Free,Linear,L,None,11,"Antibacterial, Anti-biofilm",0 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
12956,35335979,2022,KKFVDLKKIANIL,KKFVDLKKIANIL{ct:Amid},T1CEh-KK,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12957,35335979,2022,KKFVPLKKIANIL,KKFVPLKKIANIL{ct:Amid},T1CEh-KKP,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼1 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12958,35335979,2022,KKWVPLKKIANIL,KKWVPLKKIANIL{ct:Amid},T1CEh-KKPW,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<10 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12959,35335979,2022,KKWVPWKKIANIL,KKWVPWKKIANIL{ct:Amid},T1CEh-KKPWW,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",6 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12960,35335979,2022,KKWVPWKKKWVPWKKIANIL,KKWVPWKKKWVPWKKIANIL{ct:Amid},T1CEh-KKPWW2,Amidation,Free,Branched,L,None,20,"Antibacterial, Anti-biofilm",63 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,NA
13102,35606468,2022,GLLGKILGAGKKVLCGVSGLC,GLLGKILGAGKKVLCGVSGLC,Nigrocin-PN,Free,Free,Linear,L,None,21,"Antimicrobial, Anticancer",0 % Hemolysis at 10 µM,Horse,Pelophylax Nigromaculatus,Random coil,Non-hemolytic,CGGGGGTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
13103,35606468,2022,GLLGKILGAGKKVLCGVSGLC,GLLGKILGAGKKVLCGVSGLC,Nigrocin-PN,Free,Free,Linear,L,None,21,"Antimicrobial, Anticancer",<5 % Hemolysis at 100 µM,Horse,Pelophylax Nigromaculatus,Random coil,Non-hemolytic,CCHHHHHHHHTTSSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
13104,35606468,2022,GLLGKILGAGKKVLLGVSGLL,GLLGKILGAGKKVLLGVSGLL,Nigrocin-M1,Free,Free,Linear,L,None,21,"Antimicrobial, Anticancer",0 % Hemolysis at 10 µM,Horse,Pelophylax Nigromaculatus,Random coil,Non-hemolytic,CCTHHHHHHHTTSSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13105,35606468,2022,GLLGKILGAGKKVLLGVSGLL,GLLGKILGAGKKVLLGVSGLL,Nigrocin-M1,Free,Free,Linear,L,None,21,"Antimicrobial, Anticancer",<20 % Hemolysis at 100 µM,Horse,Pelophylax Nigromaculatus,Random coil,Non-hemolytic,CCCCCGGGGTCCCGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13106,35606468,2022,GLLGKILGAGKKVL,GLLGKILGAGKKVL,Nigrocin-M2,Free,Free,Linear,L,None,14,"Antimicrobial, Anticancer",0 % Hemolysis at 10 µM,Horse,Pelophylax Nigromaculatus,Random coil,Non-hemolytic,CCTHHHHHHHTTSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13107,35606468,2022,GLLGKILGAGKKVL,GLLGKILGAGKKVL,Nigrocin-M2,Free,Free,Linear,L,None,14,"Antimicrobial, Anticancer",0 % Hemolysis at 100 µM,Horse,Pelophylax Nigromaculatus,Random coil,Non-hemolytic,CCHHHHHHHHHHSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13108,35740884,2022,FLPLIIGALSSLLPKIF,FLPLIIGALSSLLPKIF{ct:Amid},Temporin-PKE,Amidation,Free,Linear,L,None,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 6.58 µM,Horse,Pelophylax Kl. Esculentus,Random coils,NA,CCHHHHHHHHTTSSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13109,35740884,2022,FLPLIIGKLSSLLPKIF,FLPLIIGKLSSLLPKIF{ct:Amid},Temporin-PKE-2K,Amidation,Free,Linear,L,None,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 19.87 µM,Horse,Synthetic Analogues Of Temporin-Pke,α-Helix,NA,CCHHHHHHHHTTSSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13110,35740884,2022,FLPLIIGALSSKLPKIF,FLPLIIGALSSKLPKIF{ct:Amid},Temporin-PKE-K12,Amidation,Free,Linear,L,None,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 122.7 µM,Horse,Synthetic Analogues Of Temporin-Pke,α-Helix,Low hemolytic,CCTHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13111,35740884,2022,FLPKIIGKLSSLLPKIF,FLPKIIGKLSSLLPKIF{ct:Amid},Temporin-PKE-3K,Amidation,Free,Linear,L,None,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 87.47 µM,Horse,Synthetic Analogues Of Temporin-Pke,α-Helix,Low hemolytic,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13112,35740884,2022,FLPKIIGKLSSKLPKIF,FLPKIIGKLSSKLPKIF{ct:Amid},Temporin-PKE-4K,Amidation,Free,Linear,L,None,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 1671 µM,Horse,Synthetic Analogues Of Temporin-Pke,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13113,35740884,2022,FLPLIIGALSSLLPKiF,FLPLIIGALSSLLPKI{d}F{ct:Amid},Temporin-PKE-i,Amidation,Free,Linear,Mix,i = D-Isoleucine,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 68.37 µM,Horse,Synthetic Analogues Of Temporin-Pke,α-Helix,Low hemolytic,NA,NA
13114,35740884,2022,FLPLiiGALSSLLPKiF,FLPLI{d}I{d}GALSSLLPKI{d}F{ct:Amid},Temporin-PKE-3i,Amidation,Free,Linear,Mix,i = D-Isoleucine,17,"Antimicrobial, Cytotoxic",50 % Hemolysis at 64 µM,Horse,Synthetic Analogues Of Temporin-Pke,α-Helix,Low hemolytic,NA,NA
13135,35638842,2022,RINSAKDDAAGLQIA,RINSAKDDAAGLQIA{ct:OH},flg15,OH,Free,Linear,L,None,15,Antimicrobial,0 ± 0 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,CGGGGGSTTTC,NA
13136,35638842,2022,FKLFKKILKVL,FKLFKKILKVL{ct:Amid},BP13,Amidation,Free,Linear,L,None,11,Antimicrobial,5 ± 0.2 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13137,35638842,2022,VWNQPVRGFKVYE,VWNQPVRGFKVYE{ct:OH},Pep13,OH,Free,Linear,L,None,13,Antimicrobial,0 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,NA,NA
13138,35638842,2022,YGIHTH,YGIHTH{ct:Amid},PIP1,Amidation,Free,Linear,L,None,6,Antimicrobial,4 ± 0.8 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
13139,35638842,2022,KKLFKKILKKL,KKLFKKILKKL{ct:Amid},BP16,Amidation,Free,Linear,L,None,11,Antimicrobial,2 ± 1 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,CCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13140,35638842,2022,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antimicrobial,4 ± 0.5 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,CCCCCCCCCSTHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13141,35638842,2022,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid}{ct:Amid},BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,11,Antimicrobial,3 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,CTTHHHHHTTSCCCSSCCSSSSSCCC,NA
13142,35638842,2022,KKLFKKIK(COC3H7)KYL,KKLFKKIK{nnr:COC3H7}KYL{nt:Acet}{ct:Amid},BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,13,Antimicrobial,4 ± 0.9 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,NA,NA
13143,35638842,2022,KKLfKKILKK(COC3H7)L,KKLF{d}KKILKK{nnr:COC3H7}L{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,Antimicrobial,0 ± 0 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,NA,NA
13144,35638842,2022,KKVVFWVKFK,KKVVFWVKFK{ct:Amid},KSL-W,Amidation,Free,Linear,L,None,10,Antimicrobial,4 ± 1 % Hemolysis at 50 µM,Horse,Synthetic,NA,NA,NA,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13145,35638842,2022,RINSAKDDAAGLQIAKKLFKKILKKL,RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid},flg15-BP16,Amidation,Free,Linear,L,None,26,Antimicrobial,2 ± 0.1 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13146,35638842,2022,KKLFKKILKKLRINSAKDDAAGLQIA,KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH},BP16-flg15,OH,Free,Linear,L,None,26,Antimicrobial,0 ± 0.3 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13147,35638842,2022,RINSAKDDAAGLQIAKKLFKKILKYL,RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid},flg15-BP100,Amidation,Free,Linear,L,None,26,Antimicrobial,48 ± 4.1 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13148,35638842,2022,KKLFKKILKYLRINSAKDDAAGLQIA,KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH},BP100-flg15,OH,Free,Linear,L,None,26,Antimicrobial,1 ± 0.9 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CCCCSSCSCSHHHHHTTSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13149,35638842,2022,RINSAKDDAAGLQIAKKLFKKIK(COC3H7)KYL,RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid},flg15-BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,26,Antimicrobial,5 ± 0.4 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13150,35638842,2022,KKLFKKIK(COC3H7)KYLRINSAKDDAAGLQIA,KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP387-flg15,OH,Acetylation,Linear,L,COC3H7 = butanoyl,26,Antimicrobial,3 ± 0.3 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13151,35638842,2022,RINSAKDDAAGLQIAKKLfKKILKK(COC3H7)L,RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},flg15-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,7 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13152,35638842,2022,KKLfKKILKK(COC3H7)LRINSAKDDAAGLQIA,KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP475-flg15,OH,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,1 ± 1.0 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13153,35638842,2022,RINSAKDDAAGLQIAKKVVFWVKFK,RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid},flg15-KSLW,Amidation,Free,Linear,L,None,25,Antimicrobial,0 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CTTHHHHGGGHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C
13154,35638842,2022,KKVVFWVKFKRINSAKDDAAGLQIA,KKVVFWVKFKRINSAKDDAAGLQIA{ct:OH},KSLW-flg15,OH,Free,Linear,L,None,25,Antimicrobial,4 ± 1.9 % Hemolysis at 50 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CTTHHHHHHHHGGGGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13155,35638842,2022,FKLFKKILKVLKKLFKKILKKL,FKLFKKILKVLKKLFKKILKKL{ct:Amid},BP13-BP16,Amidation,Free,Linear,L,None,22,Antimicrobial,86 ± 13.2 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CTTHHHHGGGHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13156,35638842,2022,KKLFKKILKKLFKLFKKILKVL,KKLFKKILKKLFKLFKKILKVL{ct:Amid},BP16-BP13,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 4.0 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CTTHHHHHHHHTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
13157,35638842,2022,FKLFKKILKVLKKLFKKILKYL,FKLFKKILKVLKKLFKKILKYL{ct:Amid},BP13-BP100,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 8.3 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCCCCCCTTTGGGGGTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13158,35638842,2022,KKLFKKILKYLFKLFKKILKVL,KKLFKKILKYLFKLFKKILKVL{ct:Amid},BP100-BP13,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 9.4 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSSCCSSHIIIIITHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
13159,35638842,2022,FKLFKKILKVLKKLfKKILKYL,FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid},BP13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGGGGGGGTSCSCTTSSSSCC,NA
13160,35638842,2022,KKLfKKILKYLFKLFKKILKVL,KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid},BP143-BP13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 6.1 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,NA
13161,35638842,2022,FKLFKKILKVLKKVVFWVKFK,FKLFKKILKVLKKVVFWVKFK{ct:Amid},BP13-KSLW,Amidation,Free,Linear,L,None,21,Antimicrobial,80 ± 11.2 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGTCGGGGTCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
13162,35638842,2022,KKVVFWVKFKFKLFKKILKVL,KKVVFWVKFKFKLFKKILKVL{ct:Amid},KSLW-BP13,Amidation,Free,Linear,L,None,21,Antimicrobial,62 ± 8.2 % Hemolysis at 50 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13163,35638842,2022,VWNQPVRGFKVYEKKLFKKILKKL,VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid},Pep13-BP16,Amidation,Free,Linear,L,None,24,Antimicrobial,2 ± 0.6 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CGGGGTCGGGGTCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13164,35638842,2022,KKLFKKILKKLVWNQPVRGFKVYE,KKLFKKILKKLVWNQPVRGFKVYE{ct:OH},BP16-Pep13,OH,Free,Linear,L,None,24,Antimicrobial,1 ± 0.4 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCCCTTTTCCCCSTTCCSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
13165,35638842,2022,VWNQPVRGFKVYEKKLFKKILKYL,VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid},Pep13-BP100,Amidation,Free,Linear,L,None,24,Antimicrobial,9 ± 1.0 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSCCCCCCSSCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13166,35638842,2022,KKLFKKILKYLVWNQPVRGFKVYE,KKLFKKILKYLVWNQPVRGFKVYE{ct:OH},BP100-Pep13,OH,Free,Linear,L,None,24,Antimicrobial,5 ± 0.3 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
13167,35638842,2022,VWNQPVRGFKVYEKKLfKKILKYL,VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid},Pep13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,5 ± 0.5 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,NA
13168,35638842,2022,KKLfKKILKYLVWNQPVRGFKVYE,KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH},BP143-Pep13,OH,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,5 ± 1.9 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCCSCC,NA
13169,35638842,2022,VWNQPVRGFKVYEKKVVFWVKFK,VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid},Pep13-KSLW,Amidation,Free,Linear,L,None,23,Antimicrobial,9 ± 2.3 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCSSCC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
13170,35638842,2022,KKVVFWVKFKVWNQPVRGFKVYE,KKVVFWVKFKVWNQPVRGFKVYE{ct:OH},KSLW-Pep13,OH,Free,Linear,L,None,23,Antimicrobial,0 ± 0.3 % Hemolysis at 50 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSSCSHHHHHHC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
13171,35638842,2022,YGIHTHKKLfKKILKK(COC3H7)L,YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},PIP1-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,4 ± 0.4 % Hemolysis at 50 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13172,35638842,2022,KKLfKKILKK(COC3H7)LYGIHTH,KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid},BP475-PIP1,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,9 ± 1.0 % Hemolysis at 50 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13173,35638842,2022,YGIHTHKKVVFWVKFK,YGIHTHKKVVFWVKFK{ct:Amid},PIP1-KSLW,Amidation,Free,Linear,L,None,16,Antimicrobial,7 ± 0.8 % Hemolysis at 50 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,CCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
13174,35638842,2022,KKVVFWVKFKYGIHTH,KKVVFWVKFKYGIHTH{ct:Amid},KSLW-PIP1,Amidation,Free,Linear,L,None,16,Antimicrobial,8 ± 1.3 % Hemolysis at 50 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
13175,35638842,2022,RINSAKDDAAGLQIA,RINSAKDDAAGLQIA{ct:OH},flg15,OH,Free,Linear,L,None,15,Antimicrobial,0 ± 0 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13176,35638842,2022,FKLFKKILKVL,FKLFKKILKVL{ct:Amid},BP13,Amidation,Free,Linear,L,None,11,Antimicrobial,13 ± 2 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13177,35638842,2022,VWNQPVRGFKVYE,VWNQPVRGFKVYE{ct:OH},Pep13,OH,Free,Linear,L,None,13,Antimicrobial,0 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,NA,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C
13178,35638842,2022,YGIHTH,YGIHTH{ct:Amid},PIP1,Amidation,Free,Linear,L,None,6,Antimicrobial,0.5 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
13179,35638842,2022,KKLFKKILKKL,KKLFKKILKKL{ct:Amid},BP16,Amidation,Free,Linear,L,None,11,Antimicrobial,1 ± 0.6 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,CCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13180,35638842,2022,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antimicrobial,4 ± 0.5 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,CCCCCCCCCSTHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13181,35638842,2022,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid},BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,11,Antimicrobial,7 ± 2 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,CTTHHHHHTTSCCCSSCCSSSSSCCC,NA
13182,35638842,2022,KKLFKKIK(COC3H7)KYL,KKLFKKIK{nnr:COC3H7}KYL{ct:Acet},BP387,Acetylation,Free,Linear,L,COC3H7 = butanoyl,13,Antimicrobial,4 ± 0.6 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,NA,NA
13183,35638842,2022,KKLfKKILKK(COC3H7)L,KKLF{d}KKILKK{nnr:COC3H7}L{ct:Acet}{ct:Acet},BP475,Acetylation,Free,Linear,Mix,COC3H7 = butanoyl,11,Antimicrobial,11 ± 5 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,NA,NA
13184,35638842,2022,KKVVFWVKFK,KKVVFWVKFK{ct:Amid},KSL-W,Amidation,Free,Linear,L,None,10,Antimicrobial,5 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic,NA,NA,NA,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13185,35638842,2022,RINSAKDDAAGLQIAKKLFKKILKKL,RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid},flg15-BP16,Amidation,Free,Linear,L,None,26,Antimicrobial,3 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13186,35638842,2022,KKLFKKILKKLRINSAKDDAAGLQIA,KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH},BP16-flg15,OH,Free,Linear,L,None,26,Antimicrobial,1 ± 0.1 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13187,35638842,2022,RINSAKDDAAGLQIAKKLFKKILKYL,RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid},flg15-BP100,Amidation,Free,Linear,L,None,26,Antimicrobial,52 ± 4.3 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13188,35638842,2022,KKLFKKILKYLRINSAKDDAAGLQIA,KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH},BP100-flg15,OH,Free,Linear,L,None,26,Antimicrobial,1 ± 0.8 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CCCCSSCSCSHHHHHTTSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13189,35638842,2022,RINSAKDDAAGLQIAKKLFKKIK(COC3H7)KYL,RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid},flg15-BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,26,Antimicrobial,15 ± 1.6 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13190,35638842,2022,KKLFKKIK(COC3H7)KYLRINSAKDDAAGLQIA,KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP387-flg15,OH,Acetylation,Linear,L,COC3H7 = butanoyl,26,Antimicrobial,5 ± 0.9 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13191,35638842,2022,RINSAKDDAAGLQIAKKLfKKILKK(COC3H7)L,RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},flg15-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,28 ± 2.3 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13192,35638842,2022,KKLfKKILKK(COC3H7)LRINSAKDDAAGLQIA,KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP475-flg15,OH,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,0 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13193,35638842,2022,RINSAKDDAAGLQIAKKVVFWVKFK,RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid},flg15-KSLW,Amidation,Free,Linear,L,None,25,Antimicrobial,1 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CTTHHHHGGGHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C
13194,35638842,2022,KKVVFWVKFK-RINSAKDDAAGLQIA,KKVVFWVKFK-RINSAKDDAAGLQIA{ct:OH},KSLW-flg15,OH,Free,Linear,L,None,25,Antimicrobial,7 ± 3.4 % Hemolysis at 150 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CTTHHHHHHHHGGGGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13195,35638842,2022,FKLFKKILKVLKKLFKKILKKL,FKLFKKILKVLKKLFKKILKKL{ct:Amid},BP13-BP16,Amidation,Free,Linear,L,None,22,Antimicrobial,86 ± 1.6 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CTTHHHHGGGHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13196,35638842,2022,KKLFKKILKKLFKLFKKILKVL,KKLFKKILKKLFKLFKKILKVL{ct:Amid},BP16-BP13,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 2.3 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CTTHHHHHHHHTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
13197,35638842,2022,FKLFKKILKVLKKLFKKILKYL,FKLFKKILKVLKKLFKKILKYL{ct:Amid},BP13-BP100,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 5.9 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCCCCCCTTTGGGGGTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13198,35638842,2022,KKLFKKILKYLFKLFKKILKVL,KKLFKKILKYLFKLFKKILKVL{ct:Amid},BP100-BP13,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 5.5 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSSCCSSHIIIIITHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
13199,35638842,2022,FKLFKKILKVLKKLfKKILKYL,FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid},BP13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 3.7 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGGGGGGGTSCSCTTSSSSCC,NA
13200,35638842,2022,KKLfKKILKYLFKLFKKILKVL,KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid},BP143-BP13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 3.6 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,NA
13201,35638842,2022,FKLFKKILKVLKKVVFWVKFK,FKLFKKILKVLKKVVFWVKFK{ct:Amid},BP13-KSLW,Amidation,Free,Linear,L,None,21,Antimicrobial,90 ± 7.3 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGTCGGGGTCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
13202,35638842,2022,KKVVFWVKFKFKLFKKILKVL,KKVVFWVKFKFKLFKKILKVL{ct:Amid},KSLW-BP13,Amidation,Free,Linear,L,None,21,Antimicrobial,65 ± 5.9 % Hemolysis at 150 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13203,35638842,2022,VWNQPVRGFKVYEKKLFKKILKKL,VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid},Pep13-BP16,Amidation,Free,Linear,L,None,24,Antimicrobial,3 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CGGGGTCGGGGTCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13204,35638842,2022,KKLFKKILKKLVWNQPVRGFKVYE,KKLFKKILKKLVWNQPVRGFKVYE{ct:OH},BP16-Pep13,OH,Free,Linear,L,None,24,Antimicrobial,1 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCCCTTTTCCCCSTTCCSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
13205,35638842,2022,VWNQPVRGFKVYEKKLFKKILKYL,VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid},Pep13-BP100,Amidation,Free,Linear,L,None,24,Antimicrobial,25 ± 2.4 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13206,35638842,2022,KKLFKKILKYLVWNQPVRGFKVYE,KKLFKKILKYLVWNQPVRGFKVYE{ct:Amid},BP100-Pep13,Amidation,Free,Linear,L,None,24,Antimicrobial,12 ± 1.1 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
13207,35638842,2022,VWNQPVRGFKVYEKKLfKKILKYL,VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid},Pep13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,8 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,NA
13208,35638842,2022,KKLfKKILKYLVWNQPVRGFKVYE,KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH},BP143-Pep13,OH,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,9 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCCSCC,NA
13209,35638842,2022,VWNQPVRGFKVYEKKVVFWVKFK,VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid},Pep13-KSLW,Amidation,Free,Linear,L,None,23,Antimicrobial,31 ± 3.7 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCSSCC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
13210,35638842,2022,KKVVFWVKFK-VWNQPVRGFKVYE,KKVVFWVKFK-VWNQPVRGFKVYE{ct:OH},KSLW-Pep13,OH,Free,Linear,L,None,23,Antimicrobial,2 ± 1.0 % Hemolysis at 150 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSSCSHHHHHHC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
13211,35638842,2022,YGIHTHKKLfKKILKK(COC3H7)L,YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},PIP1-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,11 ± 0.5 % Hemolysis at 150 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13212,35638842,2022,KKLfKKILKK(COC3H7)LYGIHTH,KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid},BP475-PIP1,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,18 ± 1.4 % Hemolysis at 150 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13213,35638842,2022,YGIHTHKKVVFWVKFK,YGIHTHKKVVFWVKFK{ct:Amid},PIP1-KSLW,Amidation,Free,Linear,L,None,16,Antimicrobial,7 ± 1.1 % Hemolysis at 150 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,CCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
13214,35638842,2022,KKVVFWVKFKYGIHTH,KKVVFWVKFKYGIHTH{ct:Amid},KSLW-PIP1,Amidation,Free,Linear,L,None,16,Antimicrobial,3 ± 2.1 % Hemolysis at 150 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
13215,35638842,2022,RINSAKDDAAGLQIA,RINSAKDDAAGLQIA{ct:OH},flg15,OH,Free,Linear,L,None,15,Antimicrobial,0 ± 0 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13216,35638842,2022,FKLFKKILKVL,FKLFKKILKVL{ct:Amid},BP13,Amidation,Free,Linear,L,None,11,Antimicrobial,27 ± 3 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13217,35638842,2022,VWNQPVRGFKVYE,VWNQPVRGFKVYE{nt:OH}{ct:OH},Pep13,OH,OH,Linear,L,None,13,Antimicrobial,2 ± 0.1 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,NA,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C
13218,35638842,2022,YGIHTH,YGIHTH{ct:Amid},PIP1,Amidation,Free,Linear,L,None,6,Antimicrobial,0 ± 2 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
13219,35638842,2022,KKLFKKILKKL,KKLFKKILKKL{ct:Amid},BP16,Amidation,Free,Linear,L,None,11,Antimicrobial,1 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,CCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13220,35638842,2022,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antimicrobial,6 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,CCCCCCCCCSTHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13221,35638842,2022,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid},BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,11,Antimicrobial,6 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,CTTHHHHHTTSCCCSSCCSSSSSCCC,NA
13222,35638842,2022,KKLFKKIK(COC3H7)KYL,KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid},BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,13,Antimicrobial,14 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,NA,NA
13223,35638842,2022,KKLfKKILKK(COC3H7)L,KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,Antimicrobial,0 ± 0 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,NA,NA
13224,35638842,2022,KKVVFWVKFK,KKVVFWVKFK{ct:Amid},KSL-W,Amidation,Free,Linear,L,None,10,Antimicrobial,6 ± 1 % Hemolysis at 250 µM,Horse,Synthetic,NA,NA,NA,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13225,35638842,2022,RINSAKDDAAGLQIAKKLFKKILKKL,RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid},flg15-BP16,Amidation,Free,Linear,L,None,26,Antimicrobial,4 ± 0.9 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13226,35638842,2022,KKLFKKILKKLRINSAKDDAAGLQIA,KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH},BP16-flg15,OH,Free,Linear,L,None,26,Antimicrobial,0 ± 0.6 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13227,35638842,2022,RINSAKDDAAGLQIA-KKLFKKILKYL,RINSAKDDAAGLQIA-KKLFKKILKYL{ct:Amid},flg15-BP100,Amidation,Free,Linear,L,None,26,Antimicrobial,63 ± 2.4 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13228,35638842,2022,KKLFKKILKYLRINSAKDDAAGLQIA,KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH},BP100-flg15,OH,Free,Linear,L,None,26,Antimicrobial,3 ± 0.0 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CCCCSSCSCSHHHHHTTSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13229,35638842,2022,RINSAKDDAAGLQIAKKLFKKIK(COC3H7)KYL,RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid},flg15-BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,26,Antimicrobial,26 ± 3.5 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13230,35638842,2022,KKLFKKIK(COC3H7)KYLRINSAKDDAAGLQIA,KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP387-flg15,OH,Acetylation,Linear,L,COC3H7 = butanoyl,26,Antimicrobial,7 ± 0.2 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13231,35638842,2022,RINSAKDDAAGLQIAKKLfKKILKK(COC3H7)L,RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},flg15-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,43 ± 2.7 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13232,35638842,2022,KKLfKKILKK(COC3H7)LRINSAKDDAAGLQIA,KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP475-flg15,OH,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,1 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13233,35638842,2022,RINSAKDDAAGLQIAKKVVFWVKFK,RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid},flg15-KSLW,Amidation,Free,Linear,L,None,25,Antimicrobial,1 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CTTHHHHGGGHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C
13234,35638842,2022,KKVVFWVKFKRINSAKDDAAGLQIA,KKVVFWVKFKRINSAKDDAAGLQIA{ct:OH},KSLW-flg15,OH,Free,Linear,L,None,25,Antimicrobial,8 ± 0.9 % Hemolysis at 250 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CTTHHHHHHHHGGGGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13235,35638842,2022,FKLFKKILKVLKKLFKKILKKL,FKLFKKILKVLKKLFKKILKKL{ct:Amid},BP13-BP16,Amidation,Free,Linear,L,None,22,Antimicrobial,87 ± 1.2 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CTTHHHHGGGHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13236,35638842,2022,KKLFKKILKKLFKLFKKILKVL,KKLFKKILKKLFKLFKKILKVL{ct:Amid},BP16-BP13,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 8.5 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CTTHHHHHHHHTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
13237,35638842,2022,FKLFKKILKVLKKLFKKILKYL,FKLFKKILKVLKKLFKKILKYL{ct:Amid},BP13-BP100,Amidation,Free,Linear,L,None,22,Antimicrobial,99 ± 7.1 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCCCCCCTTTGGGGGTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13238,35638842,2022,KKLFKKILKYLFKLFKKILKVL,KKLFKKILKYLFKLFKKILKVL{ct:Amid},BP100-BP13,Amidation,Free,Linear,L,None,22,Antimicrobial,98 ± 3.3 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSSCCSSHIIIIITHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
13239,35638842,2022,FKLFKKILKVLKKLfKKILKYL,FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid},BP13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 3.2 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGGGGGGGTSCSCTTSSSSCC,NA
13240,35638842,2022,KKLfKKILKYLFKLFKKILKVL,KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid},BP143-BP13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 7.1 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,NA
13241,35638842,2022,FKLFKKILKVLKKVVFWVKFK,FKLFKKILKVLKKVVFWVKFK{ct:Amid},BP13-KSLW,Amidation,Free,Linear,L,None,21,Antimicrobial,100 ± 8.4 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGTCGGGGTCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
13242,35638842,2022,KKVVFWVKFKFKLFKKILKVL,KKVVFWVKFKFKLFKKILKVL{ct:Amid},KSLW-BP13,Amidation,Free,Linear,L,None,21,Antimicrobial,77 ± 12.9 % Hemolysis at 250 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13243,35638842,2022,VWNQPVRGFKVYEKKLFKKILKKL,VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid},Pep13-BP16,Amidation,Free,Linear,L,None,24,Antimicrobial,4 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CGGGGTCGGGGTCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13244,35638842,2022,KKLFKKILKKLVWNQPVRGFKVYE,KKLFKKILKKLVWNQPVRGFKVYE{ct:OH},BP16-Pep13,OH,Free,Linear,L,None,24,Antimicrobial,1 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
13245,35638842,2022,VWNQPVRGFKVYEKKLFKKILKYL,VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid},Pep13-BP100,Amidation,Free,Linear,L,None,24,Antimicrobial,45 ± 9.0 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13246,35638842,2022,KKLFKKILKYLVWNQPVRGFKVYE,KKLFKKILKYLVWNQPVRGFKVYE{ct:OH},BP100-Pep13,OH,Free,Linear,L,None,24,Antimicrobial,20 ± 2.4 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
13247,35638842,2022,VWNQPVRGFKVYEKKLfKKILKYL,VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid},Pep13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,10 ± 0.6 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,NA
13248,35638842,2022,KKLfKKILKYLVWNQPVRGFKVYE,KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH},BP143-Pep13,OH,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,16 ± 1.9 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCCCCC,NA
13249,35638842,2022,VWNQPVRGFKVYE-KKVVFWVKFK,VWNQPVRGFKVYE-KKVVFWVKFK{ct:Amid},Pep13-KSLW,Amidation,Free,Linear,L,None,23,Antimicrobial,48 ± 3.8 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCSSCC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
13250,35638842,2022,KKVVFWVKFK-VWNQPVRGFKVYE,KKVVFWVKFK-VWNQPVRGFKVYE{ct:OH},KSLW-Pep13,OH,Free,Linear,L,None,23,Antimicrobial,3 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSSCSHHHHHHC,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
13251,35638842,2022,YGIHTHKKLfKKILKK(COC3H7)L,YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},PIP1-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,18 ± 0.1 % Hemolysis at 250 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13252,35638842,2022,KKLfKKILKK(COC3H7)LYGIHTH,KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid},BP475-PIP1,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,26 ± 2.8 % Hemolysis at 250 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13253,35638842,2022,YGIHTKKVVFWVKFK,YGIHTKKVVFWVKFK{ct:Amid},PIP1-KSLW,Amidation,Free,Linear,L,None,16,Antimicrobial,6 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,CCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
13254,35638842,2022,KKVVFWVKFKYGIHTH,KKVVFWVKFKYGIHTH{ct:Amid},KSLW-PIP1,Amidation,Free,Linear,L,None,16,Antimicrobial,3 ± 1.2 % Hemolysis at 250 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
13255,35638842,2022,RINSAKDDAAGLQIA,RINSAKDDAAGLQIA{ct:OH},flg15,OH,Free,Linear,L,None,15,Antimicrobial,0 ± 0 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13256,35638842,2022,FKLFKKILKVL,FKLFKKILKVL{ct:Amid},BP13,Amidation,Free,Linear,L,None,11,Antimicrobial,42 ± 3 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13257,35638842,2022,VWNQPVRGFKVYE,VWNQPVRGFKVYE{ct:OH},Pep13,OH,Free,Linear,L,None,13,Antimicrobial,0 ± 0.1 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,NA,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C
13258,35638842,2022,YGIHTH,YGIHTH{ct:Amid},PIP1,Amidation,Free,Linear,L,None,6,Antimicrobial,1 ± 0.1 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
13259,35638842,2022,KKLFKKILKKL,KKLFKKILKKL{ct:Amid},BP16,Amidation,Free,Linear,L,None,11,Antimicrobial,3 ± 3 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,CCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13260,35638842,2022,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Antimicrobial,11 ± 0.9 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,CCCCCCCCCSTHHHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13261,35638842,2022,KKLfKKILKYL,KKLF{d}KKILKYL{ct:Amid},BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,11,Antimicrobial,7 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,CTTHHHHHTTSCCCSSCCSSSSSCCC,NA
13262,35638842,2022,KKLFKKIK(COC3H7)KYL,KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid},BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,13,Antimicrobial,18 ± 1 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,NA,NA
13263,35638842,2022,KKLfKKILKK(COC3H7)L,KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,11,Antimicrobial,0 ± 0 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,NA,NA
13264,35638842,2022,KKVVFWVKFK,KKVVFWVKFK{ct:Amid},KSL-W,Amidation,Free,Linear,L,None,10,Antimicrobial,20 ± 2 % Hemolysis at 375 µM,Horse,Synthetic,NA,NA,NA,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13265,35638842,2022,RINSAKDDAAGLQIAKKLFKKILKKL,RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid},flg15-BP16,Amidation,Free,Linear,L,None,26,Antimicrobial,5 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13266,35638842,2022,KKLFKKILKKLRINSAKDDAAGLQIA,KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH},BP16-flg15,OH,Free,Linear,L,None,26,Antimicrobial,1 ± 0.5 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13267,35638842,2022,RINSAKDDAAGLQIAKKLFKKILKYL,RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid},flg15-BP100,Amidation,Free,Linear,L,None,26,Antimicrobial,66 ± 9.2 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13268,35638842,2022,KKLFKKILKYLRINSAKDDAAGLQIA,KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH},BP100-flg15,OH,Free,Linear,L,None,26,Antimicrobial,6 ± 1.6 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13269,35638842,2022,RINSAKDDAAGLQIAKKLFKKIK(COC3H7)KYL,RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid},flg15-BP387,Amidation,Acetylation,Linear,L,COC3H7 = butanoyl,26,Antimicrobial,39 ± 2.1 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13270,35638842,2022,KKLFKKIK(COC3H7)KYLRINSAKDDAAGLQIA,KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP387-flg15,OH,Acetylation,Linear,L,COC3H7 = butanoyl,26,Antimicrobial,9 ± 2.5 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13271,35638842,2022,RINSAKDDAAGLQIAKKLfKKILKK(COC3H7)L,RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},flg15-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,46 ± 3.6 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13272,35638842,2022,KKLfKKILKK(COC3H7)LRINSAKDDAAGLQIA,KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH},BP475-flg15,OH,Acetylation,Linear,Mix,COC3H7 = butanoyl,26,Antimicrobial,1 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,NA,NA
13273,35638842,2022,RINSAKDDAAGLQIA-KKVVFWVKFK,RINSAKDDAAGLQIA-KKVVFWVKFK{ct:Amid},flg15-KSLW,Amidation,Free,Linear,L,None,25,Antimicrobial,0 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CTTHHHHGGGHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C
13274,35638842,2022,KKVVFWVKFK-RINSAKDDAAGLQIA,KKVVFWVKFK-RINSAKDDAAGLQIA{ct:OH},KSLW-flg15,OH,Free,Linear,L,None,25,Antimicrobial,8 ± 2.7 % Hemolysis at 375 µM,Horse,Synthetic; Flg15 Conjugates,NA,NA,CTTHHHHHHHHGGGGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13275,35638842,2022,FKLFKKILKVLKKLFKKILKKL,FKLFKKILKVLKKLFKKILKKL{ct:Amid},BP13-BP16,Amidation,Free,Linear,L,None,22,Antimicrobial,93 ± 2.3 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CTTHHHHGGGHHHHTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13276,35638842,2022,KKLFKKILKKLFKLFKKILKVL,KKLFKKILKKLFKLFKKILKVL{ct:Amid},BP16-BP13,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 2.1 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CTTHHHHHHHHTTTSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
13277,35638842,2022,FKLFKKILKVLKKLFKKILKYL,FKLFKKILKVLKKLFKKILKYL{ct:Amid},BP13-BP100,Amidation,Free,Linear,L,None,22,Antimicrobial,100 ± 4.8 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCCCCCCTTTGGGGGTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13278,35638842,2022,KKLFKKILKYLFKLFKKILKVL,KKLFKKILKYLFKLFKKILKVL{ct:Amid},BP100-BP13,Amidation,Free,Linear,L,None,22,Antimicrobial,99 ± 3.7 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSSCCSSHIIIIITHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)CC
13279,35638842,2022,FKLFKKILKVLKKLfKKILKYL,FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid},BP13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 10.6 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGGGGGGGTSCSCTTSSSSCC,NA
13280,35638842,2022,KKLfKKILKYLFKLFKKILKVL,KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid},BP143-BP13,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,22,Antimicrobial,100 ± 7.0 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,NA
13281,35638842,2022,FKLFKKILKVLKKVVFWVKFK,FKLFKKILKVLKKVVFWVKFK{ct:Amid},BP13-KSLW,Amidation,Free,Linear,L,None,21,Antimicrobial,99 ± 8.4 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CGGGGTCGGGGTCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C
13282,35638842,2022,KKVVFWVKFKFKLFKKILKVL,KKVVFWVKFKFKLFKKILKVL{ct:Amid},KSLW-BP13,Amidation,Free,Linear,L,None,21,Antimicrobial,82 ± 10.4 % Hemolysis at 375 µM,Horse,Synthetic; Bp13 Conjugates,NA,NA,CCCCSCCCSSHHHHHHHHHTTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13283,35638842,2022,VWNQPVRGFKVYEKKLFKKILKKL,VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid},Pep13-BP16,Amidation,Free,Linear,L,None,24,Antimicrobial,4 ± 0.2 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CGGGGTCGGGGTCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13284,35638842,2022,KKLFKKILKKLVWNQPVRGFKVYE,KKLFKKILKKLVWNQPVRGFKVYE{ct:OH},BP16-Pep13,OH,Free,Linear,L,None,24,Antimicrobial,2 ± 0.4 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCCCTTTTCCCCSTTCCSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
13285,35638842,2022,VWNQPVRGFKVYEKKLFKKILKYL,VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid},Pep13-BP100,Amidation,Free,Linear,L,None,24,Antimicrobial,49 ± 9.2 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSCCCCCCSSCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13286,35638842,2022,KKLFKKILKYLVWNQPVRGFKVYE,KKLFKKILKYLVWNQPVRGFKVYE{ct:OH},BP100-Pep13,OH,Free,Linear,L,None,24,Antimicrobial,30 ± 3.2 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C
13287,35638842,2022,VWNQPVRGFKVYEKKLfKKILKYL,VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid},Pep13-BP143,Amidation,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,17 ± 0.4 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,NA
13288,35638842,2022,KKLfKKILKYLVWNQPVRGFKVYE,KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH},BP143-Pep13,OH,Free,Linear,Mix,lowercase letters correspond to D-amino acids,24,Antimicrobial,29 ± 0.9 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCCSCC,NA
13289,35638842,2022,VWNQPVRGFKVYEKKVVFWVKFK,VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid},Pep13-KSLW,Amidation,Free,Linear,L,None,23,Antimicrobial,60 ± 1.5 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,CCSSSCCCCCSSCC,CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
13290,35638842,2022,KKVVFWVKFKVWNQPVRGFKVYE,KKVVFWVKFKVWNQPVRGFKVYE{ct:OH},KSLW-Pep13,OH,Free,Linear,L,None,23,Antimicrobial,5 ± 1.0 % Hemolysis at 375 µM,Horse,Synthetic; Pep13 Conjugates,NA,NA,NA,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O
13291,35638842,2022,YGIHTHKKLfKKILKK(COC3H7)L,YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid},PIP1-BP475,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,24 ± 0.5 % Hemolysis at 375 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13292,35638842,2022,KKLfKKILKK(COC3H7)LYGIHTH,KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid},BP475-PIP1,Amidation,Acetylation,Linear,Mix,COC3H7 = butanoyl,17,Antimicrobial,39 ± 2.0 % Hemolysis at 375 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,NA,NA
13293,35638842,2022,YGIHTHKKVVFWVKFK,YGIHTHKKVVFWVKFK{ct:Amid},PIP1-KSLW,Amidation,Free,Linear,L,None,16,Antimicrobial,6 ± 0.4 % Hemolysis at 375 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,CCSTTTHHHHHHHHSCCCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O
13294,35638842,2022,KKVVFWVKFKYGIHTH,KKVVFWVKFKYGIHTH,KSLW-PIP1,Free,Free,Linear,L,None,16,Antimicrobial,5 ± 4.9 % Hemolysis at 375 µM,Horse,Synthetic; Pip1 Conjugates,NA,NA,CCCCHHHHTTTSSSGGGCTTSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O
13432,36009917,2022,GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,GL-29,Free,Free,Linear,L,None,29,Antimicrobial,10 % Hemolysis at 5.86 µM,Horse,Synthetic,α-Helix,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
13433,36009917,2022,GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,GL-29,Free,Free,Linear,L,None,29,Antimicrobial,50 % Hemolysis at 32 µM,Horse,Synthetic,α-Helix,NA,CCSSHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
13434,36009917,2022,GLWNSIKIAGKKLFVNVLDKIR,GLWNSIKIAGKKLFVNVLDKIR{ct:Amid},GL-22,Amidation,Free,Linear,L,None,22,Antimicrobial,10 % Hemolysis at 87.304 µM,Horse,Synthetic,α-Helix,NA,CCSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
13435,36009917,2022,GLWNSIKIAGKKLFVNVLDKIR,GLWNSIKIAGKKLFVNVLDKIR{ct:Amid},GL-22,Amidation,Free,Linear,L,None,22,Antimicrobial,∼6 % Hemolysis at 32 µM,Horse,Synthetic,α-Helix,NA,CCBTTBCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
13436,36009917,2022,GLWNSIKIA,GLWNSIKIA{ct:Amid},GL-9,Amidation,Free,Linear,L,None,9,Antimicrobial,No Hemolysis detected,Horse,Synthetic,α-Helix,NA,CBCCCTTCCSSCHHHHTGGGGTBCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13437,36009917,2022,LFVNVLDKIR,LFVNVLDKIR{ct:Amid},LF-10,Amidation,Free,Linear,L,None,10,Antimicrobial,No Hemolysis detected,Horse,Synthetic,α-Helix,NA,CCCTTTSCSSSCCTTTTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13438,36009917,2022,FVNVLDKIR,FVNVLDKIR{ct:Amid},FV-9,Amidation,Free,Linear,L,None,9,Antimicrobial,10 % Hemolysis at 504.21 µM,Horse,Synthetic,α-Helix,NA,CCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13439,36009917,2022,VNVLDKIR,VNVLDKIR{ct:Amid},VN-8,Amidation,Free,Linear,L,None,8,Antimicrobial,No Hemolysis detected,Horse,Synthetic,α-Helix,NA,CTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13440,36009917,2022,FVNVLDKI,FVNVLDKI{ct:Amid},FV-8,Amidation,Free,Linear,L,None,8,Antimicrobial,No Hemolysis detected,Horse,Synthetic,α-Helix,NA,CCSSHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
13441,36009917,2022,GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,GL-29,Free,Free,Linear,L,None,29,Antimicrobial,100 % Hemolysis at 512 µM,Horse,Synthetic,α-Helix,NA,CCSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
13442,36009917,2022,GLWNSIKIAGKKLFVNVLDKIR,GLWNSIKIAGKKLFVNVLDKIR{ct:Amid},GL-22,Amidation,Free,Linear,L,None,22,Antimicrobial,>80 % Hemolysis at 512 µM,Horse,Synthetic,α-Helix,NA,CCBTTBCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
13443,36009917,2022,GLWNSIKIA,GLWNSIKIA{ct:Amid},GL-9,Amidation,Free,Linear,L,None,9,Antimicrobial,<5 % Hemolysis at 512 µM,Horse,Synthetic,α-Helix,NA,CTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)O
13444,36009917,2022,LFVNVLDKIR,LFVNVLDKIR{ct:Amid},LF-10,Amidation,Free,Linear,L,None,10,Antimicrobial,∼10 % Hemolysis at 512 µM,Horse,Synthetic,α-Helix,NA,CTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13445,36009917,2022,FVNVLDKIR,FVNVLDKIR{ct:Amid},FV-9,Amidation,Free,Linear,L,None,9,Antimicrobial,<5 % Hemolysis at 512 µM,Horse,Synthetic,α-Helix,NA,CTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13446,36009917,2022,VNVLDKIR,VNVLDKIR{ct:Amid},VN-8,Amidation,Free,Linear,L,None,8,Antimicrobial,No Hemolysis detected,Horse,Synthetic,α-Helix,NA,CTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13447,36009917,2022,FVNVLDKI,FVNVLDKI{ct:Amid},FV-8,Amidation,Free,Linear,L,None,8,Antimicrobial,10 % Hemolysis at 504.21 µM,Horse,Synthetic,α-Helix,NA,CTTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
13782,25485686,2015,TrSGxLrEqwIT,TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT,Lysocin E,Free,Free,Linear,Mix,x = D-N-Methylphenylalanine,12,"Antibacterial, Antifungal",<1 % Hemolysis at 100 μg/ml,Horse,Lysobacter,NA,Non-hemolytic,NA,NA
13852,20451254,2010,FLSLIPHIVSGVASIAKHF,FLSLIPHIVSGVASIAKHF{ct:Amid},Phylloseptin-1 (PSN-1),Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Antiparasitic, Hemolytic, Antibiofilm",6.7 % Hemolytic at 5 µM,Horse,"The Waxy Monkey Frog, Phyllomedusa Sauvagei, South America",Helix,NA,CCCCCCCSSCSCCSSSSSCBSSTTCBSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13898,22484288,2012,FLFSLIPSAISGLISAF,FLFSLIPSAISGLISAF{ct:Amid},AamAP2,Amidation,Free,Linear,L,None,17,"Antibacterial Gram+,Antifungal, candidacidal, Hemolytic",~50 % Hemolytic at 100 µM,Horse,"Scorpion Venom, The North African Scorpion, Androctonus Amoreuxi",NA,NA,CCSSSSCSSCSSSCCCSSCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
13911,30802593,2019,FIVPSIFLLKKAFCIALKKC,FIVPSIFLLKKAFCIALKKC,Japonicin-2LF,Free,Free,Linear,L,None,20,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm",>80 % Hemolytic at 64 µM,Horse,"Fujian Large-Headed Frog Skin Secretion, Limnonectes Fujianensis, China, Asia",Helix,NA,CHHHHHHHHTHHHHHHHHHHHCCCSSCCGGGGSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13917,37228702,2023,FLPLLAGLAANFLPQIICKIARKC,FLPLLAGLAANFLPQIICKIARKC,Brevinin-1-AW,Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance",50 % Hemolytic at 23.96 µM,Horse,"Skin Secretion, The Wuyi Torrent Frog, Amolops Wuyiensis, China, Asia",Helix,NA,CCGGGGHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13918,37228702,2023,FLPLLAGLAANFLPKIICKIARKC,FLPLLAGLAANFLPKIICKIARKC,B1AW-K,Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance",50 % Hemolytic at 10.6 µM,Horse,Synthetic Peptide,Helix,NA,CGGGSCTTHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13951,36138742,2022,FLKIIGKLLSGLL,FLKIIGKLLSGLL,VM-3K,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 11.2 µM,Horse,Synthetic Peptide,Helix,NA,CCTHHHHHHHHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13952,36138742,2022,FLGIIGKLLSGLL,FLGIIGKLLSGLL,VM-3G,Free,Free,Linear,L,None,13,"Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 9.7 µM,Horse,Synthetic Peptide,Helix,NA,CCCCHHHHHHHHHHHHHTTTSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13953,36138742,2022,FLWIIGKLLSGLL,FLWIIGKLLSGLL,VM-3W,Free,Free,Linear,L,None,13,"Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 9.7 µM,Horse,Synthetic Peptide,Helix,NA,CTHHHHHHHHGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13965,39204443,2024,FLSLIPHAISAVSALAKHL,FLSLIPHAISAVSALAKHL,Phylloseptin-TO2,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,"Skin Secretion, Super Tiger Leg Monkey Tree Frog, Phyllomedusa Tomopterna, Central America, South America",Helix,NA,CCCCGGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13966,39204443,2024,FLSLIPKAISAVSALAKHL,FLSLIPKAISAVSALAKHL,PSTO2 7K,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 32-64 µM,Horse,Synthetic Peptide,Helix,NA,CCHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13967,39204443,2024,FLSLIPKAISAVSALAKKL,FLSLIPKAISAVSALAKKL,PSTO2 18K,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,Synthetic Peptide,Helix,NA,CCCCCSCHHHHHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13968,39204443,2024,FLSLIPKAIKAVSALAKKL,FLSLIPKAIKAVSALAKKL,PSTO2 SR (Phylloseptin-TO2 analog),Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,Synthetic Peptide,Helix,NA,CCCGGGGHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13969,39204443,2024,FLSLIPKAIKAVKALAKKL,FLSLIPKAIKAVKALAKKL,PSTO2 SR2 (Phylloseptin-TO2 analog),Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCCSSTHHHHHHHHHHTSSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13970,39138237,2024,FLPFLASLALKIL,FLPFLASLALKIL{ct:Amid},"Temporin-WY2 (Natural AMPs, Leu-rich, frog, amphibians, animals, XXA, UCLL1c)",Amidation,Free,Linear,L,None,13,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32-64 µM,Horse,"Cutaneous Secretion, The Ranidae Frog, Amolops Wuyiensis, China, Asia",Helix,NA,CCCCCCSTTHHHHHHHTSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13971,39138237,2024,FLPKLLSALAKIL,FLPKLLSALAKIL{ct:Amid},"QUB-1426 (Synthetic AMPs, Temporin-WY2 analog, Leu-rich, XXA, UCLL1c",Amidation,Free,Linear,L,None,13,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 16-32 µM,Horse,Synthetic Peptide,Helix,NA,CCCCCCGGGGGGTTTCSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13972,39138237,2024,KKKKKKFLPFLASLALKIL,KKKKKKFLPFLASLALKIL{ct:Amid},"6K-WY2 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c",Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCSSCCCHIIIIIHHHHSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13973,39138237,2024,KKKKKKFLPKLLSALAKIL,KKKKKKFLPKLLSALAKIL{ct:Amid},"6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c)",Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCCCGGGGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13974,39345903,2024,FFPIVAGVAAKVLKKIFCTISKKC,FFPIVAGVAAKVLKKIFCTISKKC,"Brevinin-1pl (natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a; BBL)",Free,Free,Linear,L,None,24,"Antibacterial, Anticancer, Anti-MRSA, Hemolytic",50 % Hemolytic at 37.64 µM,Horse,"Skin Secretions, The Northern Leopard Frog, Rana Pipiens, North America",Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)O
13975,39345903,2024,FFPKVAGVAAKVLKKIFCTISKKC,FFPKVAGVAAKVLKKIFCTISKKC,"[Lys4] brevinine-1pl (brevinine-1pl I4K analog, Synthetic AMPs, XXU; 1S=S, UCSS1a)",Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic",50 % Hemolytic at 80.77 µM,Horse,Synthetic Peptide,Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)O
13976,39345903,2024,FFPKVAGVAAKVAKKIFCTISKKC,FFPKVAGVAAKVAKKIFCTISKKC,"[Lys4, Ala13] brevinine-1pl (brevinine-1pl I4K,L13A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a)",Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 41.34 µM,Horse,Synthetic Peptide,Helix,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)[C@@H](C)O
13977,39345903,2024,FFPKVAGVAAKVLKKAFCTISKKC,FFPKVAGVAAKVLKKAFCTISKKC,"[Lys4, Ala16] brevinine-1pl (brevinine-1pl I4K,I16A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a",Free,Free,Linear,L,None,24,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic",50 % Hemolytic at 84.86 µM,Horse,Synthetic Peptide,Helix,NA,CCSTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13992,29649486,2018,MNRLIILCLVAATIYSTIALPMKEDISNEERPTSVNEKPVKKSVAVAGAVIQGAALAFQVLDKILTSLGGIGRKIAIGVDNESGMKWAARNVYFYSGTSDTVLPYSVPHSKAFLYGARKTRGSVRGAVGVLAYSMSDGNTLGILFSVPYDYNWYSNWWNIKVYRGYKRANKWMYHDLYYYARPHKGNNEWHEKSLGYGLKSKGFMTSSGQTKLEIRVSRA,MNRLIILCLVAATIYSTIALPMKEDISNEERPTSVNEKPVKKSVAVAGAVIQGAALAFQVLDKILTSLGGIGRKIAIGVDNESGMKWAARNVYFYSGTSDTVLPYSVPHSKAFLYGARKTRGSVRGAVGVLAYSMSDGNTLGILFSVPYDYNWYSNWWNIKVYRGYKRANKWMYHDLYYYARPHKGNNEWHEKSLGYGLKSKGFMTSSGQTKLEIRVSRA,Deep-sea actinoporin Cjtox I (DELTA-actitoxin-Cja1a) (DELTA-AITX-Cja1a),Free,Free,Linear,L,None,220,Cytolytic,Hemolytic,Horse,Cribrinopsis Japonica (Deep-Sea Anemone),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC
14006,21624426,2011,FIKELLPHLSGIIDSVANAIK,FIKELLPHLSGIIDSVANAIK{ct:Amid},Kasstasin,Amidation,Free,Linear,L,None,21,Antimicrobial,12.8 % Hemolytic at 128 µM,Horse,Phlyctimantis Maculatus (Red-Legged Running Frog) (Hylambates Maculatus),NA,Low hemolytic,CTTHHHHHHHTCCCCSTTTTCCTTSSCCCSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
14027,19101583,2008,ADDKNPLEECFRETDYEEFLEIARNGLKATSNPKRVV,ADDKNPLEECFRETDYEEFLEIARNGLKATSNPKRVV,L-amino-acid oxidase (BjarLAAO-I) (LAO) (EC 1.4.3.2),Free,Free,Linear,L,None,37,Antimicrobial,Hemolytic,Horse,Bothrops Jararaca (Jararaca) (Bothrops Jajaraca),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
14058,27792198,2016,MAFLKKSLFLVLFLGLVNLSICEEEKREEENKEEEDENEALSEVKRGFLEKLKTGAKDFASAFVNSIKGT,MAFLKKSLFLVLFLGLVNLSICEEEKREEENKEEEDENEALSEVKRGFLEKLKTGAKDFASAFVNSIKGT{ct:Amid},Frenatin 4.1 [Cleaved into: Frenatin 4.2],Amidation,Free,Linear,L,None,70,Antimicrobial,<5 % Hemolytic at 512ug/ml,Horse,Nyctimystes Infrafrenatus (White-Lipped Tree Frog) (Litoria Infrafrenata),NA,Non-hemolytic,CCCCCCCCCGGGGHHHHTTSSSCCSSCCSCCCTTSCSGGGTCGGGHHHHHHHHHHHHHHHHSSSSCSCSCSSCCCSSSSSCCTTTSCCSSSCCSSCSSCGGGCCSSCCSSSCSSSCGGGGHHHHGGGTSCCCCTTSCCCCCCCCCCCCCSSCSSCCSTTCCCCTTTGGGTSCSSSCCSCSSSCGGGGTTTCCCCCCCCCCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O
14061,28469603,2017,MAFLKKSLFLVFFLGFVSLSICEEEKRETDEKENEQEDDREERSEEKRLLGMIPVAITAISALSKLG,MAFLKKSLFLVFFLGFVSLSICEEEKRETDEKENEQEDDREERSEEKRLLGMIPVAITAISALSKLG{ct:Amid},Medusin-PT,Amidation,Free,Linear,L,None,67,Antimicrobial,50 % Hemolytic at 1.814 × 10^6μg/ml,Horse,Phyllomedusa Tarsius (Brownbelly Leaf Frog) (Phyllomedusa Tarsia),NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O
14062,29649486,2017,MNRLIIVCLVAAMIYSTIALPMKEDISNDERPISVNEEPVKKNAAVAGAVIQGATLTFQVLDRILTVLGDISRKIAIGVDNESGRKWTAKNAYFFSGTSDVVLPYSVPNGKAFLYDGKKTRGPVATGAVGVLAYSMSDGNTLGILFSVPYDYNWYENWWNIKVYSGSKRANKWMYENLYYNASPHKGDNGWHEKSLGYGLKSRGYMASSGQTKLEIRVTRA,MNRLIIVCLVAAMIYSTIALPMKEDISNDERPISVNEEPVKKNAAVAGAVIQGATLTFQVLDRILTVLGDISRKIAIGVDNESGRKWTAKNAYFFSGTSDVVLPYSVPNGKAFLYDGKKTRGPVATGAVGVLAYSMSDGNTLGILFSVPYDYNWYENWWNIKVYSGSKRANKWMYENLYYNASPHKGDNGWHEKSLGYGLKSRGYMASSGQTKLEIRVTRA,Deep sea actinoporin Cjtox II (DELTA-actitoxin-Cja1b) (DELTA-AITX-Cja1b),Free,Free,Linear,L,None,221,Antimicrobial,Hemolytic,Horse,Cribrinopsis Japonica (Deep-Sea Anemone),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C
14069,22232283,2011,MRTLTLLTALLLLALQVQTQSLEETADQVPAQDQPGAEAQDITISFAGDERSAREASKSLIGTASCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR,MRTLTLLTALLLLALQVQTQSLEETADQVPAQDQPGAEAQDITISFAGDERSAREASKSLIGTASCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR,Alpha-defensin 1,Free,Free,Linear,L,None,98,Antimicrobial,<3 % Hemolytic at 100 μg/ml,Horse,Equus Caballus (Horse),NA,Non-hemolytic,CCGGGGTTTTTCSTTHHHHHHHTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O
14209,15777955,2005,IGGIISFFKRLF,IGGIISFFKRLF,Grammistin Gs B,Free,Free,Linear,L,None,12,Antibacterial,Hemolytic at <10HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,Non-hemolytic,CTHHHHTTTTTSSSTTTTTSCCSCC,CC[C@H](C)[C@H](N)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
14210,15777955,2005,FIGGIISFFKRLF,FIGGIISFFKRLF,Grammistin Gs D,Free,Free,Linear,L,None,13,Antibacterial,Hemolytic at 79HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,NA,CCCSSSSSSSHHHHTSCSSCCCCSTTCCCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
14211,15777955,2005,FIGGIISFIKKLF,FIGGIISFIKKLF,Grammistin Gs E,Free,Free,Linear,L,None,13,Antibacterial,Hemolytic at 63HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,NA,CCTHHIIIIIHHHHSCTTGGGCSSSSCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
14212,15777955,2005,WWRELLKKLAFTAAGHLGSVLAAKQSGW,WWRELLKKLAFTAAGHLGSVLAAKQSGW,Grammistin Gs A,Free,Free,Linear,L,None,28,Antibacterial,Hemolytic at <10HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,Non-hemolytic,CCGGGHHHHHHHHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
14213,15777955,2005,NWRKILGKIAKVAAGLLGSMLAGYQV,NWRKILGKIAKVAAGLLGSMLAGYQV,Grammistin Gs C,Free,Free,Linear,L,None,26,Antibacterial,Hemolytic at <10HU/mg,Horse,Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata),NA,Non-hemolytic,CCTHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C